Save Time Watering on a Busy Schedule

Watering a lawn or garden doesn’t have to inconvenience a daily schedule. Gilmour watering products and accessories are designed to save time and effort, so achieving a lush lawn or garden is just as easy as it is smart.Investing in a premium garden hose spares the time spent untangling kinks and repairing leaks. The Gilmour Flexogen® hose is the strongest and lightest hose in its class and is designed to be kink resistant for a more time-effective watering experience.Managing a watering schedule can be easier with an automatic process. The Dual Outlet Electric Water Timer saves the time needed to manage watering schedules by turning on and off by itself. Simply connect the hose, enter a time, and press “on.” The timer will automatically shut off when finished, reducing the need to monitor manually. To further improve efficiency, connect a second hose to the timer to water another area of the yard simultaneously.Irregular-shaped lawns don’t need to be time-consuming to water. Investing in a sprinkler like the Gilmour Adjustable Pattern Master Circular Sprinklermakes precisely watering an irregular area easy with a few quick adjustments. Simply pull the 12 pegs up or down to shorten or lengthen the spray distance.Maintaining a lawn and garden can be quicker and easier with more efficient tools, like the Gilmour Heavy Duty Quick Connector Set. It’s a set of snap-on, snap-off connectors that makes attaching watering tools to hoses as simple as a pull or push, rather than a twist.Time doesn’t need to be wasted alternating nozzles. The Gilmour Thumb Control Watering Nozzle has eight watering patterns in one, so switching from flower to rinse is as easy as the flick of the thumb, not the swap of a nozzle.

Hunter Group ASA: Private placement completed

Oslo, 15 February 2018: Reference is made to the announcement by Hunter Group ASA ("Hunter Group" or the "Company") published earlier today regarding the private placement of NOK 75,000,000 (the "Private Placement"). The Private Placement is carried out to satisfy one of the conditions for completion of the direct and indirect acquisition of all shares in IKM Subsea Holding AS, IKM Subsea AS and IKM Technology AS (the "IKM Subsea & Technology Group") (the "Transaction").The board of directors of the Company (the "Board of Directors") is pleased to announce that the Private Placement has been successfully completed raising NOK 75 million in gross proceeds through the conditional allocation of 33,333,334 new shares in the Company at a subscription price of NOK 2.25 per share (the "Offer Shares"). The net proceeds from the Private Placement will be used to partly finance the acquisition of the IKM Subsea & Technology Group and partly for general corporate purposes. The completion of the Private Placement is conditional upon the Company's shareholders passing the required corporate resolutions to issue the Offer Shares at an extraordinary general meeting expected to be held on or about 15 March 2018 (the "EGM") and fulfilment of the conditions for completion of the Transaction. The Offer Shares issued in the Private Placement will not be tradable before the shares have been fully paid and registered with the Norwegian Central Securities Depository (the "VPS"). The Offer Shares will when issued rank equal in all respects to the existing shares of the Company and will, following approval and publication of a listing prospectus, be listed on Oslo Axess. Pending such listing, the Offer Shares will be registered on a separate ISIN and not be listed or tradable on Oslo Axess.  Following issuance of the Offer Shares, the issued share capital of the Company will consist of 164,491,347 shares, each with a nominal value of NOK 1.25. Following the completion of the Transaction, the total number of shares outstanding will be 213,039,454. In order to complete the Private Placement, the Board of Directors will propose to the EGM that existing shareholders' pre-emptive rights to subscribe for the new shares are set aside. The Board of Directors believes that this is in the best interest of the Company and its shareholders as it is necessary to facilitate the Transaction.  Further, the Company's Board of Directors contemplates to carry out a subsequent equity offering for a total subscription amount of NOK 10 million (the "Repair Issue"), in which the existing shareholders of the Company as of close of trading on 15 February 2018, as recorded in the VPS on 19 February 2018, who have not been allocated shares in the Private Placement and who are not resident in a jurisdiction where such offering would be unlawful or, for jurisdictions other than Norway, would require any prospectus, filing, registration or similar action, will be allowed to participate. The subscription price in the Repair Issue will be equal to the subscription price in the Private Placement. For these purposes, the Board of Directors will use the authorisation granted at the Company's extraordinary general meeting on 31 May 2017.  A separate announcement will be made today setting out key information for the repair issue.  ABG Sundal Collier ASA and DNB Markets have acted as joint lead managers and joint bookrunners in connection with the Private Placement. This information is subject to disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. Important information This press release is for information purposes only and shall not constitute or be construed as an offer to buy, sell, issue, or subscribe for, or the solicitation of an offer to buy, sell, issue, or subscribe for any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. Copies of this announcement are not being made and may not be distributed or sent into the Australia, Canada, Japan, the United States or any other jurisdiction in which such distribution would be unlawful or would require registration or other measures. The securities referred to herein have not been and will not be registered under the U.S. Securities Act, or any state securities laws, and will be sold within the United States only to qualified institutional buyers ("QIB"), as defined in Rule 144A under the U.S. Securities Act ("Rule 144A"), through affiliates of the Managers, in reliance upon the exemption from the registration requirements provided by section 4(2) of the U.S. Securities Act Rule 144A, and to certain non-U.S. persons in offshore transactions in reliance on Regulation S under the U.S. Securities Act. The securities to be offered will be subject to certain restrictions on transfer. Certain statements contained herein that are not statements of historical fact, may constitute forward looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause the actual results or events concerning the Company to be materially different from the historical results or from any future results expressed or implied by such forward looking statements. None of the Company, the Managers or any of their affiliates or advisors provide any assurance that the assumptions underlying such forward-looking statements are free from errors nor do any of them accept any responsibility for the future accuracy of the opinions expressed in this press release or the actual occurrence of the forecasted developments. Except as may be required by applicable law or stock exchange regulation, neither the Company nor the Managers, or any of their affiliates or advisors, assume any obligation to update any forward-looking statements or to confirm these forward-looking statements to actual results.

Nel ASA: Fourth Quarter 2017 Results

(Oslo, 16 February 2018) Nel ASA (“Nel”) reported revenues in the fourth quarter of 2017 of NOK 111.9 million, up from NOK 50.6 million in the fourth quarter of 2016. The company entered into an exclusive partnership with Nikola Motor Company (“Nikola”) during the quarter and is evaluating a possible 10x capacity expansion to accommodate mega-scale orders and to maintain a leading cost position. “Looking back at 2017, I am pleased to see that the ambitions we set out to significantly accelerate the market activities have succeeded. We ended the year with an all-time high order backlog of NOK 465 million and have entered into exciting partnerships with companies such as H2V Product and Nikola Motor. We expect to continue our market development efforts in 2018, while moving into a mode of execution. This includes preparing for significant capacity expansions to accommodate large orders and to continue to build the organization,” says Jon André Løkke, Chief Executive Officer of Nel. In the fourth quarter of 2017, Nel reported revenues of NOK 111.9 million, compared to NOK 50.6 million in the same quarter of 2016, representing a revenue growth of 120 percent. The underlying organic revenue growth for the full year was around 40 percent, excluding Proton Onsite. The high activity level within business development, investments and preparations for production ramp-up continued as planned. Also in the fourth quarter, the EBITDA was negatively affected by certain costs and ended at NOK -11.1 million, when adjusting for ramp-up costs and non-recurring items of NOK 10.9 million, in addition to non-cash share option costs of NOK 5.7 million. Following new US tax rules, the reported net profit ended at a positive NOK 22.7 million for the quarter. The net cash balance at the end of the fourth quarter increased from NOK 85.6 million to NOK 295.0 million, as a result of positive net cash flow from operations of NOK 2.7 million and the private placement, including a subsequent offering, of 98,000,000 new shares at a price of NOK 2.50 per share. During the fourth quarter, Nel entered into exclusive partnership agreement with Nikola for development of mega-scale hydrogen fueling stations for the potential construction of the world’s largest hydrogen network, consisting of 14 large-scale sites with a capacity up to 32 tons of hydrogen per day. The initial part of the partnership includes building two demo-stations for hydrogen fueling, which will serve the Nikola prototype fleet. The initial purchase order has a value of USD 3.6 million and delivery of the demo stations is intended to start in the second half of 2018. “We were very pleased to announce the partnership with Nikola. This joint endeavor will leverage Nel's highly scalable electrolyzers and targets to reduce the cost of renewable hydrogen to achieve price parity with fossil fuels. The network will be jointly developed and scaled into the world's most efficient hydrogen production and fueling sites,” says Løkke. Nel’s order backlog further increased to approximately NOK 465 million in the quarter. Following the Nikola partnership, in addition to the previously announced framework agreement with H2V Product, a subsidiary of Alain Samson owned SAMFI-INVEST Group, Nel is currently evaluating a 10x expansion of the production capacity at Notodden, Norway from 25MW to 250MW. “We are evaluating a capacity expansion that will reduce our costs by more than 30% by developing a fully automated, large-scale production line at Notodden. Driving down cost will not only allow us to maintain a leading cost position, but also enable us to offer renewable hydrogen projects that are fully competitive with fossil alternatives,” says Jon André Løkke, and adds that the initial capacity increase and debottlenecking from 25MW to 40 MW is about to be completed at minimal cost. Nel will host a presentation at 08:00 CET at Hotel Continental in Oslo on February 16, 2018. A live webcast of the call will also be available on the company’s website, www.nelhydrogen.com/webcast, and on   http://webtv.hegnar.no/presentation.php?webcastId=77872733 The fourth quarter 2017 report and presentation will be made available through www.newsweb.no (Ticker: NEL) and www.nelhydrogen.com ENDS For further information, please contact: Jon André Løkke, CEO, Nel ASA, +47 907 44 949 Bent Skisaker, CFO, Nel ASA, +47 468 21 693 About Nel ASA | www.nelhydrogen.com        Nel is a global, dedicated hydrogen company, delivering optimal solutions to produce, store and distribute hydrogen from renewable energy. We serve industries, energy and gas companies with leading hydrogen technology. Since its foundation in 1927, Nel has a proud history of development and continual improvement of hydrogen plants. Our hydrogen solutions cover the entire value chain from hydrogen production technologies to manufacturing of hydrogen fueling stations, providing all fuel cell electric vehicles with the same fast fueling and long range as conventional vehicles today.

Solteq Plc: Solteq Plc publishes its 2017 annual report and financial statements

Solteq Plc  Stock Exchange Bulletin 16.2.2018 at 8.00 am Solteq’s annual report 2017 and financial statements for the accounting period 1 January - 31 December 2017 have been published in English and Finnish. The annual report consists of the Annual review 2017 and the Financial review 2017. The financial review includes the Board of Directors’ report, the financial statements, the auditors’ report and the corporate governance statement. The annual report is available from the company website https://www.solteq.com/en/investors/. It can also be found as appendix of this bulletin. Appendices Solteq Plc. Annual Report and Financial Statement 2017 Further information Olli Väätäinen, CEOtel +358 50 5578 111e-mail olli.vaatainen@solteq.com Antti Kärkkäinen, CFO tel. +358 40 8444 393 e-mail antti.karkkainen@solteq.com DISTRIBUTION NASDAQ OMX HelsinkiKey mediawww.solteq.com Solteq in brief Solteq is a Nordic industry independent IT and software house that specialises in business solutions. We offer total solutions for both business enhancement by means of digitalisation and for omnicommerce: from back end processes all the way to the customer’s purchasing experience and from supply chain management to digital marketing. Our more than 500 experts, who work in five countries, develop and implement solutions for clients in Europe, North America, Asia and Australia. In 2017 Solteq’s net sales amounted to 62 million euro.

First patient enrolled in pivotal Phase 3 FOCuS trial evaluating WTX101 for the treatment of Wilson Disease

Wilson Therapeutics (publ) today announced that the first patient has been enrolled in the pivotal Phase 3 FOCuS clinical trial evaluating WTX101 (bis-choline tetrathiomolybdate), an investigational first-in-class copper-protein-binding agent with a unique mechanism of action, for the treatment of Wilson Disease. FOCuS is a randomized, controlled, rater-blinded, multi-center study that will enroll approximately 100 Wilson Disease patients, aged 18 years or over, to receive once-daily WTX101 or standard of care. The primary endpoint will be copper control assessed as the percentage change in free copper levels in blood from baseline to 48 weeks. Top-line data from the study is expected to be released H2 2019. Carl Bjartmar, MD, PhD, Chief Medical Officer, Wilson Therapeutics commented: “The start of the FOCuS study represents an important milestone for Wilson Therapeutics as well as for patients and families affected by Wilson Disease, as WTX101 has the potential to become the first new medicine for this serious disorder in several decades. Through its novel mode of action with its high affinity and specificity to copper, WTX101 detoxifies excess copper in the liver and in the blood by forming stable tripartite complexes with copper and albumin that are then cleared through bile, the natural elimination route of copper. This unique approach to copper control has the potential to improve symptoms and associated disabilities in Wilson Disease patients, which was demonstrated in our successful Phase 2 trial. The Phase 3 FOCuS study is the first randomized controlled trial ever conducted to support approval of a new treatment option for Wilson Disease and we look forward to further evaluating the differentiated profile of WTX101 in this head-to-head study versus standard of care.” The first patient was enrolled at the University of Michigan. Frederick K. Askari, MD, PhD, Associate Professor and Director of the Wilson Disease program at the University of Michigan, added: “WTX101 has shown great promise and I am excited to be part of the team advancing it through the clinic. The profile of this investigational drug is very encouraging, particularly the rapid control of clinical symptoms in combination with the simple once-daily dosing regimen and its promising side effect profile which could help improve compliance to therapy and treatment outcomes as a result. WTX101’s unique potential to remove copper from the saturated copper stores in the liver is also very encouraging. If the results of the Phase 2 study are replicated in this Phase 3 trial and the product gains regulatory approval, I am confident WTX101 will have the potential to make a significant difference for the Wilson Disease community.” About the FOCuS studyThe Phase 3 FOCuS clinical trial is a randomized, controlled, rater-blinded, multi-center study assessing the efficacy and safety of WTX101 monotherapy administered once daily for 48 weeks, compared to standard of care (SoC), in patients with Wilson Disease aged 18 years and older. The study will enroll approximately 100 patients with hepatic and/or neurological symptoms, who are treatment naïve, or have previously received SoC therapy. Approximately 25% of the patients enrolled are expected to be treatment naïve, or to have received SoC therapy for <28 days. Patients will be randomized in a 2:1 ratio to receive treatment with WTX101 or SoC. The study is designed to show non-inferiority versus SoC and the primary endpoint will be copper control assessed as the percentage change in free copper levels in blood from baseline (day 1) to 48 weeks. If non-inferiority is met superiority will be assessed. Free copper in blood will be measured as non-ceruloplasmin-bound copper, corrected for the amount of copper bound in tripartite tetrathiomolybdate-copper-albumin complexes (NCCcorrected). Additional endpoints will include clinical (hepatology, neurology, disease related disability, psychiatry) and quality of life related endpoints, and safety of WTX101. The study will be conducted at approximately 30 sites in the US, EU and Israel. Patients completing the Phase 3 study through 48 weeks will be offered continued WTX101 treatment in an extension phase. Further information about the study, including eligibility requirements, is available at www.clinicaltrials.gov [study ID: WTX101-301; clinicaltrials.gov identifier NCT03403205]. About WTX101 (bis-choline tetrathiomolybdate)WTX101 (bis-choline tetrathiomolybdate) is a first-in-class copper-protein-binding agent with a unique mechanism of action, under investigation as a novel therapy for Wilson Disease. In contrast to current treatments, WTX101 provides an alternative copper-protein binding mechanism by forming a tripartite complex with copper and albumin. WTX101 thereby detoxifies excess copper in both liver and blood, and promotes copper clearance through biliary excretion (the body’s natural route of elimination). A Phase 2 study evaluating the efficacy and safety of WTX101 in patients with Wilson Disease has successfully been completed. In addition, the active moiety of WTX101, tetrathiomolybdate, has been tested in several previous clinical studies in Wilson Disease patients. The data from these studies suggest that WTX101 can reduce and control free copper levels and improve symptoms and associated disabilities. The data also suggest that WTX101 is generally well tolerated with a low risk of drug-induced neurological worsening. The tolerability profile and the expected once-daily dosing regimen have the potential to improve compliance in Wilson Disease patients, leading to fewer treatment failures and ultimately improved outcomes. WTX101 has received Fast Track designation in the US and orphan drug designation for the treatment of Wilson Disease in the US and EU. In addition, WTX101 has shown potential as a treatment for several other medical conditions including Amyotrophic Lateral Sclerosis (ALS). WTX101 has received US orphan drug designation for the treatment of ALS. About Wilson DiseaseCopper is an essential trace element that plays a critical role in key physiological cellular processes. Due to its toxic potential, copper is normally tightly bound to copper-carrying proteins inside the liver, and excess copper is eliminated from the body via biliary excretion. Wilson Disease is a rare genetic disorder of impaired copper transport and excretion, caused by loss of function of the ATP7B copper-binding protein. This leads to copper overload in the liver, release of free copper into the blood, and damaging accumulation of copper in the brain and other organs. Untreated Wilson Disease inevitably leads to various combinations and severity of hepatic, neurologic and psychiatric symptoms, and is ultimately fatal. Wilson Disease affects approximately one in every 30,000 people worldwide, corresponding to a prevalence of approximately 10,000 patients in the US and 15,000 patients in the EU. The therapies currently being used in Wilson Disease were introduced in the 1950s and 60s. Since then, no new treatment options have been developed and considerable unmet medical needs still exist. About Wilson TherapeuticsWilson Therapeutics is a biopharmaceutical company, based in Stockholm, Sweden, that develops novel therapies for patients with rare copper-mediated disorders. Wilson Therapeutics’ lead product, WTX101, is in Phase 3 development as a novel treatment for Wilson Disease. Wilson Therapeutics is listed in the Mid Cap segment on Nasdaq Stockholm with the stock ticker WTX. Visit www.wilsontherapeutics.com for more information. For further information please contact: Jonas Hansson, CEO, Wilson Therapeutics ABPhone:     +46 8 796 00 00E-mail:    jonas.hansson@wtx.se Lauren Williams, Head of Investor Relations, Wilson Therapeutics ABPhone:     +44 7958 669 896 E-mail:    lauren.williams@wtx.se Wilson Therapeutics AB (publ)Corp. Reg. No.556893-0357Kungsgatan 3SE-111 43 Stockholm The information in the press release is information that Wilson Therapeutics is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 07.00 CET on February 16, 2018.

Solteq Plc: Financial Statements Bulletin 1 January - 31 December 2017 (IFRS)

Solteq Plc Stock Exchange Bulletin 16.2.2018 at 8.00 am We want to simplify the digital world to make a better tomorrow · Revenue totalled 61.5 million euros (63.0 million euros). · Operating profit was 322 thousand euros (6,444 thousand euros). · The adjusted operating profit was 2,115 thousand euros (3,114 thousand euros). · Solteq Group’s equity ratio was 33.7 % (33.5 %). · Earnings per share was -0.08 euros (0.26 euros). · During the past year, we have become a Nordic industry-independent operator that specialises in digital business solutions. Our mission is to simplify the digital world to make a better tomorrow. · The Board of Directors proposes to the Annual General Meeting that for the financial year 2017, no dividends will be paid out. Key figures and ratios +---------------------+-----+-----+---------+-----------+-----------+---------+| |10 |10 |Change -%|1-12 / 2017|1-12 / 2016|Change -%|| |-12/ |-12/ | | | | || |2017 |2016 | | | | |+---------------------+-----+-----+---------+-----------+-----------+---------+|Revenue, EUR million |16,1 |17,7 |-9,2 % |61,5 |63,0 |-2,4 % |+---------------------+-----+-----+---------+-----------+-----------+---------+|Adjusted operating |0,4 |0,9 |-57,9 % |2,1 |3,1 |-32,1 % ||profit, EUR million | | | | | | |+---------------------+-----+-----+---------+-----------+-----------+---------+|Operating profit, EUR|-0,0 |0,7 |-103,0 % |0,3 |6,4 |-95,0 % ||million | | | | | | |+---------------------+-----+-----+---------+-----------+-----------+---------+|Profit for the |-0,5 |0,2 |-342,7 |-1,5 |4,6 |-132,5 % ||financial period, EUR| | | | | | ||million | | | | | | |+---------------------+-----+-----+---------+-----------+-----------+---------+|Earnings/share, eur |-0,08|0,00 |-900,0 % |-0,08 |0,26 |-130,8 % |+---------------------+-----+-----+---------+-----------+-----------+---------+|Operating profit -% |-0,1 |4,0 %| |0,5 % |10,2 % | || |% | | | | | |+---------------------+-----+-----+---------+-----------+-----------+---------+|Adjusted operating |2,4 %|5,1 %| |3,4 % |4,9 % | ||profit -% | | | | | | |+---------------------+-----+-----+---------+-----------+-----------+---------+|Equity ratio, % |33,7 |33,5 | |33,7 % |33,5 % | || |% |% | | | | |+---------------------+-----+-----+---------+-----------+-----------+---------+ Olli Väätäinen, CEO of Solteq: Growth for the future through internationalisation  During the past year, we have grown to become a Nordic industry-independent IT provider and software house that specialises in digital business solutions. Our mission is to simplify the digital world to make a better tomorrow.  The review period was challenging. We balanced our business operations by reorganising and cost reduction. These actions will have a positive impact for the outcome of the upcoming financial years. The outcomes of the previous quarters were burdened by the maintenance of the certain large scale projects, investing in our business operations in Sweden as well as increased subcontracting. Despite the challenging year, we succeeded in expanding our operations by acquisitions. We estimate that one fifth of our revenue will come from outside Finland in 2018. In addition to organic growth, acquisitions have played a significant role in our internationalisation. We completed the integration of our Swedish subsidiary, Aponsa AB, in an operative sense by combining our previous Swedish operations to create a single entity.  We took a significant step on our path of Nordic growth in the final quarter of 2017 by agreeing to acquire the entire share capital of TM United A/S. The acquisition saw us expand our operations into the Danish and Norwegian markets. TM’s solutions are focused on digital transactions and the optimisation of the online customer experience. In addition to supporting our international growth, the acquisition complements our product offering with a new component that is an excellent fit with our strategy: the Deep Vision cloud service, which facilitates the development of online services driven by the customer experience.  We have stated trying to increase the share of revenue generated by cloud services and other continuity services in our solution offering. Revenue from cloud services is expected to see significant growth in the coming years. We are also focusing on the development of our own software products and services. The share of revenue represented by continuous services will be reported separately starting from the beginning of the year. We estimate that this will account over one fourth of our revenue this year. We are especially active in areas that enable us to incorporate artificial intelligence and robotics into our products and services. In 2017, our product development investments amounted to 333 thousand euros, centering around the last half of the year. Our operations are based on the expertise and competencies of Solteqians. Early in the year, we announced our aim of recruiting 100 new professionals during 2017. We achieved this target.  I am confident that we will improve our profitability significantly in 2018. Our business outlook for the early part of the year is strong and the full effect of the cost reduction measures we implemented in 2017 will be seen this year. Guidance on Group outlook Solteq Group’s adjusted operating profit is expected to grow significantly compared to the financial year 2017. Attachments Solteq Plc. Financial Statements Bulletin 2017 Further information Olli Väätäinen, CEO, tel. +358 50 5578 111 Antti Kärkkäinen, CFO, tel. +358 40 8444 393 DISTRIBUTION NASDAQ OMX Helsinki Major media www.solteq.com Solteq in brief Solteq is a Nordic industry independent IT and software house that specialises in business solutions. We offer total solutions for both business enhancement by means of digitalisation and for omnicommerce: from back end processes all the way to the customer’s purchasing experience and from supply chain management to digital marketing. Our more than 500 experts, who work in five countries, develop and implement solutions for clients in Europe, North America, Asia and Australia. In 2017 Solteq’s net sales amounted to 62 million euro.

Solteq Plc: Notice to the annual general meeting of shareholders 27 March 2018

Solteq Plc Stock Exchange Bulletin 16.2.2018 at 8.00 am. Shareholders of Solteq Plc are hereby invited to the Annual General Meeting of Shareholders to be held on 27 March, 2018 at 10 a.m. in the Clarion Hotel Helsinki Airport, address Karhumäentie 5. The reception of the shareholders registered for the meeting begins at 9.30 a.m. A. Matters on the agenda of the General Meeting At the general meeting, the following matters will be considered: 1. Opening of the meeting 2. Calling the meeting to order 3. Election of persons to scrutinize the minutes and to supervise the counting of votes 4. Recording the legality of the meeting 5. Recording the attendance at the meeting and adoption of the list of votes 6. Presentation of the annual accounts, the report of the board of directors and the auditor’s report for the year 2017 Review by the CEO 7. Adoption of the annual accounts 8. Resolution on the use of the profit shown on the balance sheet and the payment of dividend The Board of Directors proposes to the General Meeting that no dividend will be paid from the financial period 2017. 9. Resolution on the discharge of the members of the board of directors and the CEO from liability 10. Resolution on the remuneration of the members of the board of directors 11. Resolution on the number of members of the board of directors 12. Election of members of the board of directors 13. Resolution on the remuneration of the auditor 14. Election of auditor 15. Authorizing the board of directors to decide on the issuance of shares as well as the issuance of options and other special rights entitling to shares The board of directors proposes that the board of directors is authorized to decide on share issue, carried out with or without payment and on issuing share options, and other special rights referred to in Chapter 10, Section1 of the Finnish Companies Act as follows: The maximum total amount of shares or other rights is 5.000.000. The authorization includes the right to give new shares or convey company’s own shares. The authorization includes a right to deviate from the shareholders’ pre-emptive right of subscription if there is a significant reason in company’s opinion, e.g. to improve the capital structure, to finance and execute business acquisitions and other business improvement arrangements or to be used as a part of remuneration of personnel. The authorization includes that the board of directors may decide the terms and other matters concerning the share issue The authorization is effective until the next Annual General Meeting, however, no longer than until April 30, 2019. 16. Closing of the meeting B. Documents of the general meeting The proposals for the decisions on the matters on the agenda of the general meeting as well as this notice are available on Solteq Plc’s website. The annual report, the report of the board of directors and the auditor’s report of Solteq Plc, are available on the above-mentioned website no later than February 19, 2018. The proposals for decisions and the other above-mentioned documents are also available at the meeting. Copies of these documents and of this notice will be sent to shareholders upon request. C. Instructions for the participants in the general meeting 1. Shareholders registered in the shareholders’ register Each shareholder, who is registered on March 15, 2018 in the shareholders’ register of the company held by Euroclear Finland Ltd., has the right to participate in the general meeting. A shareholder, whose shares are registered on his/her personal Finnish book-entry account, is registered in the shareholders’ register of the company. A shareholder, who is registered in the shareholders’ register of the company and who wants to participate in the general meeting, shall register for the meeting no later than March 20, 2018 at 4 p.m. by giving a prior notice of participation, which shall be received by the company no later than on the above mentioned date. Such notice can be given: a) via e-mail: maria.viiru@solteq.com b) by telephone: +358 41 5297745 In connection with the registration, a shareholder shall notify his/her name, personal identification number or company ID, address, telephone number and the name of a possible assistant or proxy representative and the personal identification number of a proxy representative. The personal data given to Solteq Plc is used only in connection with the general meeting and with the processing of related registrations. The shareholder, his/her authorized representative or proxy representative shall, where necessary, be able to prove his/her identity and/or right of representation. 2. Holders of nominee registered shares A holder of nominee registered shares has the right to participate in the general meeting by virtue of such shares, based on which he/she on the record date of the general meeting, i.e. on March 15, 2018, would be entitled to be registered in the shareholders’ register of the company held by Euroclear Finland Ltd. The right to participate in the general meeting requires, in addition, that the shareholder on the basis of such shares has been registered into the temporary shareholders’ register held by Euroclear Finland Ltd. at the latest by March 22, 2018 by 10 am. As regards nominee registered shares this constitutes due registration for the general meeting A holder of nominee registered shares is advised to request without delay necessary instructions regarding the registration in the temporary shareholder’s register of the company, the issuing of proxy documents and registration for the general meeting from his/her custodian bank. The account management organization of the custodian bank has to register a holder of nominee registered shares, who wants to participate in the general meeting, into the temporary shareholders’ register of the company at the latest by the time stated above. 3. Proxy representative and powers of attorney A shareholder may participate in the general meeting and exercise his/her rights at the meeting by way of proxy representation. A proxy representative shall produce a dated proxy document or otherwise in a reliable manner demonstrate his/her right to represent the shareholder at the general meeting. When a shareholder participates in the general meeting by means of several proxy representatives representing the shareholder with shares at different securities accounts, the shares by which each proxy representative represents the shareholder shall be identified in connection with the registration for the general meeting. Possible proxy documents should be delivered in originals to Solteq Plc, Karhumäentie 3, 01530 Vantaa Finland before the last date for registration. 4. Other instructions and information Pursuant to chapter 5, section 25 of the Companies Act, a shareholder who is present at the general meeting has the right to request information with respect to the matters to be considered at the meeting. On the date of this notice to the general meeting, the total number of shares in Solteq Plc is 18.677.597 shares, which represents the same number of votes. Vantaa February 15, 2018 SOLTEQ PLC Board of Directors Additional information: Olli Väätäinen, CEOtel +358 50 5578 111e-mail olli.vaatainen@solteq.com Antti Kärkkäinen, CFOtel +358 40 8444 393e-mail antti.karkkainen@solteq.com         Distribution NASDAQ OMX HelsinkiKey Mediawww.solteq.com Solteq in brief Solteq is a Nordic industry independent IT and software house that specialises in business solutions. We offer total solutions for both business enhancement by means of digitalisation and for omnicommerce: from back end processes all the way to the customer’s purchasing experience and from supply chain management to digital marketing. Our more than 500 experts, who work in five countries, develop and implement solutions for clients in Europe, North America, Asia and Australia. In 2017 Solteq’s net sales amounted to 62 million euro.

Cherry AB (publ): Year-end report 2017

Comments by the CEO: "Cherry's strong development continued in 2017. We have captured market shares and our companies have strengthened their positions.    After a year as President and CEO of Cherry, I am able to confirm that Cherry can report yet another good year, from both a financial and operational perspective. A year ago, I wrote that there remained an incredible amount to be done in the gaming industry and that what is great about Cherry is that its five diversified business areas span the entire gaming industry and that Cherry AB owns and manages highly interesting companies. We have already benefited from this strength and progressed some distance in our plans.  A year later, I have the same feeling; we have much ahead of us and Cherry is the player that can most naturally benefit from all of the opportunities available. We will continue to focus on companies run by extremely strong and ambitious individuals with a mix of entrepreneurs and specialists with a strong spirit of innovation. Creativity and hard work drive the products forward, also allowing Cherry’s business areas to grow faster than their respective markets. Beyond the financial results, we can also acknowledge success in comparison with other players in the industry: at the year’s International Gaming Awards, Cherry won the Mobile Operator award, ComeOn received the Sports Betting Operator award and Yggdrasil received the award for Innovator Supplier of the Year. Favourable development over the year with potential for improvement In 2017, Cherry delivered well, achieving total revenue growth of 104 percent, of which 27 percent was organic.  Over the year, we integrated the operations of B2C company ComeOn, Cherry’s largest acquisitions over the years, into our Online Gaming business area. For the most part, this process has progressed as planned, although, in mid-2017, we saw that the company’s costs, market focus and management were not living up to our expectations. Following an intensive period in the second half of the year, the company is back on the growth curve that we envisage. Together, ComeOn’s management and I have identified several priority improvement factors for 2018, and these will be implemented over the year.  Towards the end of 2017, ComeOn launched a product that is in demand in the Swedish market – Snabbare.com. At Snabbare.com, players can find an exciting casino experience without time-consuming registration and they can withdraw their winnings faster. The response shows that products like this are appreciated and have considerable market potential.  High level of activity and acquistions in Game Development  Yggdrasil completed a strong year with a number of new agreements and launches of several new games, including the revitalized vertical – bingo, that will be launched in 2018 with a host of new features that work smoothly on mobile phones. The company continued to sign important customer license agreements with major, established operators and additional innovative games were announced. The company has made significant investments in marketing and strengthened its relationships with both operators and players. The result was the highest number of game rounds to date and substantial jackpots payouts. In regulated markets, such as Italy, development has exceeded expectations. During 2018, Yggdrasil will rejuvenate the gaming experience in classic table games such as Blackjack, Roulette and Baccarat. Players will be offered an enhanced experience in a virtual 3D environment and will be able to interact with a digital croupier. First out is Blackjack, a game in which the company has applied its REDUX™ technology, developed in-house. The game will include opportunities for side bets, as well as characteristics and personalities unique to each croupier. In our assessment, Yggdrasil’s strong development will continue, and the company is now investing in a more robust organization to safeguard growth. In 2017, the number of employees increased by 99, and at the end of the year totaled 191, and a new studio was opened in Stockholm. We took a strategically important step in the quarter with the acquisition of Highlight Games, which broadened Cherry’s gaming development operations. Highlight Games develops innovative products for the virtual sports gaming market both online and in real, including content from league football. The company is currently at an exciting early stage and is working intensively with both development and preparations for its launch of products in several markets from the second quarter of this year and beyond, meaning it will take some time before the company generates revenue. Cherry stepped in as a major investor and strategic partner, initially by acquiring 25 percent of the company, and now owns 37.5 percent of the shares in Highlight Games.  Online Marketing broadens its market Game Lounge’s performance-based marketing operations continue to grow at a rapid pace and with good profitability. We are seeing that enhanced search engine optimization, combined with building strong brands, has a positive effect. In the Japanese market, we saw a continued increase in the number of visitors, although these contributed only marginally to fourth quarter results. The plan is to continue expanding the operations into several new geographic markets. In the fourth quarter, the market broadened in which the company’s expertise is combined with existing infrastructure to put borrowers in contact with lenders offering terms suiting the borrower’s circumstances. The first step into this segment was taken in November with the acquisition of the Finnish loan reference website Lainat.fi. After the end of the period, Game Lounge invested in another complementary segment - optimizing gaming for accustomed players who seek control of their gaming. With the acquisition of Slottracker.com, Game Lounge will continue to develop strong offers for the gaming industry and other areas where the company’s unique skills make a difference. Swedish gaming commission in final stages  In early December, the Swedish Parliament held a hearing on gaming policy. The industry’s various parties met with the Committee on Cultural Affairs to respond to questions and present their views on the proposal submitted to the government by the Gaming Commission. The timetable stands firm, with a licensing system to be in place from 1 January 2019. Cherry repeated its view that the proposed tax rate of 18 percent is excessive. Legalization of the gaming market, with a high degree of channelling, should be the main purpose of regulation. The UK has successfully achieved a 95 percent channelization, with a tax rate of 15 percent. Unfortunately, we have also received indications that Svenska Spel is preparing for re-regulation by, for example, establishing a business area for licensed gaming. It is our assessment that this will complicate the effective implementation of the new regulations.  Cherry also takes the view that the proposal to increase the maximum wager will not be sufficient to offset the proposed sharp increases in the taxes on gaming tables and in the license fee. As a result, we believe the risk is high that the proposal will lead to fewer jobs and a concentration of operations and tourism to the major cities. Investments in innovation In summary, the fourth quarter showed that Cherry has a strong business model that can deliver good returns even in a shorter period of weak development in one business area. As we continue our efforts to ascertain what the market demands, monitoring consumer behaviour and technological development is crucial. We maintain contacts with entrepreneurs who have good ideas and who seek to grow profitably. The number of acquisition candidates suggests that considerable potential remains. Accordingly, we look forward with confidence to further refining our portfolio of investments in innovative and successful operations that can strengthen our positions throughout the gaming value chain. PRESENTATION OF YEAR-END REPORT  The interim report will be commented on by President and CEO Anders Holmgren and CFO Christine Rankin in a telephone conference on 16 February 2018 at 10:00 a.m. CET. The presentation materials will be available approximately one hour earlier at www.cherry.se. The presentation can be followed via www.cherry.se and/or www.financialhearings.com. To participate by phone, call +46 8 5664 2698 (SE) or +44 20 3008 9807 (UK). For further information, please contact: Anders Holmgren, CEO, Tel.: +46 708 607 534, anders.holmgren@cherry.seChristine Rankin, CFO, Tel.: +46 765 399 492, christine.rankin@cherry.seAnders Antonsson, IR & Communications, Tel.: +46 709 994 970, anders.antonsson@cherry.se The complete Year-end report is attached and is published on www.cherry.se. This information is such that Cherry AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. This information was submitted for publication on 16 February 2018, at. 7.30 a.m. CET.

Interim report October–December 2017

· Net sales increased by 15% to SEK 4,927 million (4,277) · Organic growth was 6% (4) · The order backlog was 19% higher at SEK 10,271 million (8,644) · Operating profit increased by 10% to SEK 389 million (353) · The operating margin was 7.9% (8.3) · Profit after tax was SEK 320 million (255) · Cash flow from operating activities was SEK 650 million (415) · Net debt amounted to SEK 1,862 million (2,417) · One acquisition was made in the quarter, adding annual sales of SEK 10 million · Basic earnings per share were SEK 1.59 (1.26) and diluted earnings per share were SEK 1.58 (1.26) CEO statement Organic growth above our financial targetIn 2017 and the fourth quarter we achieved growth in all countries. We grew by 15 percent in the quarter and by 17 percent for the full year. Organic growth was 6 percent for the quarter and for the full year, which is above our growth target. It’s very pleasing that our initiative to grow within the service business is generating results, with growth amounting to 16 percent for the year and to a very strong 25 percent for the fourth quarter. In the fourth quarter, service accounted for 50 percent of sales. Improved underlying margin in the quarterThe underlying margin, excluding operations at Oras, improved to 8.5 percent (8.3) in the quarter as a result of higher profitability in Sweden and Norway. The underlying operating margin for the full year was 6.5 percent, which is the same level as the previous year. Strong cash flow bolsters capital structureCash flow in the fourth quarter reduced our net debt to SEK 1,862 million and gives us the financial flexibility to continue making acquisitions. In addition, the Board proposes that we raise the dividend by 24 percent to SEK 1.55 per share. Acquisitions continue to strengthen BravidaAcquisitions are continuing to strengthen Bravida’s growth within both installation and service. In 2017 we carried out four acquisitions, which strengthened our market position. We will continue to grow through acquisitions and have already made three acquisitions so far in 2018.  The strategic acquisition of Oras means we are now the market leader in Norway and that our market position in heating & plumbing and HVAC has been significantly strengthened.  Integration of Oras has proceeded according to plan, with adaptation of the organisation, implementation of Bravida’s procedures and systems, and training of personnel. Integration is essentially now complete, and integration costs have been recognised on an ongoing basis in Bravida Norway. Operating income for 2017 was SEK 0 million and our assessment is that the acquired businesses will post an operating profit in 2018. In Finland, we acquired Adison Oy in January 2018, an acquisition that bolsters our position in the Helsinki region and is another building block in establishing a critical mass in Finland. To build on the platform we have established in Finland, Bravida has recruited Marko Holopainen as the new Head of Division from March 2018. Market remains goodAs mentioned previously, I believe the technical installations and service markets will remain good in Sweden, Norway and Denmark, and stable in Finland. Ten percent of our sales in 2017 came from new-build apartment buildings. The majority of installations in new-build homes are taking place outside Stockholm and Oslo, with installations for both tenant-owned apartments and rental apartments. I expect a gradual slowdown in technical installations in new-build housing. Bravida offers, and has the expertise to carry out, complex installations in all types of properties and our broad customer base means we aren’t dependent on individual projects or customers. A slowdown in housing construction will be substituted by other projects from industry, the public sector and housing renovation. The order backlog, which only includes installation projects, is 19 percent higher than at the same point in the previous year. The order backlog largely consists of small and medium-sized installation projects, which together with our large service business, will support growth over the coming quarters.  During 2017 we have worked intensively with, among other things, the establishing of our new division Riks in Sweden,  improvement initiatives in Finland, and several aqcuisitions. These efforts creates a good foundation which positively will contribute to Bravida's continuous development during 2018 and beyond. Mattias Johansson, Stockholm, February 2018 For further information, please contact:       Mattias Johansson, CEO and Group President of Bravida. Tel: +46 8 695 20 00Nils-Johan Andersson, CFO of Bravida. Tel: +46 70 668 50 75IRcontact@bravida.comThis information is information that Bravida Holding AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 07:30 CET on 16 February 2018. The report will be presented at 09:30 CET by CEO and Group President Mattias Johansson and CFO Nils-Johan Andersson. The presentation will be held in English and can be followed on the web or over the phone. There will be room for questions. Link to the webcast:https://tv.streamfabriken.com/bravida-q4-2017 Telephone numbers for telephone conference:SE: +46 8 5661 9353UK: +44 20 3008 9811US: +1 85 5831 5945 The report and the presentation are available on bravida.se/en/investors/ .

YEAR-END REPORT JANUARY – DECEMBER 2017

• Rental income amounted to MSEK 792 (684) in the quarter and MSEK 3,134 (2,642) for the full year • Profit from property management excluding the share in profit from jointly owned companies amounted to MSEK 375 (319) in the quarter and MSEK 1,619 (1,270) for the full year. Profit from property management including the share in profit from jointly owned companies amounted to MSEK 525 (537) in the quarter, corresponding to SEK 3.15 per ordinary share (3.23). The lower profit from property management was due to the change in value of jointly owned properties being higher in 2016. Full-year profit from property management amounted to MSEK 2,186 (1,812), corresponding to SEK 13.16 per ordinary share (11.49) • Profit after tax in the quarter totaled MSEK 528 (837), corresponding to SEK 3.17 per ordinary share before dilution (5.02). The lower profit in 2017 was due to the change in value of jointly owned properties being higher in 2016 combined with the preceding year’s changed assessment of loss carryforwards. Full-year profit after tax amounted to MSEK 3,163 (3,583), corresponding to SEK 19.22 per ordinary share before dilution (23.25) Significant events during and after the • In October, possession was taken of ten centrally located community service properties acquired in Halmstad for an underlying property value of MSEK 1,066 • In November, the Board of Directors of Hemfosa Fastigheter decided to evaluate the conditions for demerging the Group into two listed companies • At the end of the year, Hemfosa signed an eight-year lease for about 20,000 square meters of previously vacant floor space in the Arendal 1:17 logistics property in Gothenburg. Occupancy will occur on March 1, 2018 • Following the close of the quarter, the specialist hospital and local medical center in Gardermoen, Norway, were completed and the tenants have moved in • The Board proposes a dividend of SEK 4.80 per ordinary share with quarterly payment of SEK 1.20 per share, as well as a dividend of SEK 10.00 per preference share with quarterly payment of SEK 2.50 per share COMMENTS FROM THE CEO Stronger position and new initiatives There is always something going on at Hemfosa. During 2017, we continued to grow sharply through acquisitions of just over SEK 4 billion and with exciting investments and new build project in primarily community service properties. The fourth quarter was stable with increased earnings capacity and a high rate of maintenance. Although we did not complete any major transactions during the quarter, work to evaluate acquisitions of various sizes is continuously under way. In November, we took an important step towards safeguarding the best possible value for Hemfosa’s shareholder, in the future too, by deciding to evaluate the possibility of a demerger of the Group into two listed companies.  Following another active year of acquisitions, we now have a property portfolio worth a total of SEK 41 billion. Community service properties valued at just over SEK 26 billion, which account for 64 percent of the portfolio, generate stable cash flows in Sweden, Norway and Finland. We also have an attractive holding of commercial properties primarily in high-growth regions, valued at some SEK 15 billion. Hemfosa continues to grow with a low financial risk – at year-end, the equity/assets ratio was 40.4 percent. In the fourth quarter, we took possession of properties acquired at a value of about SEK 1.1 billion and increased profit from property management excluding the share in profit from jointly owned companies with MSEK 56 compared to previous year. We also report a continuing stable increase in earnings capacity during each quarter of the year. Closer cooperation with tenants of community service properties Hemfosa’s main focus is to be best at offering community service properties to the most important services in society – from schools and preschools, healthcare facilities and nursing homes, police stations and courts of law to public authorities. During the year, we made further investments in remodeling and new builds, which we regard as strategically important for additionally strengthening Hemfosa’s position in community service properties. There is a  limited supply of available acquisition objects at what we consider reasonable prices, at the same time as there is considerable demand in many parts of the country for new properties for use, for example, as schools and nursing homes. In this context, we have utilized our experience, size and financial capacity to take a more distinct grip of the market by such means as collaborations with municipalities, building contractors and service operators. A typical example is a collaboration with Emrahus, which assembles modern, innovative passive buildings for LSS (support and service for the disabled) homes in Sweden and with which we reached agreements in 2017 to acquire properties when they are ready for occupancy and leased. This entailed the acquisition of two newly produced LSS homes from Emrahus during the year and a further two to date in 2018. Our first really major investment in a new build project is the specialist hospital and local medical center at Gardermoen in Norway, which we implemented with the property developer Aspelin Ramm in a joint venture. Equipment is now being installed to enable the start of advanced cardiovascular treatment in the newly completed property, which is planned for sustainability in every detail – from construction and materials selection to function and maintenance. We are delighted over and proud of this project which, together with the project team, we completed according to the established timetable, within budget and with a clean bill of health at final inspection. This gives us the confidence, experience and credibility to implement more advanced, large-scale projects involving community service properties moving forward. During the first quarter of 2018, we are acquiring the remainder of the project and will thus become the sole owner of the properties. Evaluating the conditions for a demerger of Hemfosa In November, we initiated a process aimed at evaluating what we believe is a wise next step in Hemfosa’s development; a demerger of the Group into two listed companies. With a streamlined community service property company, we will be able to establish an even stronger position, in part by focusing more distinctly on project development and specialist know-how in the various operations conducted in our community service properties. Meanwhile, we have an excellent portfolio of other properties and transaction competencies that will have better prospects to develop their full potential on a standalone basis. We are now analyzing the opportunities and formats for such a potential demerger and this work is proceeding as planned. The Board intends to return with more information to shareholders in connection with the Annual General Meeting and the interim report for the first quarter 2018. Should any decision be made to propose a distribution of the new company, the Board will convene an extraordinary shareholders’ meeting. I look forward to the next step in the evaluation of a demerger into two new companies with roots in Hemfosa’s excellent corporate culture and entrepreneurship. Until then, we will continue to develop our partnerships with tenants and evaluate growth opportunities in an environment where we see good access to debt, reasonably stable property prices and demand for the development of community service properties. We never sit still at Hemfosa. Jens Engwall, CEO

Saab Year-End Report 2017

Statement by the President and CEO Håkan Buskhe: Strong order intake, continued growth In 2017 geopolitical tensions were evident, and defence and security spending increased in much of the world. At the same time, it has become even more important to deliver effective systems in a short time. Demand for and interest in Saab’s world-leading products and solutions are strong. In 2017, Saab strengthened its market position, at the same time that operating efficiency was improved. Several important international collaborations were established that strengthen the local position in several countries. In Poland, for example, Saab selected the Nauta Shiprepair Yard to build the special purpose Signal Intelligence vessel for the Swedish Navy. In Australia, targeted market efforts led to the announcement that Saab has been identified by the government to provide the tactical interface to the Royal Australian Navy’s fleet of nine Future Frigates. Order bookings 2017 was a strong year for Saab. Major orders were received in several areas and order bookings rose by 41 per cent to SEK 30.8 billion (21.8). Orders were received from among other areas Airborne Early Warning and Control and support and maintenance for Gripen C/D. We also received important orders for the development of next-generation products, including Sweden’s order for the development and production of the next generation of anti-ship missiles and a new signals intelligence vessel. Medium-sized orders increased as well, which is gratifying, since we have maintained a local focus for some time in our various markets to grow the base where we are active. The order backlog amounted to SEK 106.8 billion (107.6) at the end of the year. Sales growth and operating income All business areas saw sales growth during the year and organic sales growth was 10 per cent. Operating income amounted to MSEK 2,155 (1,797) with an operating margin of 6.9 per cent (6.3). In 2017 a number of efficiency improvement projects has been implemented within the company, where we for example focus on streamlining functional processes. Mainly the business area Dynamics and operations related to Airborne Early Warning and Control systems and support operations improved profitability in 2017. In 2018, the focus on efficiency improvements will continue. This is an important factor for Saab to reach its long-term goal of a 10 per cent operating margin. Operational cash flow amounted MSEK 1,388 (2,603) and during the year Saab received larger milestone payments related to large projects. Earnings per share after dilution amounted to SEK 13.10 (10.60). Outlook statement for 2018 Sales growth in 2018 is expected to be in line with Saab’s long-term goal: annual organic growth of 5 per cent. The operating margin in 2018, excluding material non-recurring items, is expected to improve compared to 2017, bringing Saab a further step closer to its financial goal: an operating margin of 10 per cent over a business cycle. Financial highlights MSEK  Full year Full year Change, Q4 2017  Q4 2016  2017  2016  % Order 30,841 21,828 41 6,586 6,868bookingsOrder backlog 106,849 107,606 -1Sales 31,394 28,631 10 9,819 9,016Gross income 7,448 6,883 8 2,405 2,451Gross margin, 23.7 24.0 24.5 27.2%EBITDA 2,994 2,743 9 1,084 1,206EBITDA 9.5 9.6 11.0 13.4margin, %Operating 2,155 1,797 20 882 960income (EBIT)Operating 6.9 6.3 9.0 10.6margin, %Net income 1,438 1,175 22 519 639of which 1,407 1,133 24 517 624ParentCompany’sshareholders’interestEarnings per 13.10 10.60 4.81 5.82share afterdilution, SEK1)Return on 10.4 9.0equity, % 2)Operational 1,388 2,603 2,146 681cash flowFree cash 852 2,359 1,772 619flowFree cash 7.93 22.07 16.47 5.78flow pershareafterdilution, SEK         1) Average 107,400,920 106,906,726       107,590,836 107,167,229 number ofshare afterdilution 2) Return on equity is measured over a rolling 12-month period. For more information and explanations regarding the usage of these key ratios, please see http://saabgroup.com/investor-relations/financial-data/key-ratios/  Press and analyst meeting Saab is pleased to invite to a press and analyst meeting, where CEO Håkan Buskhe and CFO Magnus Örnberg present the Saab Group 2017 year-end result. Date: Friday, 16 February at 10:00 (CET) Address: Grand Hôtel, Blasieholmshamnen 8, Stockholm, Sweden Venue: New York The report is published at 7.30 a.m. (CET) the same day. You are welcome to participate on site at Grand Hôtel, watch the live webcast or dial in to the conference call. It is possible to post questions also over the web and conference call. Live webcast: http://saab-interimreport.creo.se/180216 Conference call: Please dial in using one of the numbers below. UK: +442030089814 US: +18557532237 SE: +46856642697 The interim report, the presentation material and the webcast will be available on http://www.saabgroup.com/en/InvestorRelations. R.S.V.P E-mail: marie.bergstrom@saabgroup.com Tel: +46 8 463 02 45 For further information, please contact: Saab Press Centre, Ann Wolgers, Press Officer +46 (0)734 18 70 52 presscentre@saabgroup.com www.saabgroup.com  www.saabgroup.com/YouTube  Follow us on twitter: @saab  Saab serves the global market with world-leading products, services and solutions within military defence and civil security. Saab has operations and employees on all continents around the world. Through innovative, collaborative and pragmatic thinking, Saab develops, adopts and improves new technology to meet customers’ changing needs.  The information is such that Saab AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, on 16 February 2018 at 07.30 (CET).

CXENSE ASA ANNOUNCES FOURTH QUARTER AND PRELIMINARY YEAR END RESULTS FOR 2017

OSLO, NORWAY - FEBRUARY 16, 2018 - CXENSE ASA TODAY REPORTED FINANCIAL RESULTS FOR THE FOURTH QUARTER ENDING DECEMBER 31, 2017. Highlights:  Growth improvement in core DMP and Personalization segment * 18% YoY and 7.8% sequentially * 21.5% growth from 2016FY to 2017FY * 26 new contracts of which 58% upsell  On track for Q1 2018 target EBITDA USD -0.5 million * Q4 2017 adjusted EBITDA loss of USD -0.7 million * 80% gross margin, an improvement of 6 p.p. versus 5 p.p. target  Two non-core divestments completed, two ongoing * Mporium and Emediate sold for USD 4.6 million * Maxifier and Ramp on track for H1 2018 completion  Financial runway beyond break-even with USD 10.2 million cash position  LOI signed to acquire small, complementary DMP company * Will increase competitive strength through new tech capabilities * Ongoing partnership with multiple proven customer cases * Adding 10% core revenue for less than 5% dilution (payment in shares) Material: The Q4 2017 report and presentation are attached to this notice and can also be found under the following link: https://www.cxense.com/investors/financial-reports Webcast: Cxense ASA will present its Q4 2017 results at 08:30 am CET. The presentation will take place at the Felix Conference Center, Bryggetorget 3, Oslo, Norway. A live webcast will be available at: http://webtv.hegnar.no/presentation.php?webcastId=77873110 About Cxense: Cxense helps publishers and marketers across the globe to transform their raw data into their most valuable resource. Cxense's leading Data Management Platform (DMP) with Intelligent Personalization, give companies unprecedented insight about their individual customers, and enables them to action this insight real-time in all marketing and sales channels. Benefits include increasing digital revenue and user loyalty. Cxense works with brands such as Aeon, Wall Street Journal, Grupo Clarin, NBC Universal, Aller and many more. Cxense is headquartered in Norway with offices worldwide and the company is listed on the Oslo Stock Exchange with the ticker 'CXENSE.' For more information: www.cxense.com Investor Relations Contact: Jørgen Loeng, Chief Financial Officer Email: ir@cxense.com Mobile: +47 906 60 062

Alligator Bioscience AB Full Year Report 2017

Significant events, October-December • Alligator Bioscience recorded a revenue of USD 6 million from Janssen, coupled to a decision to start combination study with ADC-1013/JNJ-64457107. This milestone payment was received in January 2018. • A decision was taken to expand the management team with Chief Medical Officer Charlotte A Russell, MD, PhD and Vice President Discovery Peter Ellmark, Associate Professor. • Results from Alligator Bioscience’s clinical Phase I study presented, supporting a continued clinical development of ADC-1013. • Aptevo Therapeutics and Alligator Bioscience announced the tumor antigen 5T4 as the second target for the drug candidate ALG.APV-527. Events after the end of the period • Theradex Oncology contracted as clinical CRO for the upcoming clinical study with ATOR-1015. • Anudharan Balendran appointed VP Business Development starting 1 May 2018. • Janssen clinical Phase I study with ADC-1013 ongoing. Financial summary October-December • Net Sales, SEK 51.3 million (6.4). • Operating result, SEK 10.7 million (-22.1). • Result for the period, SEK 12.5 million (-19.4). • Result per share, SEK 0.18 (-0.31). • Cash, cash equivalents and bonds, SEK 547 million (659). January-December • Net Sales, SEK 56.9 million (58.2). • Operating result, SEK -62.3 million (-56.1). • Result for the period, SEK -63.8 million (-48.4). • Result per share, SEK -0.89 (-0.80). • Cash flow for the period before investments in bonds, SEK -108.7 million and after -183.2 (287.1). • During the period 1,275,000 warrants (330,000) were exercised for an equivalent number of shares. Financial summary (Group) 2017 2016 2017 2016 Oct-Dec Oct-Dec Jan-Dec Jan-DecNet sales, TSEK (SEK 51,299 6,433 56,875 58,240thousand)Operating profit/loss 10,733 -22,130 -62,299 -56,081Profit/loss for the period, 12,516 -19,352 -63,758 -48,356TSEK Cash flow for the period, -41,694 310,886 -183,173 287,135TSEKCash, cash equivalents and 547,041 659,136 547,041 659,136bonds, TSEKEquity ratio, % 96% 96% 96% 96%R&D costs as % of operating 80.5% 68.5% 73.3% 64.3%costs excluding impairmentsEarnings per share before 0.18 -0.31 -0.89 -0.80dilution, SEKEarnings per share after 0.18 -0.31 -0.89 -0.80dilution, SEKAverage number of employees 46 35 42 31 Conference call All interested parties are invited to participate in a telephone conference which will include a presentation of the Full Year Report. The event will be hosted by CEO Per Norlén and the presentation will be held in English. When: 1:15 pm CET Friday 16 February 2018To participate in the telephone conference, please use the dial in details shown below:SE: +46856642664UK: +442030089802US: +18558315945The presentation can also be reached at: https://tv.streamfabriken.com/alligator-bioscience-q4-2017  The conference call will be made available on the company´s website after the call: www.alligatorbioscience.com . For further information, please contact:Per Norlén, CEO, per.norlen@alligatorbioscience.com, +46 46 286 42 80.Per-Olof Schrewelius, CFO, per-olof.schrewelius@alligatorbioscience.com, +46 46 286 42 85.Cecilia Hofvander, Director IR & Communications, cecilia.hofvander@alligatorbioscience.com, +46 46 286 44 95. Alligator Bioscience AB (publ) 556597-8201Medicon Village, Scheelevägen 2, 223 81 Lund, Sweden.Phone +46 46 286 42 80. The information was submitted for publication, through the agency of the contact persons set out above, at 8:00 a.m. CET on 16 February 2018. About Alligator BioscienceAlligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs. Alligator’s growing pipeline includes four lead clinical and preclinical drug candidates (ADC-1013, ATOR-1015, ATOR-1017 and ALG.APV-527). ADC-1013 (JNJ-64457107) is licensed to Janssen Biotech, Inc., part of J&J, for global development and commercialization. Alligator’s shares are listed on Nasdaq Stockholm (ATORX). The Company is headquartered in Lund, Sweden, and has approximately 50 employees. For more information, please visit www.alligatorbioscience.com .

Year-end report, January-December 2017

16 February 2018, 8.00 a.m.  · Rental income increased by 13 percent to SEK 892.0 million (786.6). · The net operating surplus increased by 16 percent to SEK 671.2 million (578.1). · Profit from property management increased by 39 percent to SEK 440.1 million (316.0). · Profit for the year increased to SEK 634.7 million (338.4), corresponding to earnings per share of SEK 16.08 (10.20), including changes in value of SEK 318.5 million (70.6). · Net asset value per share, EPRA NAV, increased to SEK 149.85 (135.76). · The Board of Directors proposes a dividend of SEK 4.50 per share (3.50). I am pleased to be able to say that Catena has again delivered in 2017. We succeeded in improving our letting ratio during the year, from 93 percent for 2016 to 94.7 percent by the end of 2017. A higher letting ratio, together with among other things, energy-enhancing measures in our properties, led to an increase in net operating surplus. Together with an improved financing structure, this entails that we can report stronger profit from property management. The farther down the income statement we get, the better it gets. Rental income for the full year is up 13 percent, net operating surplus up 16 percent and profit from property management is up 39 percent. This is according to plan and a prerequisite for continuing to grow and develop our portfolio of modern logistics properties. During the year, Catena became included in the EPRA, which has attracted new international investors. Catena has a stated objective to grow through projects and acquisitions. We have prioritised active project development where we are well-equipped through strong finances and a land allocation of 1.7 million square metres but we also grow through acquisitions when there are opportunities to acquire strategically attractive items. A major and important acquisition during the fourth quarter was the five logistics properties in the Stockholm region we acquired from Kilenkrysset with a total lettable area of approximately 91,500 square metres. 2017 was the year when e-commerce, in absolute terms, grew faster than the traditional retail in Sweden. Not least Black Friday, Cyber Monday and the ensuing Christmas retail season mapped out the future trend, where upward of 40 percent of the retail activity was online. E-commerce in regard to FMCG and dining out is also expected to grow strongly over the next few years. I see us continuing with new production in strategic locations and engaging further in conversion and expansion projects. This way, we can broaden our customer offering, increase our income, reduce expenses and improve our performance. By being well-informed, curious and responsive, we will continue to drive the logistics solutions of the future.” Says CEO Benny Thögersen in his comments on the Interim Report. For further information, please contact Benny Thögersen, CEO, Tel. +46 706-60 83 50, benny.thogersen@catenafastigheter.se  Peter Andersson, Deputy CEO and CFO, Tel. +46 730-70 22 44, peter.andersson@catenafastigheter.se  

Year-end report 1 January – 31 December 2017

Fourth quarter (1 October – 31 December 2017)  · Net sales for the quarter amounted to MSEK 60 (290). · Operating profit before depreciation and amortisation (EBITDA) was MSEK 40 (61), of which associates had an impact of MSEK 7 (0) on the Group. Operating cash flow was MSEK 31 (41). · Operating profit (EBIT) was MSEK 22 (33). · Profit before tax amounted to MSEK 6 (12). · Profit after tax totalled MSEK 5 (10), corresponding to SEK 0.14 (0.30) per share. · Production declined to 202 GWh (238), of which Own wind power operations accounted for 108 GWh (128) and Co-owned wind power operations for 94 GWh (110), due to divestment of operating farms. · Average income from Own wind power operations was SEK 403 per MWh (433), of which SEK 280 per MWh (310) pertained to electricity and SEK 122 per MWh (122) to electricity certificates. · Repurchase of secured bonds at a nominal amount of about MSEK 52 was carried out. · An option agreement was signed with the right to acquire the Enviksberget project (app. 35 MW). Full-year (1 January – 31 December 2017)  · Net sales for the period amounted to MSEK 257 (594). · Operating profit before depreciation and amortisation (EBITDA) was MSEK 131 (138), of which associates had an impact of MSEK 7 (0) on the Group. Operating cash flow was MSEK 96 (185). · A decision was made during the year to recognise impairment of MSEK 152 (18) on the company’s assets in relation to Own wind power operations and Development and management. · Underlying EBIT (EBIT before non-cash impairment) was MSEK 54 (51) and EBIT was MSEK -99 (33). · Underlying loss before tax (loss before tax and non-cash impairment) amounted to MSEK -26 (-34). · Loss before tax amounted to MSEK -178 (-52) after non-cash impairment. · Loss after tax and impairment amounted to MSEK -180 (-41), corresponding to SEK -5.39 (-1.23) per share. · Production declined to 635 GWh (640), of which Own wind power operations accounted for 348 GWh (353) and Co-owned wind power operations for 287 GWh (287), due to divestment of operating farms.   · Average income from Own wind power operations was SEK 380 per MWh (433), of which SEK 272 per MWh (297) pertained to electricity and SEK 109 per MWh (136) to electricity certificates.  Halmstad 16 February, 2018ARISE AB (publ) For further information, please contactDaniel Johansson, VD Arise AB, +46 702 244 133Linus Hägg, CFO Arise AB, +46 702 448 916 This information is information that Arise AB] is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication through the agency of the contact persons set out above, at 08.00 CET on 16 February 2018. About AriseArise is one of Sweden´s leading wind power companies, with the business concept to develop, build and manage onshore wind farms for its own account and on behalf of investors. The company is listed on NASDAQ Stockholm.Arise AB (publ), P.O. Box 808, SE-301 18 Halmstad, Sweden, telephone +46 (0)10 450 71 00, corporate id .no. 556274-6726E-mail info@arise.se, www.arise.se 

Exel Composites Plc’s Financial Statements Release 2017: “Revenue and operating profit increased significantly”

Q4 2017 in brief ·  Order intake increased by 16.9% to EUR 21.4 million (Q4 2016: 18.3). ·  Revenue increased by 17.9% to EUR 22.4 million (19.0). ·  Adjusted operating profit improved to EUR 1.3 million (0.7), which is 5.9% of revenue (3.7%). ·  Net cash flow from operating activities was EUR 2.7 million (1.2). ·  Earnings per share amounted to EUR 0.08 (-0.09). Q1-Q4 2017 in brief ·  Order intake increased by 15.7% to EUR 86.5 million (74.8). ·  Revenue increased by 18.0% to EUR 86.3 million (73.1). ·  Adjusted operating profit amounted to EUR 6.3 million (2.6), which is 7.3% of revenue (3.6%). ·  Net cash flow from operating activities was EUR 4.9 million (3.1). ·  Earnings per share amounted to EUR 0.36 (0.02). Dividend proposal The Board of Directors proposes that a dividend of EUR 0.30 (0.10) per share be paid for the financial year 2017. Outlook for the full year 2018 Exel Composites expects revenue as well as adjusted operating profit to increase in 2018 compared to 2017. President and CEO, Riku Kytömäki The year 2017 was in many ways a very good year for Exel Composites. I am delighted to say that both revenue and adjusted operating profit increased significantly compared to 2016. This is first and foremost a result of our strategic efforts, improved operational efficiency and continued tight cost control, but also reflects signs towards a general market recovery. All our markets and customer segments performed well in the fourth quarter as well as in the twelve month review period. From the customer segment point of view, Industrial Applications continued to drive revenue growth. Construction & Infrastructure also delivered significant growth, supported by an increasing number of industrial investments and projects. In terms of regions and markets, China and the Asia-Pacific (APAC) region contributed most to revenue growth. In addition to significant organic growth, the Nanjing Jianhui business, which was acquired in April 2017, had a substantial positive impact on APAC revenue. The acquired business has performed according to expectations and has clearly strengthened Exel Composites’ position in China and APAC in 2017. Our main market area, Europe, also continued to deliver stable revenue growth. In 2017 we were able to improve our adjusted operating profit significantly after two years of decline. The main factors were increased revenue from key customers in Europe in combination with further operational efficiency improvements. In addition, our focused efforts on new customer acquisition and new business especially in China were important contributors to the operating profit improvement. In the APAC region the acquisition of Nanjing Jianhui had a positive impact on both revenue and profitability. The downsizing of the Australian unit was completed in 2017 and manufacturing operations were stopped. This improved the overall profitability of the region and of the Group. At the end of 2017 we also confirmed our overall strategic direction for the next three years. We will have an increased focus on high growth segments. We believe high growth can be found especially in construction, transportation, energy and telecommunications segments over the next few years. Within these segments global megatrends such as urbanization and sustainability increase demand for advanced composites. Our ambition is to leverage on these trends with attractive products that fit the demand. Consolidated key figures EUR 1.10.–31.12. 1.10.–31.12. Change, 1.1–31.12. 1.1.–31.12. Change,thousand 2017 2016 % 2017 2016 %Order 21,433 18,334 16.9 86,531 74,778 15.7intakeOrder 17,126 16,702 2.5 17,126 16,702 2.5backlog ¹Revenue 22,414 19,009 17.9 86,255 73,079 18.0Operating 1,389 -1,209 214.8 6,081 649 837.5profit% of 6.2 -6.4 7.1 0.9revenueAdjusted 1,327 708 87.5 6,319 2,621 141.1operatingprofit ²% of 5.9 3.7 7.3 3.6revenueProfit for 956 -1,065 189.8 4,212 198 2,025.4theperiodNet cash 2,708 1,157 134.1 4,856 3,129 55.2flow fromoperatingactivitiesReturn on 12.3 -12.5 14.8 1.7capitalemployed,%Net 30.3 12.2 30.3 12.2gearing, %Earnings 0.08 -0.09 0.36 0.02per shareEquity per 2.44 2.27 7.4 2.43 2.27 7.0share,EUREmployees 562 457 22.9 532 479 11.0onaverageEmployees 568 455 24.8 568 455 24.8at end ofperiod ¹ As per the end of the period.² Excluding material items affecting comparability, such as restructuring costs, impairment losses and reversals, and costs related to planned or realized business acquisitions or disposals. For more information, please refer to the paragraph “Change in Exel Composites’ financial reporting terminology” of the Half-year Financial Report published on 21 July 2016. Financial reporting and Annual General Meeting 2018 Exel Composites publishes the following reports in 2018: · Financial Statements Release 2017: 16 February 2018 · Business Review January - March: 9 May 2018 · Half Year Financial Report January - June: 24 July 2018 · Business Review January - September: 31 October 2018 Annual Financial Report, Corporate Governance Statement and Remuneration Statement for 2017 will be published on Thursday 1 March 2018 in electronic format at the company’s website www.exelcomposites.com. The Annual General Meeting will be held on Thursday 22 March 2018 at 10:00 at Radisson Blu Royal Hotel at the address Runeberginkatu 2, Helsinki, Finland. Financial results briefing Exel Composites will hold a financial results briefing regarding the financial statements on Friday 16 February 2018 at 12:30 at Scandic Hotel Simonkenttä’s Roba meeting room (address Simonkatu 9, Helsinki, Finland). Exel Composites’ Financial Statements Release January – December 2017 is available in full in pdf format as an attachment to this release. The report and the related presentation shall also be available at the company’s website under the Investor section. Vantaa, 16 February 2018 Exel Composites PlcBoard of Directors

Q-FREE- FOURTH QUARTER AND PRELIMINARY FULL YEAR RESULTS 2017

Highlights Q4-2017:  * 265 MNOK in revenues, up 10% YoY * 40 MNOK in EBITDA (15% margin), up from 7 MNOK (2.9% margin) in Q4-16 * 133 MNOK in order intake * -3 MNOK in net cash flow from operating activities including investments despite 47 MNOK in increased work in progress on the Slovenia Truck Tollling project Highlights FY 2017: * 973 MNOK in revenues, up 11% YoY * Operating expenses in percent of revenues reduced with 6% YoY * 110 MNOK in EBITDA excl. non-recurring items (11.3% margin) vs. 11 MNOK (1.3%) in 2016 * 1.0 bn NOK in order backlog of which 442 MNOK is scheduled for delivery in 2018 * -79 MNOK in net cash flow from operating activities including investments, heavily influenced by increased work in progress on the Slovenia Truck Tolling project - We are pleased to announce our best quarter since Q4-2009. Moreover, in 2017 Q-Free met its key financial targets of double-digit revenue growth and EBITDA margin. The solid financial performance was positively impacted by strong organic revenue growth, the restructuring done in the second half of 2016 and good cost control throughout the year. In 2018 Q-Free will continue its efforts to build leading positions in its target segments. The demand for intelligent transportation systems will continue to grow, and Q-Free is well positioned to capture its fair share of the growth going forward. A prerequisite for continued success will be to further reduce the complexity of Q-Free’s business. Hence, we have initiated a process to exit underperforming businesses and product lines, comments CEO in Q-Free, Håkon Volldal.  Enclosures: Q4-17 report and presentation For further information, please contact: President & CEO, Håkon Volldal: +47 977 19 973CFO, Tor Eirik Knutsen: +47 950 50 062  About Q-Free Q-Free is a leading global supplier of ITS (Intelligent Transportation Systems) products and solutions. The company has approximately 415 employees, offices in 18 countries, and presence on all continents. Headquartered in Trondheim, Norway, Q-Free is listed on the Oslo Stock Exchange under the ticker QFR. www.q-free.com  Twitter:@Q-FreeASA

Year-end report 2017

Continued organic growth and improved margins Fourth quarter 2017 · Revenue declined to MEUR 70.4 (71.9) · Organic growth was 1.4% · The gross margin increased to 42.1% (40.4) · Adjusted EBITA increased to MEUR 6.2 (4.6), corresponding to a margin of 8.8% (6.4) · EBIT rose to MEUR 4.4 (-5.8), corresponding to a margin of 6.3% (-8.0) · Net debt/ adjusted LTM EBITDA amounted to 3.0x Full year 2017 · Revenue rose to MEUR 284.3 (244.7) · Organic growth was 4.9% · The gross margin increased to 42.6% (40.8) · Adjusted EBITA increased to MEUR 26.2 (17.2), corresponding to a margin of 9.2% (7.0) · EBIT rose to MEUR 14.0 (-4.4), corresponding to a margin of 4.9% (-1.8) · Part of the Puls business unit was divested on 1 August 2017, and reported under divested operations · Handicare was listed on Nasdaq Stockholm on 10 October 2017 · After the reporting date, a distributor was acquired in Colorado, US with sales of around MEUR 4.2 · Earnings per share before/after dilution amounted to negative EUR 0.1 and the Board proposes SEK 0.50 in dividend be distributed for 2017 For table see enclosed PDF CEO’s comments Healthy growth and improved margins in 2017. The internal initiatives aimed at driving growth and improving margins have yielded results. Organic growth was 4.9% and the adjusted EBITA margin increased to 9.2%. During the year, we also focused on the integration of Prism Medical and our listing on Nasdaq Stockholm. A minor yet strategic acquisition was completed in Colorado in early 2018 — of a distributor who will play a key role in our North American hub strategy.  The fourth quarter — continued growth in Accessibility, lower project sales in Patient HandlingDuring the fourth quarter, revenue grew organically by 1.4% and the adjusted EBITA margin increased to 8.8% (6.4). The growth we noted during the year continued in Accessibility. The sales trend for stairlifts in North America is continuing, 25% for the quarter and 14% for the full year. Project sales in Patient Handling, North America were lower during the quarter than previously during the year. Some sales in Patient Handling go to Homecare, but the majority comprise project sales to hospitals and healthcare facilities. Deliveries to the latter can be complete installations of patient lifts, but also replacements — for example, of motors as part of the aftermarket segment. Sales of complete installations may vary between quarters, and sales of complete installations in North America during the fourth quarter were lower than previously during the year, which negatively affected total revenue and the operating margin. Patient Handling Europe developed in line with the previous quarters during the year. Favourable trend in sales to HomecareUsing a highly automated manufacturing process, we managed to retain short lead times despite higher volumes as a result of strong growth. This is an important competitive advantage in sales to Homecare (stairlifts in particular), which together with our successful utilisation of the Prism Medical distribution network in North America promoted positive growth in sales to Homecare. Growth has been particularly strong for stairlifts; we estimate that we have captured market shares in this area in both Europe and North America. Market adjustments in Patient Handling and PulsWe are allocating dedicated sales resources aimed at Institutional sales with the aim of strengthening our competitiveness for project sales in Patient Handling in North America. Parts of Puls were divested in 2017. The part of Puls that remains will be adapted to the new conditions, both organisationally and as regards operations. Acquisition of a strategically important distributor for Handicare in North AmericaIn early 2018, a Patient Handling distributor was acquired in Colorado, with sales in an additional 11 neighbouring states. The acquisition is limited in size — MEUR 4.2 in sales for 2017 — but is of major significance for the development of our sales and distribution in North America. Following the acquisition, we now have 8 hubs, the objective is a total of 18. Well on the way to our financial goalsDespite lower project sales in Patient Handling during the fourth quarter, we are satisfied with the total trend during the year. The growth rate is tracking our financial targets as regards organic growth, and we are well on the way towards our objective as regards the EBITA margin. Our medium-term financial targets aim at average annual growth of 10%, of which 4–6% organic, with an adjusted EBITA margin exceeding 12%. Macroeconomic trends continue to be favourable, which is particularly conspicuous from the positive trend in sales to Homecare. In summary, we would like to say that Handicare is well positioned for continued profitable growth. Asbjørn EskildPresident and CEO Telephone conferenceA telephone conference, hosted by Asbjørn Eskild, President and CEO, and Stephan Révay, CFO, will be held at 10:00 CET on 16 February 2018. To participate, please register in advance using the following link http://emea.directeventreg.com/registration/2894038.  A presentation will be available at www.handicaregroup.com/investors.   Dates for financial reports Interim report January–March 2018 8 May 2018Annual Report w 14 2018Annual General Meeting 8 May 2018Interim report January–June 2018 14 August 2018Interim report January–September 2018        24 October 2018Year-end report 2018 19 February 2019 For more information, contact:Asbjørn Eskild, CEO, Tel: +47 905 633 04Stephan Révay, CFO, Tel: +46 729 666 532Boel Sundvall, IR, Tel: +46 723 747 487This information is information that Handicare Group AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 8:00 a.m. CET on 16 February 2018.Forward-looking statementsTo the extent this report contains forward-looking statements based on the current expectations of Handicare’s Group management. Although management considers the expectations expressed in such forward-looking statements to be reasonable, there is no guarantee that these expectations will prove correct. Accordingly, actual future outcomes may differ significantly from those expressed in the forward-looking statements due to such factors as changed economic, market and competitive conditions, changes in regulatory requirements and other policy measures, and fluctuations in exchange rates. About HandicareHandicare offers solutions to increase the independence of disabled or elderly people, and to facilitate for their care providers and family. The offering encompasses a comprehensive range of curved and straight stairlifts, transfer, lifting and repositioning aids, vehicle adaptations and medical equipment. Handicare is a global company with sales in more than 20 countries and is a market leader in this field. The head office is in Kista, Sweden and manufacturing is located at six sites distributed across North America, Asia and Europe. In 2017, revenue amounted to MEUR 284 and the adjusted EBITA margin was 9.2%. Employees totalled around 1,150 and the share is listed on Nasdaq Stockholm. For more information; www.handicaregroup.com.

HIDDN SOLUTIONS ASA - Quarterly Report – Q4 2017

Enclosed please find Hiddn Solutions ASA’s report for the fourth quarter of 2017. Highlights from Q4 and subsequent events:  · Entered into Nordic distribution agreement with Power International AS · Signed agreement for delivery of 500 units of Hiddn's Laptop 1+ · Received repeat order from the Dutch Government for delivery of Hiddn's SafeDisks · New R&D manager in place · Strengthening of the Board of Directors · Raised NOK 15 million in gross proceeds in a Private Placement 2018 will become a “wake up year” for both the consumer and business market as the complex cyber security situation is pushing consumers and businesses towards encrypted data exchange. The focus going forward is to capitalise on the significant investments made to date and embark on a full commercial scaling and take advantage of the current technology and cybersecurity trend in the market place. For further information, please contact:   Carl Espen Wollebekk (CEO), telephone: + 47 930 55 505 /e-mail: cew@hiddn.no  Oslo, 16 February 2018 Hiddn Solutions ASA About Hiddn Solutions ASAHiddn Solutions ASA is a public limited company situated in Oslo, Norway, listed on the Oslo Stock Exchange under the ticker HIDDN.  Hiddn is supplying impenetrable proprietary hardware-based authentication and encryption products. Hiddn’s encryption product suite offers a distinctly superior level of safety and ensures that sensitive information stays confidential and unavailable to unauthorised access, even if the device is lost or stolen.  Hiddns products are currently being used amongst others by Norwegian Armed Forces, national and Dutch Authorities and on NATO’s Northrop Grumman’s Global Hawks surveillance drone. The Group is also supplying secure cabinets and physical filing systems.  For more information, please visit www.hiddnsolutions.com 

Finnair Group Financial Statement Release 1 January–31 December 2017

Finnair Plc Financial Statement Release 16 February 2018 at 9.00 am EET Q4 comparable operating result increased to 22.9 million euros and FY 2017 comparable operating result tripled to a record-high 170.4 million euros October–December 2017 ·  Revenue increased by 13.2% to 645.3 million euros (569.9)*. ·  Available seat kilometres (ASK) grew by 17.2%. ·  Comparable operating result was 22.9 million euros (1.6). ·  Operating result was 23.5 million euros (18.2). ·  Comparable EBITDAR** was 94.0 million euros (59.4). ·  Net cash flow from operating activities was 92.6 million euros (30.5), and net cash flow from investing activities was -85.6 million euros (-264.7).*** ·  Unit revenue (RASK) decreased by 3.4%. ·  Unit cost (CASK) decreased by 6.6%, and unit cost at constant currency excluding fuel decreased by 3.1%. ·  Ancillary and retail revenue per passenger grew by 3.2% to 12.60 euros. ·  Earnings per share were 0.11 euros (0.08). January–December 2017 ·  Revenue increased by 10.9% to 2,568.4 million euros (2,316.8)*. ·  Available seat kilometres (ASK) grew by 8.9%. ·  Comparable operating result was 170.4 million euros (55.2). ·  Operating result was 224.8 million euros (116.2), including a sales gain on an A350 aircraft. ·  Comparable EBITDAR** was 436.2 million euros (270.4). ·  Net cash flow from operating activities was 382.3 million euros (219.7), and net cash flow from investing activities was -157.5 million euros (-499.6).*** ·  Unit revenue (RASK) increased by 1.8%. ·  Unit cost (CASK) decreased by 2.6% and unit cost at constant currency excluding fuel increased by 0.3%. ·  The 20-million euro cost-efficiency program was completed in full by the summer. ·  Ancillary and retail revenue per passenger grew by 5.2% to 12.15 euros. ·  Earnings per share were 1.23 euros (0.55). ·  The Board of Directors proposes to the Annual General Meeting that a dividend of 0.30 euros per share be distributed for 2017. *     Unless otherwise stated, comparisons and figures in parentheses refer to the comparison period, i.e. the same period last year.**    Comparable operating result + depreciation + lease payments for aircraft.***  Net cash flow from investing activities in Q4, includes 26.8 million euros of investments to money market funds or other financial assets maturing after more than three months. In 2017, these investments decreased in net terms by 82.9 million euros. These investments are part of the Group’s liquidity management.   Outlook   Global airline traffic is expected to grow strongly in 2018. Finnair expects increased competition as existing and new operators increase capacity, particularly on routes linking Europe with Asia and with North America. Finnair plans on increasing its capacity by more than 15 per cent in 2018, with most of this growth coming in the first half of the year. Passenger volume is expected to grow broadly in line with capacity while revenue growth is expected to be slightly lower. In line with its disclosure policy, Finnair will issue guidance on its full-year comparable operating result as part of its half-year report in July. CEO Pekka Vauramo:  The year 2017 was excellent for Finnair. The favourable business environment supported our growth together with the right capacity, route network and product decisions we made in recent years. We ended 2017 in the middle of the fastest growth phase in Finnair’s history and we plan to continue our transformation and growth also in 2018. Towards the end of the year, our route network was expanded by four new long-haul destinations, namely Goa, Havana, Puerto Plata and Puerto Vallarta. At the same time, we increased our flight frequency to several Asian and European destinations. We also invested heavily in our routes to Northern Finland by increasing our capacity between Helsinki and Northern Finland by more than 20 per cent for the current winter season and by introducing direct flights to Lapland from London, Paris and Zürich. Lapland is again the number one European destination for our Chinese customers this winter. Passenger demand on our route network remained strong from October to December, and we achieved a new passenger record during the period by carrying nearly three million passengers. The favorable development continued also in ancillary revenue, cargo and travel services. Our comparable operating result for the fourth quarter was a record high 22.9 million euros.   In 2017, our revenue grew to 2,568 million euros and our comparable operating result more than tripled, reaching 170 million euros. While increasing our capacity by nearly 9 per cent, we also managed to increase our passenger load factor by 3.5 percentage points. Our customer satisfaction, measured by our Net Promoter Score, increased by 4 units to 47. During the year, we also completed the first phase of our long-haul fleet renewal. We made significant investments in the development of digital solutions and services to enhance the customer experience and to improve processes and ways to work at Finnair. Other significant steps we took included the commissioning of the new Nordic Cargo COOL terminal and the launch of the new Finnair Holidays product. These moves enable us to deliver more personalized services to our customers and to facilitate further growth going forward. In travel services, Aurinkomatkat Suntours became the largest operator in terms of the number of customers in the Finnish market in 2017.  I am satisfied with the renewal efforts we made during the year. They have contributed to our growth and improved customer satisfaction. I am also pleased with our records in monthly passenger volumes and passenger load factors, as they indicate that our route network and product have developed in the right direction.   Everyone at Finnair has made an excellent contribution during this period of growth and transformation.   The turnaround we have achieved in our operations and financial performance is a shared accomplishment by everyone at Finnair. As a sign of gratitude for the transformation that has driven the company forward on the path of profitable growth, Finnair decided to reward Finnair’s employees with a one-time bonus announced in December. Throughout this period of growth, we have invested in the development and well-being of our employees. We will continue these efforts and our other development efforts in 2018 to support our continued strong growth.   Dividend policy and the Board’s proposal for the distribution of profit The aim of Finnair’s dividend policy is to pay, on average, at least one-third of the earnings per share as a dividend during an economic cycle. The aim is to take into account the company’s earnings trend and outlook, financial situation and capital needs in the distribution of dividends. In 2017, earnings per share was 1.23 euros (0.55). Finnair Plc’s distributable equity amounted to 424,036,052.14 euros on 31 December 2017. The Board of Directors proposes to the Annual General Meeting that a dividend of 0.30 euros per share be distributed for 2017. Financial reporting The publication dates of Finnair’s financial reports in 2018 are as follows:    Interim Report 1 January – 31 March 2018:                        25 April 2018 Interim Report 1 January – 30 June 2018:                          17 July 2018 Interim Report 1 January – 30 September 2018:                 25 October 2018  FINNAIR PLCBoard of Directors Briefings  Finnair will hold a result press conference on 16 February 2018 at 11:00 a.m. and an analyst briefing at 12:30 p.m. at its office at Tietotie 9. An English-language telephone conference and webcast will begin at 2:30 p.m. Finnish time. The conference may be attended by dialling your local access number 09 7479 0361 (Finland), 0200 880 389 (Sweden), 0800 358 6377 (UK) or +44 (0)330 336 9105 (all other countries). The confirmation code is 2226645. To join the live webcast, please register at: https://slideassist.webcasts.com/starthere.jsp?ei=1181702   For further information, please contact: Chief Financial Officer Pekka Vähähyyppä, tel. +358 9 818 8550, pekka.vahahyyppa@finnair.com Director, Financial Communications Mari Reponen, tel. +358 9 818 2037, mari.reponen@finnair.com 

MUNTERS FOURTH QUARTER AND FULL YEAR 2017

Fourth quarter 2017 · Order intake increased by 22% to SEKm 1,821 (1,491) and 23% organically. The quarter included a SEKm 450 Data Center order received in November 2017. · Net sales decreased by 1% to SEKm 1,811 (1,823) while organic growth was flat, impacted by lower net sales in Data Centers. · The order backlog increased by 36% to SEKm 2,365 (1,741). · Operating profit (EBIT) decreased by 44% to SEKm 127 (228), mainly due to lower earnings in Data Centers. · Adjusted EBITA decreased by 36% to SEKm 174 (274), corresponding to an adjusted EBITA margin of 9.6% (15.0). · Net income was SEKm 152 (105). · Cash flow from operating activities was SEKm -8 (114). · Earnings per share before and after dilution were SEK 0.83 (6.32). January - December 2017 · Order intake increased by 13% to SEKm 7,197 (6,373), of which 10% organically. · Net sales increased by 9% to SEKm 6,604 (6,040), of which 6% organically. · Operating profit (EBIT) decreased by 22% to SEKm 453 (577), mainly due to lower profitability in Data Centers. · Adjusted EBITA decreased by 14% to SEKm 675 (781), corresponding to an adjusted EBITA margin of 10.2% (12.9). · Net income was SEKm 173 (85). · Cash flow from operating activities decreased to SEKm 235 (277). · Earnings per share before and after dilution were SEK 1.45 (5.08). · The Board of Directors proposes that a dividend of SEK 0.30 per share be paid for the financial year 2017. Events after period end · Katarina Lindström was appointed President Global Operations and will assume her position during the spring of 2018.                      Presentation / Audiocast / Telephone conferenceA telephone conference will be held 16 February 10.00 CET. CEO John Peter Leesi and CFO Jonas Ågrup will present and comment on the report for the fourth quarter and full year 2017.  Details for the telephone conference; SE: +46 8 503 36562 UK: +44 20 3008 9807 US: +1 855 831 5947 The presentation can also be followed via webcast: http://www.financialhearings.com/event/10288  For further information, please contact: John Peter Leesi, CEO Munters GroupPhone: +46 8 626 63 01 John Womack, Investor RelationsPhone: +46 706 782 499 THIS INFORMATION IS INFORMATION THAT MUNTERS GROUP AB IS OBLIGED TO MAKE PUBLIC PURSUANT TO THE EU MARKET ABUSE REGULATION. THE INFORMATION WAS RELEASED FOR PUBLICATION, THROUGH THE AGENCY OF THE CONTACT PERSON SET OUT ABOVE, AT 08:00 CET ON 16 FEBRUARY 2018. About Munters Founded in 1955, Munters is a leading global provider of energy efficient and mission critical precision climate control solutions for commercial and industrial applications. Munters is organised in four business areas: Air Treatment, Data Centers, AgHort and Mist Elimination, and supported by Global Operations and Global Services organisations. Each of these business areas addresses a set of end markets, customer industries and applications, with an offering based on Munters’ technologies and specialist competencies. The Company operates globally with more than 3,500 FTEs working in over 30 countries to provide Munters’ products and solutions to a diverse range of customers, including a wide range of global blue chip companies, in over 180 countries. Today, the Company has a production footprint that includes 18 major manufacturing facilities and seven assembly units across 16 countries worldwide. Munters reports annual net sales in the region of SEK 6,6 billion and is listed on Nasdaq Stockholm. For more information see www.munters.com

Notice to Exel Composites Plc’s Annual General Meeting 2018

Notice is given to the shareholders of Exel Composites Plc to the Annual General Meeting of Shareholders to be held on Thursday 22 March 2018 at 10:00 at Radisson Blu Royal Hotel at the address Runeberginkatu 2, Helsinki, Finland. The reception of persons who have registered for the meeting and the distribution of voting tickets will commence at 9:00. A. Matters on the agenda of the Annual General Meeting and their course of procedure1. Opening of the meeting2. Calling the meeting to order3. Election of persons to scrutinize the minutes and to supervise the counting of votes4. Recording the legality of the meeting5. Recording the attendance at the meeting and adoption of the list of votes  6. Presentation of the financial statements, the consolidated financial statements, the Board of Directors’ Report and the auditor’s report for the year 2017 Review by the President and CEO7. Adoption of the financial statements and consolidated financial statements8. Resolution on the disposal of the profit shown on the balance sheet and the payment of dividend The Board of Directors proposes to the Annual General Meeting that a dividend of EUR 0.30 per share be paid based on the adopted financial statements for the financial year ended on 31 December 2017. The dividend will be paid to shareholders registered in the Company’s shareholders’ register maintained by Euroclear Finland Ltd. on the record date for dividend 26 March 2018. The Board of Directors proposes to the Annual General Meeting that the dividend be paid on 4 April 2018.9. Resolution on the discharge of the members of the Board of Directors and the President and CEO from liability10. Resolution on the remuneration of the members of the Board of Directors The Shareholders' Nomination Board elected by the Annual General Meeting of Exel Composites Plc proposes to the Annual General Meeting of 22 March 2018 that the annual remuneration for the Board members shall be as follows: yearly remuneration of EUR 41,000 (previous year EUR 41,000) for the Chairman of the Board of Directors and additionally EUR 1,500 (1,500) for attendance at Board and committee meetings and other similar all-day Board assignments, and the other Board members be paid a yearly remuneration of EUR 19,000 (previous year EUR 19,000) and additionally EUR 1,000 (1,000) for attendance at Board and committee meetings and other similar all-day Board assignments. The Nomination Board also proposes that travel expenses and other out-of-pocket expenses arising from the Board work be compensated in accordance with the Company's established practice and travel rules. Out of the yearly remuneration 60% would be paid in cash and 40% in Exel Composites Plc shares, which would be acquired directly for and on behalf of the members of the Board of Directors during 26 March - 13 April 2018 from the stock exchange market in amounts corresponding to EUR 16,400 for the Chairman and EUR 7,600 for each of the other members. The annual remuneration shall encompass the full term of office of the Board of Directors. If the required amount of shares cannot be acquired during the specified period in accordance with applicable rules and regulations, the part of yearly remuneration to be paid in shares which could not be acquired can be paid in cash. Should the term of any member of the Board of Directors come to an end for whatever reason before the next Annual General Meeting, such member of the Board of Directors will have to return to the Company the remuneration or equivalent amount in cash already received but not yet earned at that point in time.   11. Resolution on the number of members of the Board of Directors The Nomination Board proposes to the Annual General Meeting that the number of members of the Board of Directors shall be confirmed to be five (5).12. Election of members of the Board of Directors The Nomination Board proposes to the Annual General Meeting to be held on 22 March 2018 that Mr Petri Helsky, Mr Kai Kauto, Mr Reima Kerttula, Ms Helena Nordman-Knutson and Mr Jouko Peussa be re-elected as members of the Board of Directors for the term ending at the closure of the Annual General Meeting of 2019. The Nomination Board further proposes that the Annual General Meeting resolves to re-elect Reima Kerttula as Chairman of the Board of Directors for the term ending at the closure of the Annual General Meeting of 2019. All nominees are independent of the Company and its major shareholders, and have given their consent for the election. All candidates for the Board of Directors have been presented on the Company's website at www.exelcomposites.com.13. Resolution on the remuneration of the auditor The Board of Directors proposes that the auditor’s compensation be paid against an invoice as approved by the Company.14. Election of auditor The Board of Directors proposes that the Company’s present auditor, Ernst & Young Oy, Authorized Public Accountants, be re-elected as auditor of the Company for the term that will continue until the end of the next Annual General Meeting. The proposed auditor has given its consent for the election. Ernst & Young has announced Mr Antti Suominen, APA, to be the auditor with principal responsibility.15. Authorizing the Board of Directors to decide on the repurchase of the Company’s own shares The Board of Directors proposes to the Annual General Meeting to be held on 22 March 2018 that the Board of Directors be authorized to decide on the repurchase of the Company’s own shares on the following terms: By virtue of the authorization the Board of Directors is entitled to decide on the repurchase of a maximum of 600,000 of the Company’s own shares. The authorization shall also contain an entitlement for the Company to accept its own shares as pledge. The number of shares that can be acquired or held as pledges by the Company on the basis of this authorization shall not exceed one tenth (1/10) of all outstanding shares of the Company. Own shares may be repurchased in deviation from the proportional holdings of the shareholders with unrestricted equity through trading of the securities on the regulated market organized by Nasdaq Helsinki Ltd at the market price of the time of the repurchase provided that the Company has a weighty financial reason thereto. The shares shall be acquired and paid in accordance with the Rules of Nasdaq Helsinki Ltd and Euroclear Finland Ltd. Shares may be repurchased to be used as consideration in possible acquisitions or in other arrangements that are part of the Company’s business, to finance investments, as part of the Company’s incentive program or to be retained, otherwise conveyed or cancelled by the Company. The Board of Directors shall decide on other terms of the share repurchase. The share repurchase authorization shall be valid until 30 June 2019 and it shall revoke the repurchase authorization given by the Annual General Meeting on 4 April 2017.16. Appointment of the Shareholders’ Nomination Board The Board of Directors proposes to the Annual General Meeting to be held on 22 March 2018 that the Annual General Meeting shall resolve to appoint a permanent Shareholders’ Nomination Board to prepare in the future proposals concerning the Board members and their remuneration for the General Meeting. In addition, the Board of Directors proposes that the Annual General Meeting adopts the Charter of the Shareholders’ Nomination Board, which regulates the nomination and composition of the Nomination Board and defines its tasks. The Charter is available as an appendix to the proposal of the Board of Directors on the company's website at www.exelcomposites.com. According to the proposal, the representatives of the four largest shareholders and the Chairman of the Board of Directors, acting as an expert member, are annually appointed to the Nomination Board. The Company’s largest shareholders entitled to appoint members to the Nomination Board shall be determined on the basis of the registered holdings in the Company’s shareholder register held by Euroclear Finland Oy as of 30 September each year. In addition, shares that are included in a shareholder's holdings and proportion of voting rights calculated in accordance with Chapter 9, Sections 5 and 6 of the Finnish Securities Markets Act and nominee-registered shares are taken into account in the determination of the largest shareholders, provided that they make such request and notify their shareholdings to the Board of Directors in writing by 30 September each year. The request must include sufficient evidence of title to the nominee-registered shares or of the obligation to take holdings into account under the Finnish Securities Markets Act. Should a shareholder not wish to use its right to nominate, this right would be passed on to the next largest shareholder who otherwise would not be entitled to appoint a member. The members of the Nomination Board shall be appointed annually and their term of office shall end when new members are appointed to replace them.17. Amending the Articles of Association The Board of Directors proposes to the Annual General Meeting that section 9 § of the Articles of Association is amended as follows: Current 9 § Auditor: The company has one regular auditor who must be approved by the Central Chamber of Commerce. The auditor's term of office ends at the close of the first Annual General Meeting following election. New 9 § Auditor: The Company has one auditor that shall be an audit firm referred to in the Auditing Act with a KHT certified auditor acting as the auditor with principal responsibility. The auditor's term of office ends at the close of the first Annual General Meeting following election.18. Closing of the Annual General Meeting B. Documents of the Annual General Meeting The proposals for the decisions on the matters on the agenda as well as this notice are available on Exel Composites’ corporate website at www.exelcomposites.com. The annual financial report of Exel Composites Plc, including the Company’s financial statements, consolidated financial statements, the Board of Directors’ report and the auditor’s report, is available on the corporate website no later than 1 March 2018. The proposals for the decisions as well as the annual financial report are also available at the Annual General Meeting. The minutes of the Meeting will be available on the corporate website as of 5 April 2018. C. Instructions for the participants in the Annual General Meeting1. Shareholders registered in the shareholders’ register Each shareholder, who is registered on Monday 12 March 2018 in the shareholders’ register of the Company held by Euroclear Finland Ltd., has the right to participate in the Annual General Meeting. A shareholder, whose shares are registered on his/her personal Finnish book-entry account, is registered in the shareholders’ register of the Company. A shareholder, who is registered in the shareholders’ register of the Company and who wants to participate in the Annual General Meeting, shall register for the meeting no later than Thursday 15 March 2018 at 16:00 EET by giving a prior notice of participation to the Company, which shall be received by the Company no later than on the above-mentioned date and time. Such notice can be given either: a) on the Company’s website www.exelcomposites.com; or b) by email to investor@exelcomposites.com; or c) by telephone at +358 20 754 1350 from Monday to Friday between 9:00 and 16:00 EET; or d) by regular mail to the address Exel Composites Plc, Annual General Meeting, Mäkituvantie 5, 01510 Vantaa, Finland. In connection with the registration, a shareholder shall notify his/her name, personal identification number, address, telephone number and the name and personal identification number of a possible assistant or proxy representative. The personal data given to Exel Composites Plc is used only in connection with the Annual General Meeting and with processing of related registrations.2. Holders of nominee registered shares A holder of nominee registered shares has the right to participate in the Annual General Meeting by virtue of such shares, based on which he/she on the record date of the Annual General Meeting, i.e. on 12 March 2018, would be entitled to be registered in the shareholders’ register of the Company held by Euroclear Finland Ltd. The right to participate in the Annual General Meeting requires, in addition, that the shareholder on the basis of such shares has been temporarily registered into the shareholders’ register held by Euroclear Finland Ltd. at the latest by Monday 19 March 2018 at 10:00 EET. As regards nominee registered shares, this constitutes due registration for the Annual General Meeting. A holder of nominee registered shares is advised to request without delay necessary instructions regarding the temporary registration in the shareholders’ register of the Company, the issuing of proxy documents and registration for the Annual General Meeting from his/her custodian bank. The account manager of the custodian bank has to register a holder of nominee registered shares, who wants to participate in the Annual General Meeting, temporarily into the shareholders’ register of the Company at the latest by the time stated above.3. Proxy representative and powers of attorney A shareholder may participate in the Annual General Meeting and exercise his/her rights at the meeting by way of proxy representation. A proxy representative shall produce a dated proxy document or otherwise in a reliable manner demonstrate his/her right to represent the shareholder at the Annual General Meeting. When a shareholder participates in the Annual General Meeting by means of several proxy representatives representing the shareholder with shares at different securities accounts, the shares by which each proxy representative represents the shareholder shall be identified in connection with the registration for the Annual General Meeting. A proxy template is available on Exel Composites’ corporate website at www.exelcomposites.com. Possible proxy documents should be delivered in originals to the address Exel Composites Plc, Annual General Meeting, Mäkituvantie 5, 01510 Vantaa, Finland, before the end of the registration period.4. Other information Pursuant to Chapter 5, Section 25 of the Finnish Companies Act, a shareholder who is present at the Annual General Meeting has the right to request information with respect to the matters to be considered at the meeting. On the date of this notice to the Annual General Meeting, the total number of shares and votes in Exel Composites Plc is 11,896,843. Vantaa, 16 February 2018 Exel Composites PlcBoard of Directors and the Shareholders’ Nomination Board

Notice to Annual General Meeting

Finnair Plc                                   Notice to General Meeting                                16 February 2018 at 09.15 a.m. Notice is given to the shareholders of Finnair Plc to the Annual General Meeting to be held on Tuesday 20 March 2018 at 4 p.m. (EET) at Messukeskus Helsinki, Messuaukio 1, Conference Centre entrance. The doors will be opened and reception of persons who have registered for the Meeting will commence at 3 p.m. (EET). Coffee will be served prior to the Meeting. A. MATTERS ON THE AGENDA OF THE GENERAL MEETING At the General Meeting, the following matters will be considered: 1. Opening of the Meeting 2. Calling the Meeting to order 3. Election of persons to scrutinise the minutes and to supervise the counting of votes 4. Recording the legality of the Meeting 5. Recording the attendance at the Meeting and adoption of the list of votes 6. Presentation of the annual accounts including the consolidated annual accounts, the report of the Board of Directors and the auditor's report for the year 2017 -        Review by the Chief Executive Officer -        Remuneration review by the Chairman of the Nomination and Compensation Committee 7. Adoption of the annual accounts including the consolidated annual accounts 8. Resolution on the use of the profit shown on the balance sheet and the payment of dividend The Board of Directors proposes to the General Meeting that a dividend of EUR 0,30 per share be paid based on the balance sheet adopted for the financial period ended on 31 December 2017. The dividend shall be paid to a shareholder who on the dividend record date 22 March 2018 is registered as a shareholder in the company's shareholders' register held by Euroclear Finland Ltd. The Board of Directors proposes that the dividend be paid on 4 April 2018. 9. Resolution on the discharge of the members of the Board of Directors and the CEO from liability 10. Resolution on the remuneration of the members of the Board of Directors The Shareholders' Nomination Board proposes that the annual remuneration of the members of the Board of Directors would remain unchanged and be the following: -        Chairperson EUR 61,200; -        Vice Chairperson EUR 32,400; -        Chairpersons of the Audit Committee and Compensation and Nomination Committee EUR 32,400, where these individuals are neither the Chairperson nor the Vice Chairperson of the Board of Directors; and -        Other members of the Board of Directors EUR 30,000 per year. The Nomination Board proposes to the AGM that each member’s fee for a meeting of the Board of Directors or its Committee would be 600 euros when the meeting takes place in the member’s country of residence and 2,400 euros for other meetings. For telephone meetings, the fee would be 600 euros. The members would be entitled to reimbursement of reasonable travel and representation expenses in accordance with the company’s general expenses policy. The members and their spouses would be entitled to discounted travel on the company’s flights in accordance with the company’s discount ticket policy regarding the Board of Directors. 11. Resolution on the number of members of the Board of Directors The Shareholders' Nomination Board proposes that the number of members of the Board of Directors would be confirmed as eight (8). 12. Election of the Chairperson and other members of the Board of Directors The Shareholders' Nomination Board proposes that Colm Barrington, Mengmeng Du, Maija-Liisa Friman, Jouko Karvinen, Jonas Mårtensson and Jaana Tuominen of the current members of the Board of Directors be re-elected as members of the Board of Directors, and that Montie Brewer and Henrik Kjellberg be elected as new members to the Board of Directors. All candidates have given their consent to the position, and all are independent of the company and its significant owners. Jussi Itävuori, after having served six years in the Board, has informed the Nomination Board that he will not be available for re-election. The Nomination Board further proposes that Jouko Karvinen be re-elected as the Chairperson of the Board. He has been a member of the Board since 2016 and the Chairperson since 2017. The biographical details of all proposed Board members can be found at Finnair’s website www.finnairgroup.com. 13. Resolution on the remuneration of the auditor In accordance with the Audit Committee's recommendation, the Board of Directors proposes that the auditors' fees be paid according to the auditors' reasonable invoice. 14. Election of the auditor In accordance with the Audit Committee's recommendation, the Board of Directors proposes that PricewaterhouseCoopers Oy, a firm of authorised public accountants, which has announced that APA Mikko Nieminen would be acting as the principal auditor, be re-elected as the auditor of the company for the term of office ending at the end of the next Annual General Meeting. 15. Authorising the Board of Directors to decide on the repurchase and/or on the acceptance as pledge of own shares The Board of Directors proposes that the Annual General Meeting would authorize the Board of Directors to decide on the repurchase and/or on the acceptance as pledge of the company's own shares as follows. The number of own shares to be repurchased and/or accepted as pledge shall not exceed 5,000,000 shares, which corresponds to approximately 3.9 per cent of all the shares in the company. Only the unrestricted equity of the company can be used to repurchase own shares on the basis of the authorisation. Own shares can be repurchased at a price formed in public trading on the date of the repurchase or otherwise at a price formed on the market. The Board of Directors decides how own shares will be repurchased and/or accepted as pledge. Own shares can be repurchased using, inter alia, derivatives. Own shares can be repurchased otherwise than in proportion to the shareholdings of the shareholders (directed repurchase). Own shares may be repurchased and/or accepted as pledge in order to, inter alia, develop the capital structure of Finnair, to finance or carry out acquisitions, investments or other business transactions, or in order to use the shares as part of Finnair's incentive and remuneration schemes. The authorisation would be effective for a period of 18 months from the resolution of the General Meeting and it would cancel the authorisation given by the General Meeting on 16 March 2017 to decide on the repurchase and/or acceptance as pledge of own shares. 16. Authorising the Board of Directors to decide on the disposal of the company's own shares The Board of Directors proposes that the Annual General Meeting would authorize the Board of Directors to decide on the disposal of own shares held by the company as follows. The number of shares to be disposed based on the authorisation shall not exceed 5,000,000 shares, which corresponds to approximately 3.9 per cent of all the shares in the company. The Board of Directors decides on all the conditions of the disposals, including to whom, at what price and in which manner the company's shares are disposed. The disposals may also be made in deviation from the shareholders' pre-emptive rights for a weighty financial reason, such as using the shares to develop the company's capital structure, to finance or carry out acquisitions, investments or other business transactions, or in order to use the shares as part of Finnair's incentive and remuneration schemes. The authorisation would be effective for a period of 18 months from the resolution of the General Meeting and it would cancel the authorisation given by the General Meeting on 16 March 2017 to decide on the disposal of the company's own shares. 17. Amending the Articles of Association The Board of Directors proposes that the Articles of Association be amended to, among other things, broaden the company's field of business, increase the maximum number of members of the Board of Directors, and to make certain technical updates. In accordance with the above, the Board of Directors proposes that: (i)         Section 2 § of the Articles of Association be amended to read as follows: "The company's field of business is to operate an airline by transporting passengers, cargo, and mail and to sell, lease, and repair aircraft and their parts and supplies, to provide hotel, forwarding, travel agency and other business operations relating to travelling and airline operations, as well as finance and insurance brokerage services and all other business operations related to the above. The company may conduct its business through subsidiaries, associated companies and joint ventures." (ii)       Section 3 § of the Articles of Association be amended to read as follows: "The administrative bodies of the company are the Board of Directors and the Chief Executive Officer. A Deputy Chief Executive Officer may also be appointed for the company. The Board of Directors shall consist of a Chairperson and of a minimum of four (4) and a maximum of nine (9) other members." (iii)      Section 8 § of the Articles of Association be amended to read as follows: "The company has one auditor. The auditor shall be an Auditing Firm referred to in the Auditing Act. The auditor shall be elected at the Annual General Meeting for a term which shall end at the closing of the first Annual General Meeting following the election." (iv)      Section 12 § of the Articles of Association will be amended to read as follows: "General Meetings of the company may be held in either Helsinki, Espoo or Vantaa. At the Annual General Meeting, the following are presented: the financial statements, the consolidated financial statements and the report of the Board of Directors, and the auditor's report; decided on: the adoption of the financial statements and the consolidated financial statements, the use of the profit shown on the balance sheet, the discharge from liability of the members of the Board of Directors and the Managing Director, the remuneration of the members of the Board of Directors, and the number of members of the Board of Directors, and the remuneration of the auditor; elected: the Chairperson and other members of the Board of Directors, and the auditor; and addressed: any other matters mentioned in the notice of the Meeting." 18. Authorising the Board of Directors to decide on donations for public-benefit purposes. The Board of Directors proposes that the Board of Directors be authorized to decide on donations up to an aggregate maximum of EUR 250,000 for charitable or corresponding purposes and that the Board be authorized to determine the recipients, purposes and other terms and conditions of the donations. The donations can be made in one or multiple installments. The authorization would be effective until the next Annual General Meeting. 19. Closing of the Meeting B. DOCUMENTS OF THE ANNUAL GENERAL MEETING The proposals for the decisions on the matters on the agenda of the General Meeting as well as this notice to the General Meeting are available on the company's website at www.finnairgroup.com. The annual accounts, the report of the Board of Directors and the auditor's report of Finnair Plc are available on the above-mentioned website on 27 February 2018 at the latest. The proposals for decisions and other above-mentioned documents are also available at the Meeting. Copies of these documents and of this notice will be sent to shareholders upon request. The minutes of the Meeting will be available on the above-mentioned website as from 3 April 2018 at the latest. C. INSTRUCTIONS FOR THE PARTICIPANTS IN THE GENERAL MEETING 1. Shareholder registered in the shareholders' register Each shareholder, who on the record date of the General Meeting, Thursday 8 March 2018, is registered in the shareholders' register of the company held by Euroclear Finland Ltd., has the right to participate in the General Meeting. A shareholder, whose shares are registered on his/her personal Finnish book-entry account, is registered in the shareholders' register of the company. A shareholder, who is registered in the shareholders' register of the company and who wants to participate in the General Meeting, shall register for the Meeting no later than by Thursday 15 March 2018 by 10.00 a.m. (EET) by giving a prior notice of participation, which has to be received by the company before the end of the registration period. Such notice can be given: a) on the company's website at www.finnairgroup.com; b) by e-mail to agm@finnair.com; c) by telephone +358 (0)20 770 6866 Monday through Friday from 9:00 to 16:00 (EET); or d) by regular mail to Finnair Plc, Register of Shareholders AAC/502, 01053 FINNAIR. In connection with the registration, a shareholder shall notify his/her name, personal identification number, address, telephone number and the name of a possible assistant or proxy representative and the personal identification number of a proxy representative. The personal data given to Finnair Plc is used only in connection with the General Meeting and with the processing of related registrations.  The shareholder, his/her authorised representative or proxy representative shall, where necessary, be able to prove his/her identity and/or right of representation. 2. Holders of nominee registered shares A holder of nominee registered shares has the right to participate in the General Meeting by virtue of such shares, based on which he/she on Thursday 8 March 2018 would be entitled to be registered in the shareholders' register of the company held by Euroclear Finland Ltd. The right to participate in the General Meeting requires, in addition, that the shareholder on the basis of such shares has been registered into the temporary shareholders' register held by Euroclear Finland Ltd. at the latest by Thursday 15 March 2018 by 10.00 a.m. (EET). As regards nominee registered shares, this constitutes due registration for the General Meeting. A holder of nominee registered shares is advised to request without delay the necessary instructions regarding the registration in the temporary shareholder's register of the company, the issuing of proxy documents and registration for the General Meeting from his/her custodian bank. The account management organization of the custodian bank has to register a holder of nominee registered shares, who wants to participate in the General Meeting, into the temporary shareholders' register of the company at the latest by the time stated above. 3. Proxy representative and powers of attorney A shareholder may participate in the General Meeting and exercise his/her rights at the Meeting by way of proxy representation. A proxy representative shall produce a dated proxy document or otherwise in a reliable manner demonstrate his/her right to represent the shareholder at the General Meeting. When a shareholder participates in the General Meeting by means of several proxy representatives representing the shareholder with shares at different securities accounts, the shares by which each proxy representative represents the shareholder shall be identified in connection with the registration for the General Meeting. Possible proxy documents should be delivered in originals to Finnair Plc, Register of Shareholders AAC/502, 01053 FINNAIR on Thursday 15 March 2018 at the latest. 4. Other information Pursuant to chapter 5, section 25 of the Companies Act, a shareholder who is present at the General Meeting has the right to request information with respect to the matters to be considered at the Meeting. On the date of this notice to the Annual General Meeting, 16 February 2018, the total number of shares and votes in the company is 128,136,115. The company or its subsidiaries hold 433,367 of the company's own shares, which do not have voting rights in the General Meeting. In Helsinki, 16 February 2018 FINNAIR PLC BOARD OF DIRECTORS

Climeon wins breakthrough geothermal order in Germany

The deal will enable GEK to utilize the excess heat of the geothermal plant that today delivers heat to the local greenhouse business and the city of Kirchweidach. The geothermal resource was originally identified through the explorational drilling for oil and gas in the area. The modular Climeon Heat Power system will work in conjunction with the heating and it is estimated that the first phase will annually deliver 14 000 MWh of electricity to the grid. The order is for 16 modules, with an option for GEK to order additional modules in a second phase to expand the production to more than 20 000 MWh annually. Baseload Capital Sweden AB will be involved in the financing of the deal. Unlike other renewable energies, such as wind and solar, geothermal heat power is in service day and night throughout the year. It can provide the same regulating power as coal or oil-fired power plants, making it the best option to offer clean power in quantities large enough to replace fossil energy sources.  The Climeon Heat power system’s ability to create energy from low temperature water offers a possibility for extensive use of geothermal energy in most geographical areas. The deaI with GEK shows that geothermal heat power could play a major role in Germany’s strong commitment to shift into sustainable, clean energy solutions. “The high efficiency combined with the modular solution made the Climeon heat power system the obvious choice for GEK. With this project we take an important step to begin providing clean Geothermal heat power to the beautiful municipality of Kirchweidach and later on to entire Germany” says Wolfgang Hageleit, Founder GEK “To invest in Geothermal heat power is good for many reasons. A long-term electricity contract (PPA) as strong financial base and a reliable 24/7 power production makes this an attractive and low risk project at the same time as we can accelerate the transformation from fossil to green energy” says Magnus Brandberg, Founding partner, Baseload Capital Sweden AB ”We are very excited with this breakthrough order. Germany is leading renewable energy in Europe and geothermal heat power especially at low temperatures has every property to become the dominating source of renewable energy. GEK is with their extensive experience in the field the perfect partner to make sure the European entry is successful and can be scaled further. This deal, just like the ones we already have with Iceland and USA, again proves our competitiveness and we see now that we can be key player in the transition from fossil fuels to renewable energy.” says Thomas Öström, Founder and CEO of Climeon This press release contains such information that Climeon AB (publ) is required to publish in accordance with the EU Market Abuse Regulation. The information was published for public disclosure on February 16, 2018, at 08:27 CET through the agency of the contact persons set out above. For additional information, please contact: Thomas Öström, CEO, Climeon +46 708 94 96 05 thomas.ostrom@climeon.com Christoffer Andersson, COO, Climeon +46 762 00 72 99 christoffer.andersson@climeon.com  About Geoenergie Kirchweidach (GEK)Geoenergie Kirchweidach (GEK) and its owner Forever Green has had the ambition to build and run a geothermal power and heating plant in Kirchweidach and have a long-term plan to develop additional projects in Bavaria. The Kirchweidach Geothermal plant will feed electricity into the public grid provide district heating to the community and its inhabitants. The district heating network is replacing the traditional heating that was done with fuel oil, LPG or pellets. Furthermore a vegetable growing greenhouse of 12 hectars is heated all year round by the geothermal plant, saving at least 8,2 million kg of CO2 per year. GEK is the owner of the drilling site and the boreholes. The generated electricity will be compensated for according to the Renewable Energy Act*. * EEG: The German Renewable Energy Act regulates the preferred supply of electricity from renewable sources into the grid and guarantees fixed feed-in tariffs. The Act came into force in the year 2000 and was the initial spark of a huge boost of renewable energies in Germany. About Climeon:Climeon is a Swedish cleantech equipment vendor and world leader in converting low temperature heat into clean electricity. The company was founded in 2011 and is headquartered in Stockholm with customers in many parts of the world. Climeon was founded to deliver an economically viable business case when it comes to converting low temperature heat into electricity. Climeon was built with the ambition to deliver a good business case for utilizing waste heat with a positive environmental impact. Climeon is listed on Swedish Nasdaq First North Premier. FNCA Sweden AB is appointed Certified Adviser. www.climeon.com

AVTECH Sweden AB (publ) YEAR END REPORT JANUARY - DECEMBER 2017

· AVTECH-group turnover for the fourth quarter 2017 amounted to MSEK 4.1 (3.2). Turnover for the twelve-month period amounted to 14.1 (11.5).  · Operating profit before depreciation for the fourth quarter 2017 was MSEK +0.3 (-2.7) for the 12-month period + 1.3 (-5.5)  · Net result for the fourth quarter 2017 amounted to MSEK -0.3 (- 2.7) and for the 12-month period -3.5 (-11.5) or SEK -0.06 (-0.20) per share.   · During the 12-month period, investments in new products were made. MSEK 3.7 (3.0) of these new investments have been activated.   · Cash flow from operating activities for the fourth quarter 2017 amounted to MSEK -1.0 (-1.3). Group liquid funds at the end of the year MSEK 20.4 (last year end 25.1).  · Equity capital at the period totaled to 30.0 MSEK (last year 33.9) or SEK 0.52 (0.60) per share. The Group's solidity ratio was 95.9 (96.9) percent.  · During the year, our partnership with the Met Office (UK) further deepened. Met Office (UK) for its part has developed, High-Resolution Weather (HRW), a unique refined weather forecast. This forecast is now a weather grid of 10x10 km which is considerably better than the market standard 140x140 km. A refined weather grid means, among other things, that a turbulence can be detected in e.g. 10 000 m altitude directly over the tip of Jylland (Denmark) rather than traditional projections where turbulence warnings issued over large parts of the North Sea. When the High-Resolution Weather (HRW) estimates are combined with AVTECH’s unique skills to transmit detailed and accurate information via data link directly, and in real time to the aircraft cockpit, increasing the possibilities for airlines to significantly improve fuel economy, safety, and timing accuracy.  · In April, a collaboration was established between the Met Office (UK), easyJet, Gatwick airport in London and AVTECH. The intention is to improve the efficiency of arriving aircraft to Gatwick, using Aventus as timing tool (TBO - Time Based Operation).   · In June 2017 the company announced that AVTECH and easyJet, one of Europe's leading airlines, has agreed to deploy AVTECH`s Aventus NowCastTM Full Flight to the whole easyJet fleet, including both Swiss and British aircrafts. The decision was a result of the positive results from the completed product evaluation. Commissioning of Aventus for the remaining part of easyJet's fleet is now in the final phase.   · In September, the first version of AVTECH's Aventus SIGMA solution was ready developed. Aventus SIGMA is a high quality service that with high precision presents, in real time, significant weather conditions such as icing, turbulence, volcanic ash, etc. to the cockpit of the aircraft. In the first version, AVTECH, and the Met Office (UK) focused on high resolution turbulence along the selected trajectory. Aventus SIGMA, during the fourth quarter of 2017 has been put into operation at BRA - Braathens Regional Airlines and Norwegian Airlines.  · In October, AVTECH announced that a commercial cooperation has begun with Lufthansa Cargo AG on Aventus NowCastTM. The product gives the pilot access to weather data of the highest quality and efficiency can then be achieved in terms of optimizing the flight path, thus reducing both fuel consumption and environmental impact. The discussions with other airlines in the Lufthansa Group also continues, where business conditions are fairly similar.  · During the year, efforts have been made to further develop Aventus system (NowCastTM and SIGMA). This development work has been conducted in cooperation with, among others, Norwegian and BRA. These efforts have resulted in an extension of the applicability of the products, including the types of aircraft that are not yet fully adapted to use the information from Aventus system.  · During the year, efforts were made to further customize user Aventus system. In September, the ongoing work to develop a SIGMA iOS Tablet App was announced, where weather forecasts and warnings as well as Aventus NowCast are visualized for the pilot user. The product should also be able to become a powerful tool for other flight operations personnel.  Events after the year end · In 2018, EasyJet is expected to join the group of developing clients for SIGMA weather warning system where BRA and Norwegian already are included. · A rising market demand for products and services in our segment and a broadening of AVTECH products has led to a decision on a substantial increase in marketing activities for 2018. · The in 2017 established cooperation project between the Met Office (UK), easyJet, the airport at Gatwick in London and AVTECH continues . Within the framework of cooperation, different solutions to streamline airspace utilization are discussed. The project will continue with the objective to develop the technical and financial models for start-up of an implementation project during 2018. · In January, a close group of pilots began using SIGMA iOS Tablet App. This is done as a last step of verification and product customization for a launch in Q2 2018. · AVTECH's stated strategy of customer-driven development of products and services has led to a close collaboration with our customers. This has resulted in products with high customer benefit that is user friendly and easily integrated without the need for changes in the aircraft's hardware. For further information, please contactChrister Fehrling, CEO, +46 (0) 8 544 104 80Britt-Marie Lodenius, CFO, +46 (0) 8 544 104 80or visit the company website www.avtech.aeroAVTECHs Sweden AB ( publ), corporate identity number 556568-3108, domiciled in Stockholm.Postal and visiting address: Färögatan 33, 24 tr, 164 51 Kista, Sweden.The company's B-shares (ticker AVT B) traded since February 2012 on NASDAQ OMX First North. The company's Class A shares are not traded in an active market. Certified Adviser is currently Redeye AB (www.redeye.se), tel: +46(0)8-545 01 330. For the explanation of technical terms, see Glossary on page 73 of the Company's share issue prospectus of 2011.The information in this press release is such that AVTECH Sweden AB (publ ) is obliged to publish under the EU market Abuse Regulation. The information was provided by the above contact person's Secretariat, for publication February 16, 2018 at 08:30 GMT. About AVTECH GroupAVTECH develops products and services for digital Air Traffic Management. Customers are the global aviation industry players such as airlines, airports, air traffic services providers, technology companies and aircraft manufacturers. With the help of the company's products and services, each individual flight or whole flight operation can be optimized in terms of cost, noise and emissions, efficiency, capacity, punctuality and safety. Headquartered in Stockholm, Kista. For more information, see www.avtech.se.

Year-end report 2017

January - December 2017 · Net sales amounted to SEK 1,857.5 million (1,697.2), a revenue growth of 9.4 percent. Adjusted for acquisitions and FX, the organic revenue growth amounted to 3.8 percent. · Operating profit before depreciation and amortization (EBITDA) amounted to SEK 308.1 million (332.0), corresponding to an EBITDA margin of 16.6 percent (19.5). · Net financial income/expense includes net foreign exchange differences of SEK -39.0 million (53.4). · Profit for the year amounted to SEK 73.8 million (85.4). · Earnings per share after dilution amounted to SEK 0.27 (0.29). · Cash flow from operating activities amounted to SEK 185.7 million (204.2). · The Board proposes a dividend of SEK 0.05 (0.12) per share. October – December 2017 · Net sales amounted to SEK 496.0 million (430.3), a revenue growth of 15.3 percent. Adjusted for acquisitions and FX, the organic revenue growth was 9.9 percent. · Operating profit before depreciation and amortization (EBITDA) amounted to SEK 62.4 million (67.8), corresponding to an EBITDA margin of 12.5 percent (15.7). · Net financial income/expense includes net foreign exchange differences of SEK -15.4 million (33.6). · Profit for the period amounted to SEK 24.5 million (21.4). · Earnings per share after dilution amounted to SEK 0.09 (0.08). · Cash flow from operating activities amounted to SEK 34.8 million (39.2). Notable events during the fourth quarter · Opus issued USD 50 million L/C backed bonds in the U.S. · Opus received notice of contract extension from the New York Taxi & Limousine Commission. · Opus raised a USD 25 million five-year credit facility. Notable events after the end of the period ·  Opus acquired the U.S. vehicle inspection company Gordon-Darby. This information is information that Opus Group AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08:30 CET on February 16, 2018.

Nordic Mining ASA (OAX:NOM) - Interim report per 31 December 2017

Corporate · In the period December 2017 to January 2018, Nordic Mining has executed a private placement and a subsequent offering with gross proceeds of NOK 59.6 million. The net proceeds have been received in January/February 2018. The Group’s cash balance at 31 December 2017 amounted to NOK 21.5 million. · On a general note, the Group evaluates financing strategies to ensure adequate liquidity for its projects and to provide for future financial strength and flexibility. The good progress for ongoing projects, mainly the Engebø rutile and garnet project and the Keliber lithium project, is expected to be positive for the Group’s financial flexibility going forward. There is no assurance that the Group will be successful in obtaining the required financing for its prioritised projects. Consequently, the Group might have to adjust project progress in accordance with the prevailing funding.  Engebø rutile and garnet project · Prefeasibility study completed; significant upside potential and moderate upfront investmentsThe prefeasibility study (PFS) was completed in line with estimated costs and published in October 2017. The PFS substantiates attractive project financials and perspectives:         o    Pre-tax NPV@8% of USD 332 million         o    Pre-tax IRR 23.8%         o    Pay-back period: < 5 years         o    Life of mine: 29 years          The PFS indicates an upside potential up to USD 465 million (pre-tax NPV@8%) for a scalable concept with increased capacity, higher sales volumes and utilisation of inferred mineral resources which will substantially increase the life of mine. The estimated    initial investment of USD 207 million for a 1.5 mtpa operation is around 30% lower than previously anticipated.         The PFS outlines a robust dual-mineral operation with production of high-quality rutile and garnet, and low operating costs due to outcropping orebody, high mineral grades, low stripping ratio, geotechnical stability, limited transportation costs, and good product           recoveries. In total, the estimated revenue-to-cash cost for rutile indicates a first quartile position in the global titanium feedstock industry. · Strategic partnership with The Barton GroupIn November 2017, Nordic Mining signed a Heads of Agreement with The Barton Group (Barton) related to offtake and commercial cooperation for garnet from Engebø. Barton is a leading US garnet producer and distributor with a strong foothold, particularly in the North American markets.Barton participated in the private placement in Nordic Mining in December 2017 and has currently a shareholding of 2.3%. Barton intends to be an industrial anchor investor in the construction financing to establish the Engebø operation.  · Definitive feasibility study is progressingThe positive PFS results support further project progress towards production, and the definitive feasibility study (DFS) is currently progressing. The main purpose of the DFS is to qualify the project for adequate construction financing with a combination of debt and equity. In the DFS program, process optimisation work is carried out including variability testing for variations in ore feed, to provide input to the process design criteria and process flowsheets. A limited drilling program will be finalised in February 2018. This will provide additional data for updating of the resource model and estimates, and the geotechnical parameters for mine planning. The open pit mine plan and schedules will be optimised and defined. The DFS is scheduled for completion late in 2018. · Project organisation and execution planningNordic Mining intends to attract additional competent personnel to strengthen the Engebø project team for the planning and execution phases. Various trade-off studies and market research will be carried out to ensure an effective execution strategy for the    project. Extensive cooperation has been initiated with the local municipalities and other authorities to coordinate site infrastructure preparations. · Positive market development and outlook for rutile and garnetThe average rutile price (95% TiO2) in the second half of 2017 has been reported in the range USD 825 – 875 per tonne. Recent information indicates a tightening market balance. Price increases have been implemented in the first part of 2018 following from higher demand and reduced stockpiles. In the coming years, the production from current producers is expected to decrease due to depletion of operating deposits. The Australian consultancy company TZMI estimates a long-term price for rutile around USD 1,070 per tonne.Currently, there is no production of garnet in Europe and a new source of supply at Engebø will be beneficiary in a market perspective.The Engebø deposit is situated next to a deep-water port and close to substantial markets for rutile and garnet. The location provides logistical advantages. · Permits grantedThe zoning plan for the mining and processing areas and the environmental permit for the project are fully granted. The Engebø project will be developed in accordance with high international standards for environment, health and safety. Keliber lithium project · Definitive feasibility study scheduled in H1 2018The definitive feasibility study (DFS) is aiming to provide a solid foundation for project financing to implement the lithium project. Additional drilling will continue till end of February with the purpose to further increase the resource base for the DFS. The trade-off study of the location of the lithium carbonate plant has been concluded in favour of Kokkola Industrial Park. The DFS is scheduled for completion in the first half of 2018. · Construction start targeted in 2018Keliber targets completion of the permitting process and start of construction in the second half of 2018. · Strong lithium market and outlookThe lithium market is developing on a positive note and product prices have increased, indicatively with 10-20%, into the first part of 2018. Contract prices for lithium carbonate doubled in 2017 compared to 2016. Going forward, a continued tight market balance is expected. The fastest demand growth for lithium is related to batteries for electric/hybrid vehicles and energy storage.Keliber has dialogues with potential customers for lithium carbonate with the purpose to secure offtake agreements. In addition to the DFS, bankable offtake arrangements are required for the establishment of the construction financing package to implement the project. · Successful financing in 2017Keliber executed a private placement and a repair issue with total gross proceeds of EUR 10.0 million in the first half of 2017. In addition, incentive share issues for board members and management were completed in 2017 with total proceeds of EUR 0.3 million. Nordic Mining participated pro-rata to its shareholding in the April 2017 repair issue. Following from the equity issues in 2017, Nordic Mining’s shareholding in Keliber is approximately 22.0%.    The fourth quarter presentation will be held today, Friday 16 February 2016 at 10:00 (CET) in Nordic Mining’s office at Vika Atrium, Munkedamsveien 45 (Entrance A, 5th floor), N-0250 Oslo.The presentation and Q&A session will be held in English and transferred via webcast. You will have the opportunity to post questions online throughout the webcast session. The webcast will be available on http://webtv.hegnar.no/presentation.php?webcastId=77874886  For further information, please contact CFO Lars K. Grøndahl, telephone +47-90160941.Oslo, 16 February 2018Nordic Mining ASANordic Mining ASA (www.nordicmining.com)  Nordic Mining ASA ("Nordic Mining" or "the Company") is a resource company with focus on high-end industrial minerals and metals in Norway and internationally. The Company's project portfolio is of high international standard and holds a significant economic potential. The Company's assets are in the Nordic region.Nordic Mining is undertaking a large-scale project development at Engebø on the west coast of Norway where the Company has rights and permits to a substantial eclogite deposit with rutile and garnet. Permits for the project have been granted by the Norwegian government, and a prefeasibility study was completed in October 2017. Nordic Mining's associated company Keliber in Finland is in the process of completing its definitive feasibility study and preparing for production of lithium carbonate. Nordic Mining has rights for exploration and production of high-purity quartz in Kvinnherad in Norway. Further, the Company holds exploration rights at Reinfjord in northern Norway where a prospective area of sulphide mineralisation has been discovered. Nordic Mining is also exploring opportunities related to seabed mineral resources.Nordic Mining is listed on Oslo Axess with ticker symbol "NOM".

Senzime proposes directed new issue that includes Segulah Venture AB, amounting to a total of SEK 25 million

Senzime’s Board of Directors is proposing an Extraordinary General Meeting to decide on a directed new issue of no more than 4,166,667 shares. The subscription price is SEK 6 per share, which means that, at full subscription, Senzime will receive SEK 25 million before issue costs. "Now, Senzime takes a big step towards the market. We have unique, CE-approved medical technology systems ready to cost-effectively prevent millions of healthcare complications - every year. We have conducted many years of research and today have a number of distributor and license agreements in place. This financing will enable us to accelerate market rollout and will strengthen our position in negotiations with additional potential strategic partners," says Lena Söderström, President and CEO of Senzime. ”Segulah Venture looks forward to taking part in Senzime's continued journey. The company has developed solutions that solve difficult medical problems and have now begun their commercial launch, which makes it an interesting time for us to join as long-term owners," says Lennart Kalén, Chairman of Segulah Venture AB. The purpose of the decision and the reason for the deviation from shareholders' preferential rights is to acquire capital, to tie strategically important investors to the Company, and to strengthen the ownership base of the Company, thereby increasing the conditions for successful commercialization of Senzime's products, as well as providing a time- and cost-effective issue process. Given this background, it is considered that it is in the interests of all shareholders to deviate from the pre-emptive right. The directed new issue is aimed at a few strategically important investors who, through subscription agreements, undertake to subscribe to the new shares. The subscription agreements contain certain conditions, including the fact that the market price of Senzime's share does not fall below a certain level at the date of subscription. In the circle of subscribers, Segulah Venture AB has undertaken to subscribe to 2,500,000 shares, corresponding to a subscription of SEK 15 million. The subscription price in the directed new issue has been determined at arm's length negotiations with Segulah Venture AB and corresponds to a discount of approximately 8 percent compared to the volume weighted average price of the share in the previous 10 trading days. Marketability has been ensured through the above-mentioned negotiations and taking into account prevailing market conditions. One condition for Segulah Venture AB's investment is that some existing main shareholders in the Company also participate in the funding. Against this background, shareholders Ulf Lindskog with family and network, and Adam Dahlberg with family and network are included in the circle of subscribers, who together subscribe for shares of 10 MSEK. A detailed record of the shareholders to which the issue is directed will be included in the notice of the Extraordinary General Meeting. The Board will convene an Extraordinary General Meeting to be held on March 5, 2018, for a resolution on the new issue. Through the issue, the share capital will increase by no more than SEK 520,833.38 to SEK 5,607,611.26, which means a dilution of no more than 9.3 percent of both the number of shares and votes (options not taken into account). Advisor In connection with the transaction, Senzime has engaged Advokatfirman Lindahl as legal adviser. For further information, please contact:  Lena Söderström, CEO of Senzime AB                                      Tel: +46 708-16 39 12, lena.soderstrom@senzime.com  TO THE EDITORS  About Senzime  Senzime develops unique patient-oriented monitoring systems that make it possible to assess patients' biochemical and physiological processes before, during and after surgery. The portfolio of technologies includes bedside systems that enable automated and continuous monitoring of life-critical substances such as glucose and lactate in both blood and tissues, as well as systems to monitor patients’ neuromuscular function perioperatively and in the intensive care medicine setting. The solutions are designed to ensure maximum patient benefit, reduce complications associated with surgery and anesthesia, and decrease health care costs. Senzime operates in growing markets that in Europe and the United States are valued in excess of SEK 10 billion. The company's shares are listed on Nasdaq First North (ticker SEZI). FNCA is Certified Adviser for Senzime. www.senzime.com  This information is insider information that Senzime AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication through the agency of the contact person set out above, on February 16, 2018.  

Senzime’s Year-end Bulletin 2017

"Now, Senzime takes a big step towards the market. We have unique, CE-approved medical technology systems ready to cost-effectively prevent millions of healthcare complications - every year. We have conducted many years of research and today have a number of distributor and license agreements in place. This financing will enable us to accelerate market rollout and will strengthen our position in negotiations with additional potential strategic partners," says Lena Söderström, President and CEO of Senzime. Financial information fourth quarter 2017 ·  Net sales amounts to KSEK 15 (185) ·  Income after financial items amounts to KSEK -3,671 (-3,572). ·  Earnings per share before dilution amounts to SEK -0.09 (-0.10). Financial information January - December 2017 ·  Net sales amounts to KSEK 189 (1,628) ·  Income after financial items amounts to KSEK -13,027 (-9,412). ·  Earnings per share before dilution amounts to SEK -0.33 (-0.34). For further information, please contact: Jessica Roxhed, CFO Tel: +46 703-94 94 98, e-mail: jessica.roxhed@senzime.com  TO THE EDITORS   About Senzime   Senzime develops unique patient-oriented monitoring systems that make it possible to assess patients' biochemical and physiological processes before, during and after surgery. The portfolio of technologies includes bedside systems that enable automated and continuous monitoring of life-critical substances such as glucose and lactate in both blood and tissues, as well as systems to monitor patients’ neuromuscular function perioperatively and in the intensive care medicine setting. The solutions are designed to ensure maximum patient benefit, reduce complications associated with surgery and anesthesia, and decrease health care costs. Senzime operates in growing markets that in Europe and the United States are valued in excess of SEK 10 billion. The company's shares are listed on Nasdaq First North (ticker SEZI). FNCA is Certified Adviser for Senzime. www.senzime.com  This information is insider information that Senzime AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication through the agency of the contact person set out above, on February 16th 2018.

Nomination Committee motions ahead of the 2018 Annual General Meeting of Beijer Alma

The Nomination Committee proposes the re-election of Chairman of the Board Johan Wall and directors Johnny Alvarsson, Carina Andersson, Anders G. Carlberg, Caroline af Ugglas and Anders Ullberg. After ten years as a director at Beijer Alma, Peter Nilsson has declined re-election.   The Nomination Committee proposes that Cecilia Wikström be elected as a new director. Beijer Alma is an international industrial group with most of its operations conducted in markets outside Sweden, primarily in Europe. Her broad contact network and in-depth knowledge of the European public and private sectors would make Cecilia Wikström a major asset to Beijer Alma’s Board of Directors as it pursues the company’s continued international expansion. In 2017, Cecilia Wikström was ranked among the four most influential Members of the European Parliament. She has served as Chair of the Conference of Committee Chairs since 2017 and previously served as a Member of the Swedish Riksdag, and worked as an executive recruiter in the private sector. Cecilia has deep ties to the academic world, having previously served as a member of the Board at Uppsala University and now at Örebro University. Cecilia Wikström was born in 1965 and holds a Bachelor of Theology from Uppsala University. Beijer Alma’s Nomination Committee was appointed at the 2017 Annual General Meeting and comprises the following members: Anders Wall, in his capacity as principal owner, and Chairman of the Board Johan Wall, as well as three representatives of the next largest shareholders: Henrik Didner (Didner & Gerge AB), Hans Ek (SEB Fonder) and Vegard Søraunet (Odin Fonder). All Nomination Committee motions will be presented in the notice of the Annual General Meeting.

Hansa Medical receives FDA Orphan Drug Designation for IdeS and the treatment of Guillain-Barré syndrome

“We are pleased to receive orphan designation for IdeS in the US for the treatment of Guillain-Barré syndrome. IdeS’ fast and effective ability to cleave IgG antibodies has significant treatment potential in Guillain-Barré syndrome and we are planning a Phase II study with IdeS in this acute neurological disease”, states Ulf Wiinberg, Acting CEO at Hansa Medical AB. Guillain Barré syndrome (GBS) is an acute autoimmune disease in which the peripheral nervous system is attacked by the immune system and IgG-antibodies. It affects 1-2 in 100,000 people annually1. In February 2017, preclinical data demonstrating the treatment potential of IdeS in GBS were published2. In a model of GBS, inactivation of IgG by IdeS treatment significantly promoted the recovery and reduced the degeneration of peripheral nerves. The data show that treatment with IdeS could potentially become a novel therapeutic strategy for the treatment of GBS. 1. McGrogan et al., “The Epidemiology of Guillain-Barré Syndrome Worldwide“, Neuroepidemiology;2009, 32(2):150-632. Wang et al. “IgG-degrading enzyme of Streptococcus pyogenes (IdeS) prevents disease progression and facilitates improvement in a rabbit model of Guillain-Barré syndrome”, Exp Neurol. 2017 May;291:134-140 This is information that Hansa Medical AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below at 9:45am CET on February 16, 2018. For further information, please contact:Hansa Medical AB (Publ)Emanuel Björne, Vice President Business Development and Investor RelationsMobile: +46707175477E-mail: emanuel.bjorne@hansamedical.comwww.hansamedical.com About IdeSIdeS, IgG-degrading enzyme of Streptococcus pyogenes, is an enzyme that depletes IgG antibodies fast and effectively. Hansa Medical is developing IdeS as a proprietary treatment to enable kidney transplantation in sensitized patients, previously unable to undergo transplantation surgery due to the presence of anti-HLA IgG antibodies. Efficacy data reported from three Phase II studies have demonstrated that IdeS rapidly and significantly reduced anti-HLA antibodies, enabling transplantation. IdeS is currently being evaluated in highly sensitized patients that do not respond to available desensitization methods. Results from two ongoing studies are expected in 2018. In addition to transplantation, IdeS is being evaluated in a clinical Phase II study in the rare autoimmune disease anti-GBM antibody disease and IdeS has potential applications in a variety of additional autoimmune diseases. IdeS is protected by several patents and results of studies with IdeS have been published in a number of peer reviewed scientific journals. About Hansa MedicalHansa Medical is a biopharmaceutical company developing novel immunomodulatory enzymes for transplantation and acute autoimmune diseases. The lead product, IdeS, is a proprietary antibody-degrading enzyme currently in late-stage clinical development for kidney transplant patients, with significant potential for further development in other solid organ transplants and in acute autoimmune indications. The company also has a strong pipeline of preclinical projects that may provide a second wave of potential drugs. Under the project name NiceR, novel immunoglobulin-cleaving enzymes are developed for repeat dosing with the objective of applying the Hansa Medical technology in relapsing autoimmune diseases and oncology. Hansa Medical is based in Lund, Sweden, and its shares are listed on Nasdaq Stockholm (ticker: HMED).

Solteq Plc: Correction to the notice to the Annual General Meeting of shareholders March 27, 2018

Solteq Plc Stock Exchange Bulletin 16.2.2018 at 11.00 am. The notice to the Annual General Meeting (released at 08:00 this morning) was incomplete as a part of the board’s proposals were missing from it. Enclosed the invitation in its correct form: Shareholders of Solteq Plc are hereby invited to the Annual General Meeting of Shareholders to be held on 27 March, 2018 at 10 a.m. in the Clarion Hotel Helsinki Airport, address Karhumäentie 5. The reception of the shareholders registered for the meeting begins at 9.30 a.m. A. Matters on the agenda of the General Meeting At the general meeting, the following matters will be considered: 1. Opening of the meeting 2. Calling the meeting to order 3. Election of persons to scrutinize the minutes and to supervise the counting of votes 4. Recording the legality of the meeting 5. Recording the attendance at the meeting and adoption of the list of votes 6. Presentation of the annual accounts, the report of the board of directors and the auditor’s report for the year 2017 Review by the CEO 7. Adoption of the annual accounts 8. Resolution on the use of the profit shown on the balance sheet and the payment of dividend The Board of Directors proposes to the General Meeting that no dividend will be paid from the financial period 2017. 9. Resolution on the discharge of the members of the board of directors and the CEO from liability 10. Resolution on the remuneration of the members of the board of directors 11. Resolution on the number of members of the board of directors 12. Election of members of the board of directors 13. Resolution on the remuneration of the auditor 14. Election of auditor 15. Proposal by the board of directors for parallel company names and to amend the articles of association The board of directors proposes that the company shall adopt Solteq Apb and Solteq Plc as parallel company names. The board of directors proposes that clause 1 § Business name and domicile of Articles of Association is amended as follows: 1 § Business name and domicile The company’s business name is Solteq Oyj, Solteq Abp in Swedish and Solteq Plc in English. The company is domiciled in Vantaa. 16. Authorizing the board of directors to decide on the issuance of shares as well as the issuance of options and other special rights entitling to shares The board of directors proposes that the board of directors is authorized to decide on share issue, carried out with or without payment and on issuing share options, and other special rights referred to in Chapter 10, Section1 of the Finnish Companies Act as follows: The maximum total amount of shares or other rights is 5,000,000. The authorization includes the right to give new shares or convey company’s own shares. The authorization includes a right to deviate from the shareholders’ pre-emptive right of subscription if there is a significant reason in company’s opinion, e.g. to improve the capital structure, to finance and execute business acquisitions and other business improvement arrangements or to be used as a part of remuneration of personnel. The authorization includes that the board of directors may decide the terms and other matters concerning the share issue The authorization is effective until the next Annual General Meeting, however, no longer than until April 30, 2019. 17. Authorizing the board of directors to decide on accepting the company’s own shares as pledge The board of directors proposes that the board of directors is authorized to decide on accepting the company’s own shares as pledge as follows: The board of directors is authorized to decide on accepting the company’s own shares as pledge (direct) regarding business acquisitions or when executing other business arrangements. Accepting pledge may occur at once or in multiple transactions. The number of own shares to be accepted as pledge shall not exceed 2,000,000 shares. The authorization includes that the board of directors may decide on other terms concerning the pledge. The authorization is effective until the next Annual General Meeting, however, no longer than until April 30, 2019. 18. Closing of the meeting B. Documents of the general meeting The proposals for the decisions on the matters on the agenda of the general meeting as well as this notice are available on Solteq Plc’s website. The annual report, the report of the board of directors and the auditor’s report of Solteq Plc, are available on the above-mentioned website no later than February 19, 2018. The proposals for decisions and the other above-mentioned documents are also available at the meeting. Copies of these documents and of this notice will be sent to shareholders upon request. C. Instructions for the participants in the general meeting 1. Shareholders registered in the shareholders’ register Each shareholder, who is registered on March 15, 2018 in the shareholders’ register of the company held by Euroclear Finland Ltd., has the right to participate in the general meeting. A shareholder, whose shares are registered on his/her personal Finnish book-entry account, is registered in the shareholders’ register of the company. A shareholder, who is registered in the shareholders’ register of the company and who wants to participate in the general meeting, shall register for the meeting no later than March 20, 2018 at 4 p.m. by giving a prior notice of participation, which shall be received by the company no later than on the above mentioned date. Such notice can be given: a) via e-mail: maria.viiru@solteq.com b) by telephone: +358 41 5297745 In connection with the registration, a shareholder shall notify his/her name, personal identification number or company ID, address, telephone number and the name of a possible assistant or proxy representative and the personal identification number of a proxy representative. The personal data given to Solteq Plc is used only in connection with the general meeting and with the processing of related registrations. The shareholder, his/her authorized representative or proxy representative shall, where necessary, be able to prove his/her identity and/or right of representation. 2. Holders of nominee registered shares A holder of nominee registered shares has the right to participate in the general meeting by virtue of such shares, based on which he/she on the record date of the general meeting, i.e. on March 15, 2018, would be entitled to be registered in the shareholders’ register of the company held by Euroclear Finland Ltd. The right to participate in the general meeting requires, in addition, that the shareholder on the basis of such shares has been registered into the temporary shareholders’ register held by Euroclear Finland Ltd. at the latest by March 22, 2018 by 10 am. As regards nominee registered shares this constitutes due registration for the general meeting A holder of nominee registered shares is advised to request without delay necessary instructions regarding the registration in the temporary shareholder’s register of the company, the issuing of proxy documents and registration for the general meeting from his/her custodian bank. The account management organization of the custodian bank has to register a holder of nominee registered shares, who wants to participate in the general meeting, into the temporary shareholders’ register of the company at the latest by the time stated above. 3. Proxy representative and powers of attorney A shareholder may participate in the general meeting and exercise his/her rights at the meeting by way of proxy representation. A proxy representative shall produce a dated proxy document or otherwise in a reliable manner demonstrate his/her right to represent the shareholder at the general meeting. When a shareholder participates in the general meeting by means of several proxy representatives representing the shareholder with shares at different securities accounts, the shares by which each proxy representative represents the shareholder shall be identified in connection with the registration for the general meeting. Possible proxy documents should be delivered in originals to Solteq Plc, Karhumäentie 3, 01530 Vantaa Finland before the last date for registration. 4. Other instructions and information Pursuant to chapter 5, section 25 of the Companies Act, a shareholder who is present at the general meeting has the right to request information with respect to the matters to be considered at the meeting. On the date of this notice to the general meeting, the total number of shares in Solteq Plc is 18.677.597 shares, which represents the same number of votes. Vantaa February 15, 2018 SOLTEQ PLC Board of Directors Additional information: Olli Väätäinen, CEOtel +358 50 5578 111e-mail olli.vaatainen@solteq.com Antti Kärkkäinen, CFOtel +358 40 8444 393e-mail antti.karkkainen@solteq.com         Distribution NASDAQ OMX HelsinkiKey Mediawww.solteq.com Solteq in brief Solteq is a Nordic industry independent IT and software house that specialises in business solutions. We offer total solutions for both business enhancement by means of digitalisation and for omnicommerce: from back end processes all the way to the customer’s purchasing experience and from supply chain management to digital marketing. Our more than 500 experts, who work in five countries, develop and implement solutions for clients in Europe, North America, Asia and Australia. In 2017 Solteq’s net sales amounted to 62 million euro.

Summons to bondholder meeting in NOR10 and voluntary offer

Oslo, 16 February 2018: Norwegian Energy Company ASA ("Noreco" or the "Issuer") has today summoned bondholders in NOR10 (ISIN: NO0010697030) to a bondholders' meeting to be held on 2 March 2018 at 10:00 CET. The Issuer wishes to extend the maturity of the Bond Issue until 6 September 2018. For the extended period of six months, the Issuer proposes increasing the Fixed Rate payable on the Bonds from 6.5% p.a. at present to 10% p.a. In addition, the Issuer wishes to have a call option for the Bonds, exercisable from 6 June 2018 until the new maturity date of 6 September 2018 at 101.50% of par value (plus accrued but unpaid interest). The Issuer has informed the Bond Trustee that the largest Bondholders have signed voting undertakings in favour of the proposal. Furthermore, the Issuer intends to offer each Bondholder, subject to trading restriction in certain jurisdictions, the opportunity to sell to the Issuer its Bonds at a price that equals 100% of par value (plus accrued but unpaid interest until the settlement date of the sale). Bondholders that are interested in selling their Bonds to the Issuer should reach out to Arctic Securities AS at the below contact details by 12:00 hours (Oslo time) 23 February 2018: Arctic Securities AS, Attn.: Anders Berger Email: anders.berger@arctic.com Phone no.: +47 21 01 32 72 Contact: Frederik Rustad Tel.: +47 22 33 60 00 or email: investorrelations@noreco.com 

Conference call regarding Elekta’s Q3 report for 2017/18

STOCKHOLM, February 16, 2018 – Elekta (EKTA-B.ST) will publish its Q3 report for 2017/18 on March 2, as per: · The report will be published at 07:30 CET. · Elekta will host a telephone conference starting at 10:00 CET with Richard Hausmann, President and CEO, and Gustaf Salford, CFO. To take part in the conference call, please dial in about five minutes in advance. · UK dial-in number: +44 (0) 203 008 9808 · US dial-in number: +1 855 753 2237 · Swedish dial-in number: +46 (0) 8 566 426 91  The telephone conference will also be broadcasted live online, through the following link (however, in order to ask questions it is necessary to call in): http://event.on24.com/wcc/r/1610945-1/DED93131C299D012C6AE58D8B0CA96B6?partnerref=rss-events  # # # For further information, please contact:Johan Andersson, Director Investor Relations, Elekta AB.Tel: +46 702 100 451, e-mail: johan.andersson@elekta.com Time zone: CET: Central European Time Tobias Bülow, Director Financial Communications, Elekta ABTel: +46 722 215 017, e-mail: tobias.bulow@elekta.com Time zone: CET: Central European Time About ElektaElekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,600 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm. www.elekta.com

Proposal by the Shareholders’ Nomination Board of Tieto Corporation to the Annual General Meeting to be convened on 22 March 2018

Tieto Corporation STOCK EXCHANGE RELEASE 16 February 2018, 13.00 EET The Shareholders’ Nomination Board of Tieto Corporation proposes to the Annual General Meeting that the meeting would decide as follows: 1 Remuneration of the Board of Directors  The Shareholders’ Nomination Board proposes that the remuneration of the Board of Directors will be annual fees and remain unchanged as follows: EUR 91 000 to the Chairman, EUR 55 000 to the Deputy Chairman and EUR 36 000 to the ordinary members of the Board of Directors. The same fee as to the Board Deputy Chairman will be paid to the Chairman of a Board committee unless the same individual is also the Chairman or Deputy Chairman of the Board. In addition to these fees it is proposed that the member of the Board of the Directors be paid the same remuneration of EUR 800 for each Board meeting as currently and for each permanent or temporary committee meeting. It is the company’s practice not to pay fees to Board members who are also employees of the Tieto Group. The Shareholders’ Nomination Board proposes that 40% of the fixed annual remuneration be paid in Tieto Corporation’s shares purchased from the market. The shares will be purchased within two weeks from the release of the interim report 1 January–31 March 2018. According to the proposal, the Annual General Meeting will resolve to acquire the shares directly on behalf of the members of the Board which is an approved manner to acquire the company’s shares in accordance with the applicable insider rules. The Shareholders’ Nomination Board is of the opinion that increasing long-term shareholding of the Board members will benefit all the shareholders. 2 Number of the members of the Board of Directors The Shareholders’ Nomination Board proposes to the Annual General Meeting that the Board of Directors shall have seven members. 3 Composition of the Board of Directors The Shareholders’ Nomination Board proposes to the Annual General Meeting that the current Board members Kurt Jofs, Harri-Pekka Kaukonen, Timo Ahopelto, Johanna Lamminen, Endre Rangnes and Jonas Synnergren be re-elected and in addition, Liselotte Hägertz Engstam is proposed to be elected as a new Board member. Sari Pajari and Jonas Wiström have informed that they are not available for re-election. The Shareholders’ Nomination Board proposes that Kurt Jofs shall be re-elected as the Chairman of the Board of Directors. The term of office of the Board members ends at the close of the next Annual General Meeting. All the proposed candidates have given their consent to being elected. Liselotte Hägertz Engstam (born 1960), a Swedish citizen, is a non-executive Board professional and currently acts as the Chairman of the Board at Aino Health AB and as a Board Member of Zalaris A/S (publ), Transtema Group AB and Itello AB, among others. She has earlier held Nordic and international executive positions at global IT companies HCL Technologies and IBM as well as at a construction group Skanska. Liselotte Hägertz Engstam holds a Master of Science (Civ.Eng.) from the Chalmers University of Technology and executive education from institutions such as Harvard, IMD and INSEAD. The biographical details of the candidates and information on their holdings is available on Tieto’s website at www.tieto.com/cv. In addition to the above candidates, the company’s personnel shall appoint two members, each with a personal deputy, to the Board of Directors. The term of office for the personnel representatives is two years and Esa Koskinen (deputy Ilpo Waljus) and Robert Spinelli (deputy Anders Palklint) are appointed to the Board until the Annual General Meeting 2020. 4 Shareholders’ Nomination Board The Annual General Meeting 2010 of Tieto Corporation decided to establish a Shareholders’ Nomination Board to prepare proposals for the election and remuneration of the members of the Board of Directors to the Annual General Meeting. The Shareholders' Nomination Board comprises four members nominated by the largest shareholders and the Chairman of the Board of Directors. The largest shareholders of the company were determined on the basis of the shareholdings registered in the Finnish and Swedish book-entry systems on 31 August 2017. The composition of the Shareholders’ Nomination Board having prepared the proposal for AGM 2018 is the following: Martin Oliw, Partner, Cevian Capital AB, Antti Mäkinen, Managing Director, Solidium Oy, Timo Ritakallio, President and CEO, Ilmarinen Mutual Pension Insurance Company, Satu Huber, Chief Executive Officer, Elo Mutual Pension Insurance Company, and Kurt Jofs, Chairman of the Board of Directors, Tieto Corporation. The Shareholders’ Nomination Board shall report in the Annual General Meeting on how its work was conducted. For further information, please contactEsa Hyttinen, Deputy General Counsel, tel. +358 20 727 1764, +358 40 766 6196, email esa.hyttinen (at) tieto.com DISTRIBUTION NASDAQ Helsinki Principal Media Tieto aims to capture the significant opportunities of the data-driven world and turn them into lifelong value for people, business and society. We aim to be customers’ first choice for business renewal by combining our software and services capabilities with a strong drive for co-innovation and ecosystems.  Headquartered in Finland, Tieto has over 14 000 experts in close to 20 countries. Tieto’s turnover is approximately EUR 1.5 billion and shares listed on NASDAQ in Helsinki and Stockholm. www.tieto.com 

Notice to the Annual General Meeting of Tieto Corporation

Tieto Corporation STOCK EXCHANGE RELEASE 16 February 2018, 13.30 EET Notice is given to the shareholders of Tieto Corporation to the Annual General Meeting to be held on Thursday 22 March 2018 at 4.00 p.m. (EET) at Tieto’s headquarters, address Keilalahdentie 2-4, 02150 Espoo, Finland. The reception of persons who have registered for the meeting and the distribution of voting tickets will commence at 3.00 p.m. (EET). A. Matters on the agenda of the Annual General Meeting At the Annual General Meeting, the following matters will be considered: 1      Opening of the meeting 2      Calling the meeting to order 3      Election of persons to scrutinize the minutes and to supervise the counting of votes 4      Recording the legality of the meeting 5      Recording the attendance at the meeting and adoption of the list of votes 6      Presentation of the annual accounts, the report of the Board of Directors and the auditor’s report for the year 2017 · Review by the CEO 7      Adoption of the annual accounts 8     Resolution on the use of the profit shown on the balance sheet and the payment of dividend The Board of Directors proposes to the Annual General Meeting that a dividend of EUR 1.20 per share and an additional dividend of EUR 0.20 be paid from the distributable assets for the financial year that ended on 31 December 2017. The dividend shall be paid to shareholders who on the record date for the dividend payment on 26 March 2018 are recorded in the shareholders’ register held by Euroclear Finland Oy or the register of Euroclear Sweden AB. The dividend shall be paid as from 9 April 2018. 9      Resolution on the discharge of the members of the Board of Directors and the CEO from liability 10     Resolution on the remuneration of the members of the Board of Directors The Shareholders’ Nomination Board proposes that the remuneration of the Board of Directors will be annual fees and remain unchanged as follows: EUR 91 000 to the Chairman, EUR 55 000 to the Deputy Chairman and EUR 36 000 to the ordinary members of the Board of Directors. The same fee as to the Board Deputy Chairman will be paid to the Chairman of a Board committee unless the same individual is also the Chairman or Deputy Chairman of the Board. In addition to these fees it is proposed that the member of the Board of the Directors be paid the same remuneration of EUR 800 for each Board meeting as currently and for each permanent or temporary committee meeting. It is the company’s practice not to pay fees to Board members who are also employees of the Tieto Group. The Shareholders’ Nomination Board proposes that 40% of the fixed annual remuneration be paid in Tieto Corporation’s shares purchased from the market. The shares will be purchased within two weeks from the release of the interim report 1 January–31 March 2018. According to the proposal, the Annual General Meeting will resolve to acquire the shares directly on behalf of the members of the Board which is an approved manner to acquire the company’s shares in accordance with the applicable insider rules. The Shareholders’ Nomination Board is of the opinion that increasing long-term shareholding of the Board members will benefit all the shareholders. 11      Resolution on the number of members of the Board of Directors The Shareholders’ Nomination Board proposes to the Annual General Meeting that the number of Board members be seven. 12      Election of members of the Board of Directors and the Chairman The Shareholders’ Nomination Board proposes to the Annual General Meeting that the current Board members Kurt Jofs, Harri-Pekka Kaukonen, Timo Ahopelto, Johanna Lamminen, Endre Rangnes and Jonas Synnergren be re-elected and in addition, Liselotte Hägertz Engstam is proposed to be elected as a new Board member. Sari Pajari and Jonas Wiström have informed that they are not available for re-election. The Shareholders’ Nomination Board proposes that Kurt Jofs shall be re-elected as the Chairman of the Board of Directors. The term of office of the Board members ends at the close of the next Annual General Meeting. All the proposed candidates have given their consent to being elected. Liselotte Hägertz Engstam (born 1960), a Swedish citizen, is a non-executive Board professional and currently acts as the Chairman of the Board at Aino Health AB and as a Board Member of Zalaris A/S (publ), Transtema Group AB and Itello AB, among others. She has earlier held Nordic and international executive positions at global IT companies HCL Technologies and IBM as well as at a construction group Skanska. Liselotte Hägertz Engstam holds a Master of Science (Civ.Eng.) from the Chalmers University of Technology and executive education from institutions such as Harvard, IMD and INSEAD. The biographical details of the candidates and information on their holdings are available on Tieto’s website at www.tieto.com/cv. In addition to the above candidates, the company’s personnel shall appoint two members, each with a personal deputy, to the Board of Directors. The term of office for the personnel representatives is two years and Esa Koskinen (deputy Ilpo Waljus) and Robert Spinelli (deputy Anders Palklint) are appointed to the Board until the Annual General Meeting 2020. 13      Resolution on the remuneration of the auditor The Board of Directors proposes to the Annual General Meeting, in accordance with the recommendation of the Audit and Risk Committee of the Board of Directors, that the auditor to be elected at the Annual General Meeting be reimbursed according to the auditor's invoice and in compliance with the purchase principles approved by the Committee. 14      Election of the auditor The Board of Directors proposes to the Annual General Meeting, in accordance with the recommendation of the Audit and Risk Committee of the Board of Directors, that the firm of authorized public accountants PricewaterhouseCoopers Oy be re-elected as the company's auditor for the financial year 2018. The firm of authorized public accountants PricewaterhouseCoopers Oy has notified that KHT Tomi Hyryläinen will act as the auditor with principal responsibility. The Audit and Risk Committee has prepared its recommendation in accordance with the EU Audit Regulation (537/2014). The Audit and Risk Committee confirms that its recommendation is free from influence by a third party and that no clause of the kind referred to in paragraph 6 of Article 16 of the EU Audit Regulation, which would restrict the choice by the Annual General Meeting as regards the appointment of the auditor, has been imposed upon it. 15      Authorizing the Board of Directors to decide on the repurchase of the company’s own shares The Board of Directors proposes to the Annual General Meeting that the Board of Directors be authorized to decide on the repurchase of the company’s own shares as follows: · The amount of own shares to be repurchased shall not exceed 7 400 000 shares, which currently corresponds to approximately 10% of all the shares in the company. Only the unrestricted equity of the company can be used to repurchase own shares. · Own shares can be repurchased at a price formed in public trading on the date of the repurchase or at a price otherwise formed on the market. · The Board of Directors decides how the share repurchase will be carried out. Own shares can be repurchased inter alia by using derivatives. The company’s own shares can be repurchased otherwise than in proportion to the shareholdings of the shareholders (directed repurchase). The authorization cancels previous unused authorizations to decide on the repurchase of the company’s own shares. The authorization is effective until the next Annual General Meeting, however, no longer than until 30 April 2019. 16     Authorizing the Board of Directors to decide on the issuance of shares as well as on the issuance of option rights and other special rights entitling to shares The Board of Directors proposes to the Annual General Meeting that the Board of Directors be authorized to decide on the issuance of shares as well as on the issuance of option rights and other special rights entitling to shares referred to in chapter 10 section 1 of the Companies Act in one or more tranches as follows: · The amount of shares to be issued based on the authorization (including shares to be issued based on the special rights) shall not exceed 7 400 000 shares, which currently corresponds to approximately 10% of all the shares in the company. However, out of the above maximum amount of shares to be issued no more than 700 000 shares, currently corresponding to less than 1% of all of the shares in the company, may be issued as part of the company’s share-based incentive programs. · The Board of Directors decides on the terms and conditions of the issuance of shares as well as of option rights and other special rights entitling to shares. The authorization concerns both the issuance of new shares as well as the transfer of treasury shares. The issuance of shares as well as of option rights and other special rights entitling to shares may be carried out in deviation from the shareholders’ pre-emptive right (directed issue). The authorization cancels previous unused authorizations to decide on the issuance of shares as well as on the issuance of option rights and other special rights entitling to shares. The authorization is effective until the next Annual General Meeting, however, no longer than until 30 April 2019. 17    Closing of the meeting B. Documents of the Annual General Meeting The agenda of the Annual General Meeting, the proposals of the Board of Directors and the Shareholders’ Nomination Board and this notice are available on the company’s website www.tieto.com/agm. The annual report, the report of the Board of Directors and the auditor’s report of Tieto Corporation are available on the website at the latest on 28 February 2018. These documents are also available at the meeting. Copies of these documents and of this notice will be sent to shareholders upon request. The minutes of the meeting will be available on the company’s website at the latest on 5 April 2018. C. Instructions for the participants in the Annual General Meeting 1 Shareholders registered in the shareholders’ register Each shareholder, who is registered on 12 March 2018 in the shareholders’ register of the company held by Euroclear Finland Oy, has the right to participate in the Annual General Meeting. A shareholder, whose shares are registered on his/her Finnish book-entry account, is registered in the shareholders’ register of the company. A shareholder, who is registered in the shareholders’ register of the company and wants to participate in the Annual General Meeting, shall register for the meeting no later than on 16 March 2018 at 3.00 p.m. (EET) by giving a prior notice of participation, which must be received by the company no later than by the above mentioned time. Such notice can be given: · through Tieto’s website at www.tieto.com/agm · by e-mail agm@tieto.com · by phone +358 20 727 1740 (Mon-Fri 9.00 a.m.-3.00 p.m. EET) or · by mail to Tieto, Legal/AGM, P.O. Box 2, FI-02101 Espoo, Finland. In connection with the registration, a shareholder shall notify his/her name, personal identification number or business ID, address, telephone number and the name of a possible assistant or proxy representative and the personal identification number of a proxy representative. The personal data given to Tieto Corporation is used only in connection with the Annual General Meeting and with the processing of related registrations. The shareholder, his/her authorized representative or proxy representative shall, where necessary, be able to prove his/her identity and/or right of representation at the meeting. 2 Holders of nominee registered shares A holder of nominee registered shares has the right to participate in the general meeting by virtue of such shares, based on which he/she on the record date of the general meeting, i.e. on 12 March 2018, would be entitled to be registered in the shareholders’ register of the company held by Euroclear Finland Oy. The right to participate in the general meeting requires, in addition, that the shareholder on the basis of such shares has been registered into the temporary shareholders’ register held by Euroclear Finland Oy at the latest by 19 March 2018 by 10 a.m. (EET). As regards nominee registered shares this constitutes due registration for the general meeting. A holder of nominee registered shares is advised to request without delay necessary instructions regarding the registration in the temporary shareholders' register of the company, the issuing of proxy documents and registration for the general meeting from his/her custodian bank. The account management organization of the custodian bank has to register a holder of nominee registered shares, who wants to participate in the general meeting, into the temporary shareholders’ register of the company at the latest by 19 March 2018 by 10 a.m. For further information on the Annual General Meeting please visit www.tieto.com/agm. 3 Shares registered in Euroclear Sweden AB A shareholder with shares registered in Euroclear Sweden AB’s Securities System who wishes to attend and vote at the Annual General Meeting must: 1      be registered in the shareholders’ register maintained by Euroclear Sweden AB not later than on 12 March 2018.Shareholders whose shares are registered in the name of a nominee must, in order to be eligible to request a temporary registration in the shareholders’ register of Tieto Corporation maintained by Euroclear Finland Oy, request that their shares are reregistered in their own names in the register of shareholders maintained by Euroclear Sweden AB, and procure that the nominee sends the request for temporary registration to Euroclear Sweden AB on their behalf. Such reregistration must be made as of 12 March 2018 and the nominee should therefore be notified well in advance. 2      request temporary registration in the shareholders’ register of Tieto Corporation maintained by Euroclear Finland Oy. Such request shall be submitted in writing to Euroclear Sweden AB no later than on 13 March 2018 at 15.00 Swedish time. This temporary registration made through written request to Euroclear Sweden AB is considered a notice of attendance at the general meeting. Further information on attending the Annual General Meeting is available on www.tieto.com/agm. 4 Proxy representative and powers of attorney A shareholder may participate in the Annual General Meeting and exercise his/her rights at the meeting by way of proxy representation. A proxy representative shall produce a dated proxy document or otherwise in a reliable manner demonstrate his/her right to represent the shareholder at the Annual General Meeting. When a shareholder participates in the Annual General Meeting by means of several proxy representatives representing the shareholder with shares at different securities accounts, the shares by which each proxy representative represents the shareholder shall be identified in connection with the registration for the Annual General Meeting. Possible proxy documents should be delivered in originals to Tieto, Legal/AGM, P.O. Box 2, FI-02101 Espoo, Finland before 16 March 2018. 5 Further instructions and information Pursuant to chapter 5, section 25 of the Finnish Companies Act, a shareholder who is present at the Annual General Meeting has the right to request information with respect to the matters to be considered at the meeting. On the date of this notice to the Annual General Meeting the total number of shares and votes in Tieto Corporation is 74 109 252. The meeting will be conducted primarily in Finnish, and simultaneous translation will be available into English and as necessary into Finnish. Coffee will be served after the meeting. Espoo, 16 February 2018 Tieto Corporation Board of Directors For further information, please contact Esa Hyttinen, Deputy General Counsel, tel. +358 20 727 1764, +358 40 766 6196, email esa.hyttinen (at) tieto.com DISTRIBUTION NASDAQ Helsinki Principal Media Tieto aims to capture the significant opportunities of the data-driven world and turn them into lifelong value for people, business and society. We aim to be customers’ first choice for business renewal by combining our software and services capabilities with a strong drive for co-innovation and ecosystems.  Headquartered in Finland, Tieto has over 14 000 experts in close to 20 countries. Tieto’s turnover is approximately EUR 1.5 billion and shares listed on NASDAQ in Helsinki and Stockholm. www.tieto.com 

Nordea publishes a prospectus regarding the move into the Banking Union and the merger of Nordea Bank AB into Nordea Holding Abp

Nordea publishes a prospectus regarding the proposed merger of Nordea Bank AB (publ) (Nordea Sweden) into Nordea Holding Abp (Nordea Finland) and the subsequent listing of the shares in Nordea Finland. On 6 September 2017, the Board of Directors of Nordea Sweden decided to initiate a re-domiciliation process of the parent company of the Nordea Group from Sweden to Finland, being a member of the Banking Union, which is proposed to be executed as a cross-border reversed merger by way of absorption. Nordea Sweden’s shareholders will receive as merger consideration one new share in Nordea Finland for each share in Nordea Sweden that they own as of the date of the registration of the completion of the merger with the Finnish Trade Register. The shares in Nordea Finland are intended to be listed on the official lists of Nasdaq in Helsinki, Stockholm and Copenhagen upon completion of the merger. The Finnish Financial Supervisory Authority has today approved Nordea Finland’s prospectus in relation to the proposed merger and the subsequent listing of the shares in Nordea Finland received as merger consideration. Nordea expects the net present value (NPV) of the total savings related to resolution fees, deposit guarantees and other transitional effects due to the re-domiciliation to the Banking Union to be approximately EUR 0.9-1.2bn (the calculation does not include potential impact on corporate taxes or capital requirement), compared to remaining domiciled in Sweden. This estimate has slightly shifted based on the current financial information from the expected range of the NPV of EUR 1.1-1.3bn that was communicated by Nordea on 14 December 2017, and is expected to re-shift positively or negatively to reflect changes both in the bank’s balance sheet and the external environment. The difference is primarily attributable to refined calculations relating to the bank’s balance sheet after deductions, lowering the expected positive NPV impact of resolution fees and interest rate deductibility on sub-debt expenses. The NPV estimate remains subject to change and is based on a number of assumptions and judgments. If these assumptions and judgments change, this could impact the estimated benefits expected to arise from the re-domiciliation. The prospectus has been notified to the relevant financial supervisory authorities for use in Sweden, Denmark, Norway, United Kingdom, France and Spain. Finnish, Swedish, Danish, Norwegian, French and Spanish language translations of the prospectus summary are included in the prospectus as annexes, and will be published separately on the Nordea website www.nordea.com . The prospectus will be made available at www.nordea.com  today and, on or about 19 February, at the offices of Nordea Finland at Aleksis Kiven katu 7, FI-00020 Nordea, Helsinki, Finland, as well as at the reception of Nasdaq Helsinki at Fabianinkatu 14, FI-00100 Helsinki, Finland and at the head office of Nordea at Smålandsgatan 17, SE 105 71 Stockholm, Sweden. For further information:Rodney Alfvén, Head of Investor Relations, +46 72 235 05 15Claes Eliasson, Acting Head of Group External Communications, +46 72 141 67 12 Important Notice The distribution of this release may be restricted by law and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restrictions. This release is not directed to, and is not intended for distribution to or use by, any person or entity in any jurisdiction where such distribution, publication or use would be contrary to law or regulation or which would require any registration within such jurisdiction. Any decision with respect to the proposed merger should be made solely on the basis of information contained in the actual notices to the annual general meeting of Nordea, and the prospectus related to the merger as well as on an independent analysis of the information contained therein. You should consult the merger prospectus for more complete information about the Nordea Group and the merger. This release includes forward-looking statements, in particular the NPV estimates discussed herein. Such forward-looking statements are subject to change and based on a number of assumptions and judgments discussed in more detail in the prospectus. The information was submitted for publication, through the agency of the contact persons set out above, at 14:00 CET on 16 February 2018. 

Proposed restructuring of the Aligera Holding AB (publ) group: Invitation for holders of bonds to participate in Super Senior Facility (SSF)

Reference is made to the press release published by Aligera Holding AB (publ) (the “Company” and the bankruptcy estate of the Company, the “Estate”) on26 January 2018 and the press release published on the initiative of a group of the larger holders (named last in this press release) (the “Bondholder Committee”) of the Company’s SEK 500,000,000 senior secured bonds (ISIN SE0005933231) (the “Existing Bonds”) via Nordic Trustee & Agency AB (publ), the agent under the terms and conditions of the Bonds (the “Agent”), on 8 February 2018, in relation to the Restructuring (as defined below). Summary · The Bondholder Committee has on 15 February 2018 entered into a restructuring and lock-up agreement (the “Lock-up Agreement”) including a term sheet (the “Term Sheet”) in relation to the proposed restructuring of the Company’s assets, mainly the Company’s material subsidiaries (including the Guarantors under the Existing Bonds that for the time being have been put into voluntary liquidation with the trustee of the Estate appointed as liquidator) (the “Operating Companies”) and their wind turbines, (the “Restructuring”). Closing of the Restructuring is estimated to take place during the second quarter 2018. · The parties to the Lock-up Agreement undertake to, inter alia, (i) vote in favour of the Restructuring in a written procedure intended to be initiated by 5 March 2018 at the latest; and (ii) not to sell their holdings of Existing Bonds during a lock-up period other than with a right of first refusal for the other parties and during an initial hard lock-up period only to the other parties. · As part of the Restructuring, the Existing Bonds will be exchanged into equity and a reinstated bond (the “Reinstated Bond”) in a newly established special purpose vehicle in the form of a Swedish limited liability company (Sw. aktiebolag) (“NewCo”), that will acquire, inter alia, the shares in the Operating Companies from the Estate (subject to agreement on a share and loan purchase agreement with the Estate). The equity in NewCo will be allocated between the holders of Existing Bonds based on their pro rata holding of Existing Bonds but also depending on their participation in the SSF (as defined below). · The Operating Companies will in connection to closing of the acquisition from the Estate, receive new cash funding through a super senior facility (the “SSF”). The SSF is fully underwritten by the Bondholder Committee. · All holders of Existing Bonds who are, directly or indirectly, registered in the debt register for the Existing Bonds held with Euroclear Sweden AB on 28 February 2018 (the “First Record Date”) are hereby invited by the Bondholder Committee to participate in the SSF pro rata to its holding of Existing Bonds on the First Record Date. · To ensure completion of the Restructuring and to stabilise the transaction process, subscription to participate in the SSF is made through: (a) signing of a combined subscription letter (to subscribe to participate in the SSF) and accession letter (to accede to the Lock-up Agreement) (the “Subscription/Accession Letter”); and (b) providing proof of holding of Existing Bonds on 28 February 2018 (the First Record Date). · Any person who has undertaken to participate in the SSF may not sell its holding of Existing Bonds based on which it has subscribed to participate in the SSF and must provide proof of such holding (minimum) at the relevant record date for entitlement to allotment of the SSF (date to be communicated later in the process) (the “Second Record Date”). · The subscription period to participate in the SSF is 19 February – 2 March 2018 (5 p.m. CET). A copy of this press release has on this day been dispatched to the holders of Existing Bonds in accordance with the notice provisions in the terms and conditions for the Existing Bonds. Copies of the Lock-Up Agreement, the Term Sheet and the Subscription/Accession Letter can be obtained from and including 19 February 2018 by contacting the Agent or Gernandt & Danielsson Advokatbyrå KB (“G&D”) (see contact details last in this press release), subject to providing proof of holding of Existing Bonds. The Restructuring and the SSF For a full description of the Restructuring and the main documents for the Restructuring (including the SSF), please refer to the Lock-up Agreement and Term Sheet. The Restructuring can be summarised as follows: · a significant portion of the Existing Bonds shall be exchanged into equity (mandatory convertible instruments (Sv. konvertibler)) and the Reinstated Bond in NewCo. The remainder of the Existing Bonds shall remain as a claim by all holders of Existing Bonds against the Estate; · NewCo will acquire the Operating Companies, any intragroup loans provided by the Company to the Operating Companies and potentially other assets from the Estate (subject to agreement on a share and loan purchase agreement with the Estate); · NewCo and/or the Operating Companies will receive new cash funding through the SSF; · the Reinstated Bond will rank below the SSF but before the equity and will be allocated to all holders of Existing Bonds based on their pro rata holding of Existing Bonds; · the SSF will consist of a MSEK 40 super senior facility (that may wholly or partially be construed as a UCITS investor compliant bond) with an original issue discount (OID) of 12.5 per cent., providing a cash funding of MSEK 35 to NewCo and/or the Operating Companies (with headroom for an additional MSEK 10, uncommitted on the same terms). The SFF will have cash interest of 7.5 per cent. and a term of 36 months. Further, the SFF will entitle to a preference return of 20 percent of MSEK 40 in the event of a sale of substantially all assets or a majority of the shares in NewCo/the Operating Companies. The SSF will be fully underwritten by the Bondholder Committee with an underwriters fee of 5 per cent.; · both the Reinstated Bond and the SSF will be secured with priority for the SSF. The SSF’s preference return will rank behind the Reinstated Bond but ahead of any other future unsecured indebtedness of NewCo; · the equity in NewCo will be split between all holders of Existing Bonds. Those holders of Existing Bonds that contribute to the SSF will share 70 per cent. (63 per cent. if management incentive shares) of the equity in NewCo pro rata to their SSF contribution. Holders of Existing Bonds who does not participate in the SSF will share the remaining 30 per cent. (27 per cent. if management incentive shares) of the equity pro rata to their holding of Existing Bonds. There will be a possibility to issue shares to management corresponding to maximum 10 per cent. of the equity (pro forma on a fully diluted basis considering the convertibles unless already booked as equity). The holding of equity in NewCo will be governed by a standard term shareholders’ agreement including drag-along, tag-along and pre-emption rights, etc. and the receipt of equity by the holders of Existing Bonds is subject to the entry into such shareholders’ agreement; · the intention is to initiate an exit through a private sale or public listing of NewCo or the Operating Companies or a sale of NewCo’s and/or the Operating Companies’ assets no later than 30 months after the first utilisation date under the SSF; · Robus (as defined below) has, upon the request of the trustee of the Estate, offered a bridge facility to the Operating Companies to bridge urgent financing needs of the Operating Companies (to be used for maintenance and repair work on the wind turbines and to stabilise cash flow) before the Restructuring is completed (the “Bridge Facility”), subject to the provision of security over certain assets by the Operating Companies. The Bridge Facility is subject to negotiation and agreement with the trustee of the Estate and will, to the extent provided, be rolled-over to the SSF upon the first utilisation date under the SSF; · Robus may through its participation in the SSF and its holding of Existing Bonds become a majority owner of NewCo and will as such take an active role in the development of NewCo and its assets; · Closing of the Restructuring is estimated to take place during the second quarter 2018. How to participate in the SSF All holders of Existing Bonds who are, directly or indirectly, registered in the debt register for the Existing Bonds held with Euroclear Sweden AB on 28 February 2018 (the First Record Date) are hereby invited to participate in the SSF pro rata to their holding of Existing Bonds at the First Record Date. There is no right to over subscription or over allotment. Subscription to participate in the SSF can be made during the period19 February – 2 March 2018 (5 p.m. CET) in accordance with the instructions set out below. To subscribe to participate in the SSF, the following actions must be taken: i) sign the Subscription/Accession Letter (authorised signature by the beneficial holder of the Existing Bonds or any person (entity or individual) with authority to manage and act in relation to the holding of such beneficial holder);ii) provide proof of holdings of Existing Bonds on 28 February 2018 (the First Record Date); andiii) send the signed Subscription/Accession Letter and the statement of holdings of Existing Bonds on 28 February 2018 (the First Record Date) to G&D in accordance with the instructions in the Subscription/Accession Letter so that it is received by G&D no later than 2 March 2018, 5 p.m. CET. Detailed instructions on how to subscribe to participate in the SSF are set out in the Subscription/Accession Letter, which can be obtained from and including 19 February 2018 by contacting the Agent or G&D (see contact details last in this press release), subject to providing proof of holding of Existing Bonds. The Subscription/Accession Letter will constitute an irrevocable and binding commitment to participate in the SSF and the subscriber will in the Subscription/Accession Letter guarantee, inter alia, that it has sufficient funds to cover its pro rata share of the SSF. Closing of the Restructuring is estimated to take place during the second quarter 2018 and allotment of the SSF will take place on or around such time. For the avoidance of doubt, any person who has undertaken to participate in the SSF may not sell its Existing Bonds held on 28 February 2018 (the First Record Date) (based on which it has subscribed to participate in the SSF) and must provide proof of such holding (minimum) as per the Second Record Date to be entitled to participate in and receive allotment in the SSF. Any person acceding to the Lock-up Agreement will become a party to the Lock-up agreement and undertake not to sell its holdings of Existing Bonds as per 28 February 2018 during a lock-up period other than with a right of first refusal for the other parties and during an initial hard lock-up period only to the other parties. Allotment of SSF The facility amount under the SSF (i.e., commitment of MSEK 35 considering the OID) shall be allotted between all holders of Existing Bonds who have duly committed to participate in the SSF pro rata to their holdings of Existing Bonds on 28 February 2018 (the First Record Date) provided that their holding is kept at the Second Record Date. If the facility amount under the SSF is not fully subscribed for by holders of Existing Bonds, the remaining part of the facility amount shall be allocated between the Bondholder Committee as underwriters of the SSF according to the terms and conditions of the underwriting agreement between the Bondholder Committee and NewCo. Time Table 19 February – Subscription period for participation in SSF2 March 20182 March 2018, Subscription/Accession Letter and statement of holdings of5 p.m. CET Existing Bonds per the First Record Date must be received by G&D at the latest28 February First Record Date2018TBD Second Record DateQ2 2018 Estimated closing of Restructuring and allotment under SSF The Bondholder Committee On the day of this press release, the Bondholder Committee jointly represents over 60 per cent. of the total nominal amount of the Existing Bonds and are constituted by the following beneficial holders/representatives of beneficial holders: Prime Capital Debt SCS SICAV-FIS Robus Recovery Sub-Fund (a fund managed by Robus Capital Management Ltd.) (“Robus”), JRS Asset Management AB, LMK Forward AB and LMK-Stiftelsen. About this press release This press release has been prepared and communicated on the sole initiative of the Bondholder Committee. The Agent is not responsible for the content of this press release and the Restructuring is presented to the holders of Existing Bonds by the Bondholder Committee, without any evaluation, advice or recommendations from the Agent whatsoever. Contact details and more information For further information in relation to the Restructuring and to retrieve copies of the Lock-up Agreement, the Term Sheet and the Subscription/Accession Letter, please contact: Gernandt & Danielsson Advokatbyrå KB Mikael Borg                                   Caroline Jägenstedt WikmanTelephone: +46 8 670 66 44            Telephone: +46 8 670 66 36E-mail: mikael.borg@gda.se           Email: caroline.j.wikman@gda.se  (caroline.j.wikman@gda.se) For general matters regarding the Existing Bonds and to retrieve copies of the Lock-Up Agreement, the Term Sheet and the Subscription/Accession Letter, please contact: Nordic Trustee & Agency AB (publ)Christoffer Andersson, CEOTelephone: + 46 8 783 79 00E-mail: sweden@nordictrustee.com ***

Kährs Group: Year-end Report 2017

Fourth quarter, October-December · Net sales totalled SEK 769 million (736), an increase of 4 per cent compared with the same period in 2016. Organic sales growth was 5 per cent · Operating EBITA rose 30 per cent and totalled SEK 70 million (54), corresponding to an operating margin of 9,1 per cent (7.3) · Operating profit (EBIT) improved by SEK 79 million during the fourth quarter and totalled SEK 55 million (-24), corresponding to 7.2 per cent (-3.3). The improvement for the quarter can be attributed to higher sales and gross margin, as well as lower items affecting comparability of SEK 15 million (78) · Consolidated profit for the quarter was SEK 26 million (-30) · Earnings per share totalled SEK 857 (-1,011) January - December 2017 · Net sales for 2017 totalled SEK 3,072 million (2,894), an increase of 6 per cent compared with the same period in 2016. Organic sales growth was 5 per cent · Operating EBITA rose 22 per cent compared with the full-year 2016 and totalled SEK 276 million (227), corresponding to an operating margin of 9,0 per cent (7.8) · Operating profit (EBIT) for the period was SEK 148 million (133), corresponding to 4.8 per cent (4.6), including a negative impact for items affecting comparability of SEK 128 million (94) relating primarily to a provision for tariff costs in the US as well as changes in production structure in Finland · Consolidated profit for the period was SEK 86 million (59) · Earnings per share totalled SEK 2,861 (1,972) President and CEO Christer Persson comments:”The Kährs Group showed stable sales growth of 4 per cent in the fourth quarter of 2017. The Nordics and Resilient Global segments demonstrated the strongest growth, but the Europe segment also performed somewhat better than the previous year, while sales for Other Markets declined during the quarter. Consolidated operating EBITA increased by 30 per cent during the quarter to SEK 70 million, corresponding to a margin of 9.1 per cent. Kährs Group had a successful year in 2017 during which we further strengthened our competitive position in several markets. We launched an array of important initiatives over the course of the year to promote continued positive growth.” For further information, please contact:Christer Persson, President and CEO, tel: +46 70 271 20 14Peter Ericsson, CFO, tel: +46 70 461 10 39   About Kährs Holding AB (publ)Kährs Holding AB (publ) is a leading European flooring manufacturer in hardwood and resilient flooring with a number of strong brands in its product portfolio, including Kährs, Karelia and Upofloor. The Company’s innovations have shaped the industry throughout history and Kährs Group is dedicated to providing the market with innovative new flooring solutions. Kährs Group, which delivers products to more than 70 countries, is the market leader in Sweden, Finland, Norway and Russia and holds a strong position in other key markets, such as the UK and Germany. The Group has approximately 1,700 employees and annual sales of more than SEK 3 billion. www.kahrsgroup.com

Comments regarding financial situation in CybAero AB

On July 24, 2017, CybAero signed a financing agreement with Dubai-based Bracknor Investment Group, providing a financing solution amounting to USD 5.25 million in the form of seven convertible loans Ongoing discussions with Bracknor on the delivery of the agreement's third tranche of USD 850 000 are at an impasse and CybAero no longer thinks it is likely that Bracknor will deliver the requested funds. This has led CybAero to an acute liquidity shortage. CybAero is currently examining how long the existing liquidity is sufficient to run the company. CybAero examines if more than half of the share capital has been consumed. If so, CybAero will establish a balance sheet review, in accordance with the Swedish Companies Act, Chapter 25, 13. CybAero is currently discussing with other financiers about the opportunity to solve the emerging situation. If the discussions are not successful a bankruptcy could not be ruled out. For additional information, contact:Michael Auerbach, Chairman CybAero ABPhone +46 13 465 29 00Email: ir@cybaero.se Web:  www.cybaero.se         Videos: www.youtube.com/cybaero About CybAeroCybAero develops and manufactures Remotely Piloted Aircraft Systems (RPAS) for safer and more effective aerial operations in various environments, including those hazardous in nature. The company has made a great international impact with its APID One helicopter, which can be adapted for both military and civilian applications such as coastal and border surveillance, search and rescue missions, and mapping. CybAero’s head office is located in Mjärdevi Science Park in Linköping, Sweden. The company has been listed on the NASDAQ First North since 2007. FNCA Sweden AB is the company's certified adviser. This information is information that CybAero AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 15:00 CET on 16 february 2018.

Catena Media issues EUR 150 million new senior unsecured bonds and refinances existing EUR 100 million secured bonds

Catena Media plc (“Catena Media” or “the Group”) has successfully placed EUR 150 million senior unsecured bonds due 2021 (the “New Bonds”) under a framework of EUR 250 million (the “New bond Loan”). The interest rate for the New Bonds is Euribor 3m + 5.50 per cent, with a Euribor floor at 0. Catena Media intends to list the New Bonds on Nasdaq Stockholm. The proceeds from the transaction will be used to refinance Catena Media’s existing EUR 100 million outstanding bonds with ISIN SE0008964720 maturing in September 2019 (the “Existing Bonds”) and for general corporate purposes, including acquisitions. Through the issue of the New Bond Loan, the Company secures multiple financial benefits compared to the Existing Bonds including i.a.: · Reduced interest rate margin, from 6.75% to 5.50% · Increased framework amount, from EUR 100 million to EUR 250 million · Release of security, which security can be utilized for other sources of financing · Increased permission for additional debt, including bank debt, from approximately EUR 3 million to the higher of EUR 30 million or 75% of the Group’s EBITDA  “We are very pleased with the great interest that has been shown from investors to participate in this transaction, both from our existing bondholders rolling over to the New Bonds as well as from new investors. The New Bonds provide us with a lower cost of financing as well as increased flexibility for additional financing, which we consider as an important step in our continued development. With this, we have enhanced our capacity to continue on our strategic path and to be a leading player in the ongoing consolidation of the affiliate market space”, says Henrik Persson Ekdahl, Acting CEO. Further information regarding the redemption of the Existing Bonds will be announced by Catena Media in a separate press release. Carnegie and Danske Bank acted as Joint Bookrunners to Catena Media in connection with the transaction and Gernandt & Danielsson acted as legal advisor. For further information, please contact: Henrik Persson Ekdahl, Acting CEO, Catena Media plcPhone: +46 706 91 43 43, E-mail: henrik.persson@catenamedia.com Åsa Hillsten, Head of IR & Communications, Catena Media plcPhone: +46 700 81 81 17, E-mail: asa.hillsten@catenamedia.com This information is information that Catena Media plc is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons above, on February 16th, 2018 at 15:30 CET. About Catena Media Catena Media plc is an online performance marketing company that has established a leading position through strong organic growth and acquisitions. The business was started in 2012 and the group had 282 employees by the end of 2017 in the US, Australia, Japan, Serbia, UK, and Malta, where the Head Office is situated. In 2017, revenues reached EUR 67,6 million. The company is listed on Nasdaq Stockholm Mid Cap. Further information is available at www.catenamedia.com.

Catena Media plc announces early redemption of existing bonds due 2019

Catena Media plc (“Catena Media” or “the Company”) gives notice that it will redeem in full its outstanding bonds 2016/2019 with ISIN SE0008964720 (the “Existing Bonds”). The early redemption date is set to March 16, 2018. As determined in the manner described in the terms and conditions of the Existing Bonds, all Existing Bonds will be redeemed at the redemption price of 103.38 per cent. of the nominal amount (i.e. EUR 103,380 per Existing Bond). Any accrued and unpaid interest will also be paid in respect of the Existing Bonds in accordance with the terms and conditions of the Existing Bonds.   The redemption amount will be paid to each person who is registered as owner of Existing Bonds in the debt register maintained by Euroclear Sweden at end of business on March 9, 2018. In connection with the redemption, the Existing Bonds will be delisted from Nasdaq Stockholm. A notice of early redemption is sent to directly registered owners and registered authorised nominees (Sw. förvaltare) of the Existing Bonds as of February 16, 2018 in the debt register. This announcement is for information purposes only and is not to be construed as an offer to purchase or sell or a solicitation of an offer to purchase or sell with respect to any securities of Catena Media.  For further information, please contact: Henrik Persson Ekdahl, Acting CEO, Catena Media plcPhone: +46 706 91 43 43, E-mail: henrik.persson@catenamedia.com  Åsa Hillsten, Head of IR & Communications, Catena Media plcPhone: +46 700 81 81 17, E-mail: asa.hillsten@catenamedia.com The information was submitted for publication, through the agency of the contact persons above, on February 16, 2018 at 15:45 (CET). About Catena Media Catena Media plc is an online performance marketing company that has established a leading position through strong organic growth and acquisitions. The business was started in 2012 and the group had 282 employees by the end of 2017 in the US, Australia, Japan, Serbia, UK, and Malta, where the Head Office is situated. In 2017, revenues reached EUR 67,6 million. The company is listed on Nasdaq Stockholm Mid Cap. Further information is available at www.catenamedia.com.

Kesko to discontinue its building and home improvement trade operations in Russia

Kesko to discontinue its building and home improvement trade operations in Russia  Kesko Corporation has agreed today to sell 12 building and home improvement store properties in Russia to Leroy Merlin Vostok LLC, a Russian division of the French Leroy Merlin. Leroy Merlin is the biggest building and home improvement store chain in Russia. The transaction price paid for the properties in cash is approximately RUB 12 billion (some €169 million). “In accordance with its strategy, Kesko is focusing on the grocery trade, building and technical trade, and car trade. In recent years, we have significantly grown our building and technical trade. Our objective is to grow sales and improve profitability especially in the stable and growing Northern European markets. We have decided to withdraw from the Russian market. Our investments in Russia have not met the objectives set for them, and expanding our operations in Russia outside St. Petersburg and Moscow would have required significant additional investments. The transaction will have a minor impact on Kesko’s net sales and operating profit, but it will significantly improve our return on capital employed,” says Mikko Helander, Kesko’s President and CEO.  In 2017, Kesko had 14 K-Rauta stores in Russia. In the transaction, Kesko sells 12 K-Rauta properties in the St. Petersburg and Moscow regions. The business operations conducted in the properties and stocks are not included within the scope of the transaction; instead, those business operations will be discontinued during spring 2018. The ownership of the properties will transfer to the buyer in H1/2018. The operations of two K-Rauta properties in the Moscow region not included in the transaction will be discontinued during H1/2018. Combined, the operations to be discontinued employ approximately 1,800 people. In 2017, Kesko’s building and home improvement trade operations in Russia recorded net sales of €184 million and a comparable operating profit of €0.6 million. The divestment of the properties will result in a positive cash flow of €169 million for Kesko Corporation. In Kesko’s consolidated income statement, the discontinuation of the Russian building and home improvement trade operations is presented as discontinued operations for both this year and the comparison period. A gain on sale of approximately €10 million will be recorded in discontinued operations for the divested properties. The profit impact of the shutdown of operations in discontinued operations is estimated to be some €-20 million. Moreover, as a result of the discontinuation of Kesko’s Russian building and home improvement trade operations, negative exchange differences of approximately €-37 million included in equity in the consolidated statement of financial position will be recorded as expenses under discontinued operations in the consolidated financial statement. Leroy Merlin is an international building and home improvement retail company with more than 450 stores all over the world. Leroy Merlin expanded to Russia in 2004 and currently has 75 stores in the country with more than 23,000 employees. Leroy Merlin is part of the privately owned French Groupe Adeo, which is the largest building and home improvement trade operator in Europe. Kesko Corporation’s outlook for Q1/2018-Q4/2018 will remain unchanged, as stated in the financial statements release published on 1 February 2018: In comparable terms, the net sales for the next 12 months are expected to exceed the level of the previous 12 months. Due to divestments and restructuring, Kesko Group's net sales for the next 12 months are expected to fall below the level of the previous 12 months. The comparable operating profit for the next 12-month period is expected to exceed the level of the preceding 12 months. However, investments in store openings and redesigns, in the expansion of logistics operations, and in digital services will burden profitability during the period.  Further information:Jukka Erlund, Executive Vice President, Chief Financial Officer, Kesko Corporation, tel. +358 105 322 113, jukka.erlund@kesko.fiJorma Rauhala, Deputy to President and CEO of Kesko Corporation, President of the building and technical trade division, tel. +358 105 322 211, jorma.rauhala@kesko.fiInvestors and analysts: Kia Aejmelaeus, Vice President, Investor Relations, Kesko Corporation, tel. +358 40 765 4616, kia.aejmelaeus@kesko.fiMedia: Jessica Diktonius, Vice President, Communications, building and technical trade division, tel. +358 40 709 9176, jessica.diktonius@kesko.fi Kesko Corporation DISTRIBUTIONNasdaq Helsinki LtdMain news mediawww.kesko.fi Kesko and K-retailers form K Group, whose sales total €13 billion. K Group is the third largest retail operator in northern Europe and it employs approximately 42,000 people. Kesko operates in the grocery trade, the building and technical trade and the car trade. Its divisions and chains act in close cooperation with retailer entrepreneurs and other partners. Kesko's net sales are €10 billion and it employs approximately 25,000 people. Kesko has some 1,800 stores engaged in chain operations in Finland, Sweden, Norway, Estonia, Latvia, Lithuania, Russia, Belarus and Poland. Kesko is a listed company and its shares are listed on Nasdaq Helsinki. The company's domicile and main premises are in Helsinki. Kesko is the world's most sustainable trading sector company (The Global 100 Most Sustainable Corporations in the World). www.kesko.fi Leroy Merlin is an international retail company selling goods for home, cottage and garden improvement, construction, and decoration. Leroy Merlin incorporates more than 450 stores all over the world and offers its customers a wide selection of quality goods, attractive prices, and a high level of services. Each store offers a wide range of products in five main areas: home, interior design, building materials, repair, and garden. The first Leroy Merlin hypermarket in Russia opened in 2004 in Mytishchi, Moscow Region. By 2018, 75 stores had been launched in our country. More than 23,000 people are employed at Leroy Merlin stores across Russia. «Low prices every day» – the concept, which unites all stores in Russia.

Scandi Standard – Fourth quarter presentation

Scandi Standard will publish its report for the fourth quarter 2017 on Tuesday, 20 February 2018 at 07.30 CET. Conference call at 10.0o CETThe Company will host a conference call for the financial community at 10.00 CET the same day.The conference call will be hosted by Leif Bergvall Hansen, CEO and Anders Hägg, CFO. Dial in numbers:Sweden: 010 884 80 16UK: 020 3936 2999USA: 1 845 709 8568All other locations: +44 20 3936 2999 Participant Access Code: 78 87 03 The presentation used in the conference call will be published at http://www.scandistandard.com prior to the call. The conference call will also be audio webcasted in "listen-only" mode at the Scandi Standard website or click: Audio web cast For further information, please contact:ir@scandistandard.com Please note: This information is information that Scandi Standard AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 07.30 CET on 19 February 2018.   About Scandi Standard Scandi Standard is passionate about the tasty, healthy and climate-smart chicken! We are the leading producer of chicken-based food products in the Nordic region and Ireland. The company produces, markets and sells ready to eat, chilled and frozen products under the well-known brands Kronfågel, Danpo, Den Stolte Hane, Naapurin Maalaiskana and Manor Farm. In Norway eggs are also produced   and sold. We are approximately 3 000 employees and have a total sales of more than SEK 7,5 billion. For more information, please visit www.scandistandard.com.  

BerGenBio completes recruitment into first stage of Phase II breast cancer trial with selective AXL inhibitor bemcentinib combined with KEYTRUDA®

The Phase II trial (BGBC007) follows a two-stage design: it is an open label, multi-centre study of bemcentinib in combination with KEYTRUDA in patients with previously treated, locally advanced and unresectable or metastatic triple negative breast cancer (TNBC) or triple negative inflammatory breast cancer (TN-IBC). Up to 56 patients in total will be included in the study (NCT03184558). The trial is designed to evaluate efficacy and safety of the combination, and to correlate the patient response with biomarker status (AXL kinase and PD-L1 expression). In parallel, companion diagnostics using these biomarkers, and others, are being developed for the identification of patients predicted to be most suitable for treatment with the bemcentinib / KEYTRUDA combination. Interim results are expected mid-year 2018. The trial, which began in October 2017, is being conducted under a clinical collaboration with Merck & Co., Inc., Kenilworth, N.J., USA, through a subsidiary, and is taking place at more than 16 clinical sites in the US and Europe. Richard Godfrey, Chief Executive Officer of BerGenBio, commented: “We are delighted to have completed patient enrolment into the first part of this Phase II trial in such a short time and ahead of schedule. Immuno-oncology therapies, such as KEYTRUDA, are now established as a major treatment option for cancer patients and we are excited with the progress being seen across our clinical trials exploring if bemcentinib in combination with KEYTRUDA can result in significantly improved patient outcomes. Positive results from these trials, and from our broader Phase II development programme will help confirm the great potential we see for bemcentinib as a cornerstone therapy across multiple cancer indications and in combination with existing and emerging modalities of cancer treatment. We look forward to interim results from this and other studies during 2018.” Preliminary safety data, reported at the ASCO-SITC Clinical Immuno-Oncology Symposium (January 2018), found that the bemcentinib / KEYTRUDA combination was well tolerated in a sample of patients across three cancer indications in which it is being studied (advanced breast cancer, lung cancer and melanoma) with a safety profile similar to KEYTRUDA alone. Nineteen of the 34 patients evaluated in this analysis were from the BGBC007 breast cancer trial. -End- About TNBC Breast cancer is the most common cancer in women – it is estimated that more than 250,000 new cases will be diagnosed in the US in 2018. 20% of breast cancers lack receptors for three common hormones (oestrogen, progesterone and HER2) and are thus called triple-negative breast cancers (TNBC). Treatment options for TNBC are limited to intense chemotherapy, but disease recurrence is frequent and aggressive. Consequently, novel treatment strategies for TNBC are urgently needed. About BerGenBio ASA   BerGenBio ASA is a clinical-stage biopharmaceutical company focused on developing a pipeline of first-in-class AXL kinase inhibitors as a potential cornerstone of combination cancer therapy. The Company is a world leader in understanding the essential role of AXL kinase in mediating cancer spread, immune evasion and drug resistance in multiple aggressive solid and haematological cancers. BerGenBio’s lead product, bemcentinib (BGB324), is a selective, potent and orally bio-available small molecule AXL inhibitor in four Company sponsored Phase II clinical trials in major cancer indications, with read-outs anticipated during 2018. It is the only selective AXL inhibitor in clinical development. The Company sponsored clinical trials are: · Bemcentinib with TARCEVA® (erlotinib) in advanced EGFR mutation driven non-small cell lung cancer (NSCLC) · Bemcentinib with KEYTRUDA in advanced adenocarcinoma of the lung, and · Bemcentinib with KEYTRUDA in triple-negative breast cancer (TNBC). · Bemcentinib as a single agent and combination therapy in acute myeloid leukaemia (AML) / myeloid dysplastic syndrome (MDS) The clinical trials combining bemcentinib with KEYTRUDA in adenocarcinoma of the lung and TNBC are conducted in collaboration with Merck & Co., Inc., Kenilworth, NJ, USA, through a subsidiary. In addition, a number of investigator-sponsored trials are underway, including a trial to investigate bemcentinib with either MEKINIST® (trametinib) plus TAFINLAR® (dabrafenib) or KEYTRUDA in advanced melanoma, as well as a trial combining bemcentinib with docetaxel in advanced NSCLC. BerGenBio is simultaneously developing a companion diagnostic test to identify patient subpopulations most likely to benefit from treatment with bemcentinib. This will facilitate more efficient registration trials and support a precision medicine based commercialization strategy. The Company is also developing a diversified pre-clinical pipeline of drug candidates, including BGB149, an anti-AXL monoclonal antibody. For further information, please visit: www.bergenbio.com  KEYTRUDA® is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA, TARCEVA® is a registered trademark of OSI Pharmaceuticals, LLC., marketed by Roche-Genentech. TAFLINAR® is a registered trademark of Novartis International AG and MEKINIST® is a registered trademark of GSK plc. Contacts   Richard GodfreyCEO, BerGenBio ASA+47 917 86 304 Tom Henrik SundbyFinance Director, BerGenBio ASAtom.sundby@bergenbio.com+47 477 54 415 Media Relations David Dible, Mark Swallow, Marine PerrierCitigate Dewe Rogersonbergenbio@citigatedewerogerson.com +44 207 638 9571 Forward looking statements This announcement may contain forward-looking statements, which as such are not historical facts, but are based upon various assumptions, many of which are based, in turn, upon further assumptions. These assumptions are inherently subject to significant known and unknown risks, uncertainties and other important factors. Such risks, uncertainties, contingencies and other important factors could cause actual events to differ materially from the expectations expressed or implied in this announcement by such forward-looking statements This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Tele2 IoT and Nokia empower enterprises with new model for global IoT deployments

The companies are entering a strategic and bilateral partnership centered around groundbreaking technologies from both companies, such as Nokia’s Worldwide IoT Network Grid (WING) and SIM technologies from Tele2 IoT. Based on the Nokia WING platform, Tele2 IoT will launch an offering that will set enterprises free to develop their own global mobile IoT solutions and ensure a flexible long-term connectivity strategy for their IoT deployments. Enterprises can have their own core network for IoT, delivered as-a-service. This network will be globally distributed and available in key regions, making it possible to achieve local benefits with low latency. Together with new SIM technology, this will enable enterprises to explore new use cases and improve and simplify the management and operations of global mobile IoT deployments. The offering will minimize operations cost and maximize the control of an IoT deployment through a consistent and unified infrastructure for connectivity management, including the telecom standards for LowPowerWideArea (LPWA) technologies, such as LTE-M and NB-IoT. Both companies are fully committed to making this a new paradigm for global IoT connectivity and Tele2 IoT will launch the offering to new customers in the third quarter of 2018. Rami Avidan, CEO of Tele2 IoT, comments: “This is a very important partnership we are forging with Nokia. We want to simplify the global IoT connectivity ecosystem for large enterprises. The offering we will launch based on this partnership will create totally new growth opportunities and give the reliability that is needed for business-critical applications. With this offering we are breaking technical and commercial barriers and combining that with open and dynamic business models”. Ankur Bhan, head of WING at Nokia, comments: “Nokia WING will enable Tele2 IoT to offer its enterprise customers a global service with flexible control, low latency and high levels of efficiency and enterprise automation. Together we will work on enabling new IoT solutions that can be adopted in various industries to deliver seamless, reliable, and efficient processes to help businesses run more intelligently.” Read more about the solution here:http://www.tele2iot.com/nokia/ For more information, please contact:Angelica Gustafsson, Head of Public Relations, Tele2 AB, Phone: +46 704 26 41 42Erik Strandin Pers, Head of Investor Relations, Tele2 AB, Phone: +46 733 41 41 88 TELE2’S MISSION IS TO FEARLESSLY LIBERATE PEOPLE TO LIVE A MORE CONNECTED LIFE. We believe the connected life is a better life, and so our aim is to make connectivity increasingly accessible to our customers, no matter where or when they need it. Ever since Jan Stenbeck founded the company in 1993, it has been a tough challenger to the former government monopolies and other established providers. Tele2 offers mobile services, fixed broadband and telephony, data network services, content services and global IoT solutions. Every day our 17 million customers across 8 countries enjoy a fast and wireless experience through our award winning networks. Tele2 has been listed on the NASDAQ OMX Stockholm since 1996. In 2017, Tele2 had net sales of SEK 25 billion and reported an operating profit (EBITDA) of SEK 6.4 billion. For definitions of measures, please see the last pages of the Annual Report 2016. Follow @Tele2group on Twitter for the latest updates.

Ripasso Energy signs a Memorandum of Understanding to form a project financing company with capacity to acquire 72 PWR BLOK units

Ripasso Energy will be responsible for client contact, EPC (Engineering, Procurement and Construction), O&M (Operations and Maintenance) and provide a cash credit line of up to MEUR 11 over 5 years to GenCo. Ripasso Energy will own 30% of GenCo. The two shareholders, East Guardian Asset Management AG and Miura Holding Limited, will together own 70% of the new company and provide collateral of MEUR 36 in order to facilitate the long-term financing of the purchase of PWR BLOK units by GenCo from Ripasso Energy. All three shareholders of GenCo will participate in the operations of the new company.  GenCo will be set up on the condition that a larger client within the ferrochrome industry signs a power purchase agreement. Sales meetings with potential clients are planned for March and April this year. The establishing of GenCo is also contingent on that a binding legal agreement is signed by all parties. “It is very rewarding that these shareholders, both having supported us greatly during the last two financing rounds, now express enough confidence in PWR BLOK to support the next step in the growth of Ripasso Energy with their balance sheets. The possibility to offer PWR BLOK without significant capital investment or the need to take a technology risk greatly enhances the possibility to build a large order book already this year”, says Sven Sahle, Executive Chairman and largest shareholder of Ripasso Energy. ”The introduction of PWR BLOK and the subsequent first order from Afarak Mogale was a step change in the development of Ripasso Energy and validates the commercial viability of an innovative use of the Stirling technology. We are confident that this massively cost- and energy-saving application of the technology will be adopted across the board in the metals and mining sector, among others”, says Erik Wigertz, CEO of East Guardian Asset Management AG. East Guardian Asset Management AG is a multi-strategy asset manager based out of Zürich, Switzerland.  PWR BLOK is a container-based solution in which Ripasso Energy’s Stirling engines are used to harness energy from flare and industrial residual gas combustion. This allows for significant electricity and cost savings to industries, as well as reducing the global CO2emissions.  The product was launched in September 2017 and the first sales agreement was signed in December the same year. The PWR BLOK 400-F contains 14 Stirling engines and delivers a net output of 400 kW. For additional information related to this press release, please contact Ripasso Energy’s CEO and founder Gunnar Larsson at ir@ripassoenergy.com. For additional information about the company, please visit www.ripassoenergy.com . You can also sign up for the company’s newsletter on the website.  Ripasso Energy is a Swedish cleantech company founded in 2008 to further develop the Stirling technology’s outstanding ability to convert heat energy into electricity. The company offers different solutions for power generation at record low prices, compared to other climate-smart and sustainable alternatives. Ripasso Energy’s Stirling engine has unofficial world record in converting solar energy to electricity with close to twice as high efficiency as competitive technologies. The company is listed in Sweden (NGM Nordic MTF), and can also be traded at Börse Stuttgart in Germany. Read more at www.ripassoenergy.com . Ripasso Energy is required to disclose this information in accordance with the EU Market Abuse Regulation. The information was submitted for publication at the initiative of the above contact person on February 19, 2018, at 08.00 CET.

RhoVac AB announces that all patients in company's clinical phase I/II study successfully completed their treatment phase with RV001.

RhoVac's drug candidate RV001, which targets metastatic cancer cells, is in clinical phase I/II development in patients with diagnosed prostate cancer. The cancer vaccine targets protein RhoC, which is highly over-expressed in metastatic cancer cells - no matter what form of cancer it is derived from. The goal of the RV001 project is to develop a cancer vaccine that prevents or limits the spread of cancer. On April 5th 2017, the company announced that the first patient in the Phase I/II study had started treatment with the cancer vaccine RV001 and in mid-November 2017, the treatment phase was completed for this first patient. All patients have now finished treatment and in March 2018 the final blood samples will be taken for immunological monitoring. The timetable of the clinical study has been in full alignment with the original plan, and the final result will be reported, as previously announced, in the second quarter of 2018. Completion of phase I/II clinical study, is another important milestone for RhoVac in development of cancer vaccine RV001 and we noted that no safety issues have been identified that hinders the continuation of the study. The next step is to prepare for the immunological analyses for all patients and confirm the significant vaccine-mediated immune response that was reported in December 2017. Comments from RhoVac's CEO, Anders Ljungqvist -We are delighted that we have reached the final phase of our clinical study and that we are fully on the scheduled timeline. It has been a fantastic trip. I would like to thank everyone who helped us in the project, in particular Copenhagen Prostate Cancer Center at Rigshospitalet, the Phase I-unit Zelo at Bispebjerg and Frederiksberg Hospital, and DanTrials ApS for a very professional and dedicated work. A special thanks to all patients who participated in the study; without their commitment, we could not have complied with the time plan. 

MTG announces sale of Nova Group

·  MTG sells its 95% shareholding in Nova Broadcasting Group in Bulgaria to PPF Group ·  All cash transaction values 100% of the business at an enterprise value of EUR 185 million (approximately SEK 1,830 million) ·  In line with MTG’s ongoing strategic transformation from a traditional national broadcaster into a global digital entertainer MTG has signed an agreement to sell its 95% shareholding in Nova Broadcasting Group Jsc. (“Nova”) in Bulgaria to PPF Group, the investment company controlled by Petr Kellner. The transaction values 100% of the business at an enterprise value of EUR 185 million (approximately SEK 1,830 million). The proceeds will be used to invest in our Nordic entertainment, Studios and global digital entertainment businesses. Nova is Bulgaria’s largest commercial media group and comprises 7 TV channels and 19 online businesses that together generated SEK 991 million in sales and SEK 195 million in operating income (EBIT) for the full year 2017. Nova employs 650 people. Closing is subject to regulatory approvals and expected to take place during H1 2018. MTG first entered Bulgaria in 2007 when investing in Balkan Media Group Limited, which operated the Diema TV channels, and then later acquired Nova in 2008. Jørgen Madsen Lindemann, MTG President & CEO: “We have built Nova into Bulgaria’s number one commercial media group with 33% commercial share of viewing, and ownership of some of the country’s top digital brands. Under the excellent leadership of Didier Stoessel and his management team, Nova has evolved very rapidly into the market leading digital entertainment group, and I would like to thank all those that have made this possible. “MTG’s investments are focused on our Nordic Entertainment, Studios and global digital entertainment verticals, which is why we have found a new home for our Bulgarian employees with a partner that will invest in Nova’s future. We wish Didier and the whole Nova team every continued success. This will bring to a close the disposal of our international entertainment operations and leaves MTG as a more focused group, which is in line with our previously stated strategy.” The sale of Nova will result in a net capital gain, which will be reported as an item affecting comparability following the closing of the transaction. Citigroup Global Markets is acting as financial adviser to MTG. **** NOTES TO EDITORS  MTG (Modern Times Group MTG AB (publ)) is a leading international digital entertainment group and we are shaping the future of entertainment by connecting consumers with the content that they love in as many ways as possible. Our brands span TV, radio and next generation entertainment experiences in esports, digital video content and online gaming. Born in Sweden, our shares are listed on Nasdaq Stockholm (‘MTGA’ and ‘MTGB’). About PPF GroupPPF Group invests into multiple market segments such as banking and financial services, telecommunications, real estate and biotechnology. PPF’s reach spans from Europe to Russia, the USA and across Asia. PPF Group owns assets of almost EUR 35 billion (as at 30 June 2017). Contact us:press@mtg.com (or Tobias Gyhlénius, Head of Public Relations; +46 73 699 27 09)investors@mtg.com (or Stefan Lycke, Head of Investor Relations; +46 73 699 27 14) Download high-resolution photos: Flickr Follow us:mtg.com  / Facebook  / Twitter  / LinkedIn  / Instagram  / YouTube 

Globeleq selects IFS Applications 9 to support expansion plans

Globeleq is a leading investor, developer, owner and operator of power projects in Africa. The company develops economically sustainable businesses that contribute to the continued development of the electricity sectors on the continent. Currently, Globeleq owns, operates and has investments in eight power plants located in Tanzania, South Africa, Cote d’Ivoire, Cameroon and Kenya, with a gross capacity of 1,237 MW and another 2,000 MW in development. With an ever increasing population and a burgeoning middle class, over the next two decades, the continent will experience a significant uplift in energy consumption across Africa, with parts of the region meeting a four-fold increase in energy consumption by 2040 from 2010 (McKinsey). To cope with demand and support its own plans to expand and improve power across the region, Globeleq needed a single, integrated enterprise software suite that could enhance visibility and asset availability across the entire business. After a competitive process, Globeleq selected IFS Applications 9 to replace the disparate systems operating across its power plants and regional offices in Africa, as well as its headquarters in London. With its goal to modernize its current business processes and enable integration with new power plants in the future, the company decided to upgrade its legacy systems and business processes. Globeleq required a consolidated, common and robust Enterprise Resource Planning (ERP) system, with full Enterprise Asset Management (EAM) capabilities, to support its current infrastructure, as well as improve the way information is managed and viewed across the business. Through IFS Applications 9, Globeleq will be able to automate the flow of information in real-time, from maintenance engineering to its other departments, including finance and Human Resources. Globeleq will also take advantage of IFS Mobile Work Order (MWO) capability, which works both on and offline, meaning that technicians are able to access vital information when they need it, regardless of whether they are connected. By streamlining this maintenance process, it eliminates paperwork, delayed communication, and results in improved productivity and operational efficiency. When Globeleq’s maintenance engineers carry out critical tasks on mobile tablets and use IFS’s MWO, they will benefit from having real-time information at their fingertips. This data will then flow back into operations within the business, such as finance and administration. IFS Applications for Energy & Utilities offers full ‘cradle to grave’ Asset Lifecycle Management (ALM) contract management and project management. Globeleq will be able to manage all phases of the asset lifecycle – from operations to maintenance – and gain a holistic approach to lifecycle management, which will help Globeleq on critical challenges such as avoiding downtime, extend asset life and reduce service and repair costs. “IFS was by far the most complete ERP solution on the market,” Michael Parsons, Finance Director, Globeleq. “Throughout the process, the team at IFS demonstrated that they genuinely understood our business. Its rich heritage in the Energy & Utilities sector resonated with us and was a key factor, along with its likeminded culture, in deciding to sign the deal in December 2017. With the right technologies, management and operational expertise, we are better positioned to give our employees the most effective tools to deliver the highest output and create efficiency at all of our plants and offices.” “We are delighted that Globeleq has chosen to rollout IFS Applications 9 to improve and modernize its IT back-office,” commented Colin Beaney, Industry Director for Energy & Utilities, IFS. “With IFS at the heart of its business processes, Globeleq will gain greater visibility across its entire business, supporting the company as it expands across a region that has a significant need for improved power provision.” For more information on how IFS helps organizations in the Energy & Utilities sector, please visit: www.ifsworld.com/corp/industries/energy-and-utilities/.

TOKMANNI GROUP CORPORATION: NOTIFICATION OF MANAGER’S TRANSACTIONS

Person subject to the notification requirement  Name:                                              Takoa Invest Oy  Position:                                          Closely associated legal person  Person discharging managerial responsibilities in issue  Name:                                              Saastamoinen, Seppo Markku Position:                                          Member of the Board ____________________________________________________________________ Notification Type:                              Initial Notification Reference number:                           743700VMG6KWF0FW1560_20180217180550_4  ____________________________________________________________________ Issuer  Name:                                               Tokmanni Group Corporation LEI:                                                   743700VMG6KWF0FW1560  ____________________________________________________________________ Transaction details  Transaction date:                            2018-16-02 Venue:                                              OFF-EXCHANGE TRANSACTIONS (XOFF)  Nature of Transaction:                    Acquisition Instrument type:                              Share ISIN:                                                  FI4000197934  Volume:                                            260 000  Unit price:                                        7,59500  Aggregated transactions  Volume:                                            260 000  Volume weighted average price:   7,59500  For further information, please contact:   Joséphine MickwitzHead of IR and CommunicationsTel. +358 20 728 6535 Tokmanni in brief  Tokmanni is the largest general discount retailer in Finland measured by number of stores and revenue. In 2017, Tokmanni’s revenue was EUR 796 million and on average it had approximately 3,200 employees. Tokmanni is the only nationwide general discount retailer in Finland, with 175 stores across Finland as at 31 December 2017. Distribution: Nasdaq HelsinkiKey Media

Nordic Capital forms a leading European dental clinic platform

As part of the transactions, Nordic Capital has signed agreements to acquire Top Mondzorg BV, the owner of Dental Clinics Nederland and TopOrtho (“Dental Clinics”) with a combined 88 clinics in the Netherlands and Adent Cliniques Dentaires Groupe SA (“Adent”) with 22 clinics in Switzerland. Nordic Capital acquired Adent and Dental Clinics from Oaktree Capital Management. In addition, Nordic Capital has agreed to acquire DPH Dental Partner Holding GmbH, Germany’s largest dental laboratory operator and SFE Beteiligungsgesellschaft mbH, the owner of Zahnstation, the Cologne-based dental clinic chain with 6 locations. Nordic Capital intends to continue the investment into the Group’s leading quality standards, best-in-class operating model and strong local brands, which are recognised for the best clinical environments, leading edge technology and highly trained staff by patients and dentists alike. With its scale and expanding presence in the most attractive European dental care markets, the Group will be at the forefront of innovation, remaining focused on providing the best dental care for its patients. “Through these acquisitions Nordic Capital will establish a leader in the European dental services markets with best in class operational capabilities and a strong track record of organic and acquisitive growth. The European dental care markets remain very fragmented and there is significant potential to continue to actively drive consolidation. We aim to draw on Nordic Capital's extensive experience from ownership of high quality and rapidly expanding healthcare clinic chains, including the leading European veterinary care provider AniCura, to capitalise on this growth opportunity. We look forward to working together with management to continue to grow the Group in its existing markets in the Netherlands, Switzerland, Germany, and beyond" says Jonas Agnblad, Partner, Advisor to the Nordic Capital Funds. Nordic Capital is a leading healthcare investor with a 25-year track record of building high quality, sustainable healthcare businesses in Europe and the US. The transactions are subject to customary regulatory approvals. Media contacts: Katarina Janerud, Communications manager Advisor to the Nordic Capital Funds Tel: +46 8 440 50 50 e-mail: katarina.janerud@nordiccapital.com  About Dental Clinics Dental Clinics is an innovative, leading dental care provider in the Netherlands with 88 dental and orthodontic clinics operating under the Dental Clinics and TopOrtho brands. The modern clinics offer a full range of general and specialist dental treatments and serve more than 500,000 patients annually. The Company was founded in 2007 and has subsequently expanded through organic growth and a successful clinic acquisition strategy. Dental Clinics’ patient-oriented operating model is underpinned by strong focus on team work, relentless quality management and an efficient organisation. The Company is focused on offering high quality dental care in a modern and safe environment.  About Adent Adent is a quality focused dental chain with 22 large clinics in Switzerland, and the only Swiss dental care provider operating across the French and German speaking regions of the country. The Company was founded in 1997 when the first clinic was opened in Ecublens, and has subsequently expanded through clinic acquisitions and the opening of new sites. Adent’s clinics offer a full range of general and specialist dental treatments, and operate extended opening hours in accessible locations to ensure best service and quality of care for its patients. About Dental Partner Holding Dental Partner Holding is a leading European provider of high technology dental laboratory services, operating a country-wide network of 35 laboratories in Germany under the Flemming Dental brand together with 3 locations in Norway under the Artinorway brand. Founded in 1998, the Company is headquartered in Hamburg with a technology centre in Leipzig for the modern, digitally enabled manufacturing of dental prostheses. The Company’s operations are based on the highest quality standards, comprehensive local services to dentists and efficient centralised manufacturing using the latest digital technologies. About Zahnstation Zahnstation is a fast-growing dental chain in Germany, currently operating a network of 6 dental clinics in the Cologne area. Zahnstation’s clinics offer a range of general and specialist dental treatments, with a focus on high quality care and patient convenience through extended opening hours and accessible locations.  About Nordic Capital Nordic Capital private equity funds have invested in mid-market companies primarily in the Nordic region since 1989. Through committed ownership and by targeting strategic development and operational improvements, Nordic Capital enables value creation in its investments. The Nordic Capital Funds invest in companies in northern Europe and in selected investment opportunities internationally. The most recent fund is Nordic Capital Fund VIII with EUR 3.5 billion in committed capital, principally provided by international institutional investors such as pension funds. The Nordic Capital Funds are based in Jersey, Channel Islands, and are advised by the NC Advisory companies in Sweden, Denmark, Finland, Norway, Germany and the UK. For further information about Nordic Capital please see www.nordiccapital.com     

Crnogorski Telekom signs energy management deal with Ericsson

Crnogorski Telekom, Montenegro’s leading telecommunications service provider and a member of the Deutsche Telekom Group, has signed a 10-year Energy Infrastructure Management agreement with Ericsson (NASDAQ: ERIC). This is the first Energy Infrastructure Management contract announced since Ericsson unveiled its collaboration  with Panasonic Corporation of North America last year. Ericsson’s Energy Infrastructure Management is an efficient means of measuring, monitoring and maintaining energy infrastructure for mobile operators and tower companies. It uses big data analytics, energy management software, and lithium-ion batteries for energy storage. Crnogorski Telekom currently uses a combination of diesel generators and lead-acid batteries as a source of backup power for its cell sites. Compared to lead-acid batteries, Panasonic’s lithium-ion batteries offer superior energy density, are less vulnerable to damage from excessive discharging and extreme temperatures, and require less maintenance. Under the terms of the contract with Crnogorski Telekom, Ericsson will assume responsibility for the design, roll out and management of lithium-ion battery and power infrastructure solutions for the operator’s cell sites. Ericsson will provide these services via an Energy Network Operations Center, thereby ensuring the highest levels of energy efficiency and availability. Panasonic, Ericsson’s partner, will handle the manufacturing, supply, asset ownership, dimensioning, 10-year performance service-level agreements (SLAs), and support for battery and power infrastructure. Valentina Radulovic, Technology Director from Crnogorski Telekom, says: “We are pleased to announce the signing of the Energy Infrastructure Management agreement with Ericsson. This is another sustainable solution which we decided to implement in order to further reduce energy consumption and carbon emissions. As the technology leader in the Montenegrin market, we will continue with sustainable innovations that will result in a more efficient, reliable and powerful network for our customers.” Philip Herman, Vice President Green Tower Solutions at Panasonic Enterprise Solutions, says: “Energy Infrastructure Management minimizes energy consumption and total cost of ownership while maximizing system resilience and connectivity uptime, which is why we like to think of this offering as ‘energy-functions optimization’. We’re combining Panasonic’s expertise in energy solutions with Ericsson’s strength in telecommunications, and the result is networks that are smarter, more efficient and more sustainable. Our batteries’ high energy density, high voltage, lack of memory effect, and flat discharge voltage make for a very stable power supply.” Peter Laurin, Head of Managed Services at Ericsson, says: “Together with Panasonic, we will reduce the cost of energy equipment ownership for targeted Crnogorski Telekom sites by up to 40 percent. This is primarily a result of Ericsson’s advanced power source selection logic, extended battery life-cycles, and the reduced need for site visits. Our offering is based on an as-a-service business model, which provides Crnogorski Telekom with immediate savings with minimal upfront investment. Energy typically accounts for anything from 10 to 60 percent of an operator’s operational expenditure.” The operational benefits include the ability to remotely monitor site infrastructure, which can be particularly useful in a country such as Montenegro that features some of the most rugged terrain in Europe. Ericsson’s Energy Infrastructure Management provides analysis of operating and sensor data, which enables proactive maintenance and reduces the need for unexpected, urgent site visits. Ericsson’s Energy Infrastructure Management also reduces energy losses associated with the operation of rectifiers and air conditioners at cell sites by optimizing capacity and run cycles, thereby further reducing costs. Furthermore, the service helps to lower operators’ energy costs by limiting use of power from the grid to off-peak times. Ericsson and Panasonic will closely monitor usage of the lithium-ion batteries to ensure their operating parameters are not exceeded, thereby prolonging battery life and reducing pollution. Lithium-ion batteries are also less vulnerable to damage resulting from excessive discharging and extreme temperatures than lead-acid batteries. Since the batteries are closely monitored, their replacement and modernization can be carefully planned. NOTES TO EDITORS Managed Services  For media kits, backgrounders and high-resolution photos, please visit www.ericsson.com/press FOLLOW US: www.twitter.com/ericssonwww.facebook.com/ericssonwww.linkedin.com/company/ericssonwww.youtube.com/ericsson  MORE INFORMATION AT: News Center  media.relations@ericsson.com(+46 10 719 69 92) investor.relations@ericsson.com(+46 10 719 00 00) ABOUT ERICSSON Ericsson enables communications service providers to capture the full value of connectivity. The company portfolio across Networks, Digital Services, Managed Services and Emerging Business is geared to make our customers more efficient, go digital, and find new revenue streams. Ericsson’s investments in innovation have delivered the benefits of telephony and mobile broadband to billions of people around the world. The Ericsson stock is listed on Nasdaq Stockholm and on NASDAQ in New York. www.ericsson.com ERICSSON AT MWC The do zone at Mobile World Congress 2018 is where Ericsson is showcasing the powerful engagement, value and growth that comes with innovation in 5G, IoT and digital operations. With our live technology demonstrations and customer collaborations, we’re rolling up our sleeves and digging in. We’re showing, not just saying, why emerging technologies are essential to maximize business potential. Join us live and online at www.ericsson.com/mwc ABOUT PANASONIC ENTERPRISE SOLUTIONS Panasonic Enterprise Solutions Company, a division of Panasonic Corporation of North America, designs, installs and services technology solutions for its customers, including sustainable energy solutions for the telecommunications industry. Newark, NJ-based Panasonic Corporation of North America is a leading technology partner and integrator to businesses, government agencies and consumers across the region. The company is the principal North American subsidiary of Osaka, Japan-based Panasonic Corporation and leverages its strengths in Immersive Entertainment, Sustainable Energy, Integrated Supply Chains and Connected Solutions to provide secure and resilient integrated solutions for B2B customers. Panasonic was highlighted in Forbes Magazine’s Global 2000 ranking as one of the Top Ten Best Regarded Companies for 2017. The ranking is based on outstanding scores for trustworthiness, honesty with the public and superior performance of products and solutions. Learn more about Panasonic’s ideas and innovations at PanasonicMovesUs.com .

GomSpace: Early publication of year-end report Q4 2017

GomSpace Group AB (publ) (the ”Company”) has earlier communicated that the interim report for Q4 2017 will be published on February 28, 2018. Due to the fact that the work with the report has progressed faster than expected, the Company will publish the interim report for Q4 2017 on February 21, 2018. For more information, please contact:Niels Buus (CEO)Tel: +45 40 31 55 57                        Email: nbu@gomspace.com            About GomSpace Group AB The Company’s business operations are mainly conducted through the wholly-owned Danish subsidiary, GomSpace A/S, with operational office in Aalborg, Denmark. GomSpace is a space company with a mission to be engaged in the global market for space systems and services by introducing new products, i.e. components, platforms and systems based on innovation within professional nanosatellites. The Company is listed on the Nasdaq First North Premier exchange under the ticker GOMX. FNCA Sweden AB is the Company’s Certified Adviser. For more information, please visit our website on www.gomspace.com.             Miscellaneous     +-------------------------------------------------------------------------+|This information was submitted for publication, through the agency of the||contact person set out above, at 14:15 p.m. CET on February 19, 2018. |+-------------------------------------------------------------------------+

BAKKAFROST: Operational EBIT of DKK 331 Million for the Fourth Quarter of 2017

The Bakkafrost Group delivered a total operating EBIT of DKK 331.2 million in Q4 2017. Harvested volumes were 11.5 thousand tonnes gutted weight. The combined farming and VAP segments made an operational EBIT of DKK 265.4 million. The farming segment made an operational EBIT of DKK 228.8 million. The salmon spot prices decreased in Q4 2017, compared to the previous quarter. The price decrease had a negative effect on the operational EBIT in the farming segment. The VAP segment made an operational EBIT of DKK 36.5 million, which is an improvement due to the decrease in the salmon spot prices in Q4 2017. The EBITDA for the FOF segment was DKK 93.6 million. The total volumes harvested in Q4 2017 were 11.5 thousand tonnes gutted weight. Bakkafrost trans­ferred 3.4 million smolts, and Havsbrún sourced 50.9 thousand tonnes of raw material in Q4 2017. The farming segment made an operational EBIT of DKK 228.8 million for Q4 2017, which corresponds to NOK 25.76 per kg. The VAP segment made an operational EBIT of DKK 36.5 million for Q4 2017. The VAP segment has had a loss from the first quarter of 2016 until Q3 2017. The salmon spot prices decreased in Q4 2017, and from the end of Q3 2017 until the end of Q4 2017, the margins were positive. The combined farming and VAP segments made an operational EBIT of DKK 265.4 mil­lion for Q4 2017, which corresponds to NOK 29.88 per kg. The FOF segment (fishmeal, oil and feed) made an operational EBITDA of DKK 93.6 million for Q4 2017. Commenting on the result, CEO Regin Jacobsen said: “Bakkafrost had an excellent performance in the quarter, considering that the salmon spot price has decreased over 25%, compared to the same quarter last year. The VAP segment had a positive margin in the quarter for the first time since 2015. Havsbrún had a record year in raw material sourcing during its 50 years long history. Looking forward, we are excited about the agreement we have made with P/F Fiskaaling and the Faroese Authorities about the Faroese brood stock program. To develop the Faroese brood stock program will demand effort and resources for Bakkafrost, but we believe this might be an exciting project, which can benefit us in the long run.” In Q4 2017, Bakkafrost signed an agreement with P/F Fiskaaling and the Faroese Ministry of Foreign Affairs and Trade concerning the Faroese brood stock program. According to the agreement, Bakkafrost will take over responsibility of the brood stock program from P/F Fiskaaling from 1 April 2018, and from 1 January 2018 to 1 April 2018, Bakkafrost will hold all expenses in this regard. Bakkafrost will continue to develop the brood stock program, renting the existing brood stock facilities from P/F Fiskaaling until 2021. During the next three years, Bakkafrost will examine the feasibility of the brood stock program and determine, whether investments in a new brood stock facility will be needed. According to the agreement, the genome rights in the Faroese brood stock program will be transferred to Bakkafrost in 2021. Bakkafrost aims at giving the shareholders a competitive return on their investment, both through payments of dividends and by securing an increase in the value of the equity through positive operations. The long-term goal of the Board of Directors is that 30-50% of earnings per share shall be paid out as dividend. The financial position of Bakkafrost is strong with a solid balance sheet, a competitive operation and available credit facilities. Therefore, the Board of Directors proposes to the Annual General Meeting that DKK 10.50 (NOK 13.65*) per share shall be paid out as dividend. The proposed dividend corresponds to 50% of adjusted earnings for 2017. The Annual General Meeting will be convened on the 13th of April 2018. The Bakkafrost Group’s net interest bearing debt amounted to DKK 258.1 million at the end of Q4 2017. Bakkafrost had undrawn credit facilities of DKK 1,004.6 million at the end of Q4 2017 and the equity ratio was 70% at 31 December 2017. In January 2018, Bakkafrost made an agreement with its existing lender, Nordea, to refinance its existing DKK 850 million bank facility and its outstanding NOK 500 million bond loan – which has a maturity during Q1 2018 – with a senior secured five-year EUR 200 million credit facility. The facility includes an accordion increase option, which provides flexibility for the parties to agree an increased size of the facility by further up to EUR 200 million during the term of the facility. The facility is subject to signing a facility agreement, which is expected to take place during Q1 2018. * The dividend per share in NOK is subject to changes depending on the exchange rate between DKK and NOK, which will be announced after the Annual General Meeting.  OUTLOOK Market The salmon prices have dropped significantly during the second half of 2017 from all-time high levels earlier in 2017 and in 2016. This drop was expected, as the combination of high prices and supply ramp up emerged with the harvest of new generation fish released in 2016. The two most important farming regions, Norway and Chile, increased their volumes significantly in Q4 2017, compared to same period in 2016. The strong supply increase is the main driver for the price drop in Q4 2017. The latest update from Kontali Analyse estimates that the global supply of Atlantic salmon increased around 12% in Q4 2017, compared to Q4 2016. Going forward, the global harvest growth is expected to be around 6% in 2018. Bakkafrost operates in the main salmon markets, Europe, USA, the Far East and Russia. Variation in sales distribution between the different markets are driven by the change in demand from quarter to quarter in the different regions. Bakkafrost, however, aims to have a balanced market diversification to reduce market risk. Farming The outlook for the farming segment is good. The estimates for harvesting volumes and smolt releases are dependent on the biological development. Bakkafrost focuses on reducing biological risk continuously and has made several new investments and procedures to diminish this risk. Bakkafrost focuses on using non-medical methods in treatments against sea lice and has invested in new technology to comply with this strategy. Bakkafrost expects to harvest 51,000 tonnes gutted weight in 2018. Bakkafrost expects to release 13.9 million smolts in 2018, compared with 9.9 million smolts in 2017 and 11.7 million smolts released in 2016. The number of smolts released is a key element of predicting Bakkafrost’s future production. Bakkafrost aims at being self-supplied with 500 grams smolts in 2020. The benefits are a shorter production time at sea as well as reduced biological risk. The new hatchery under construction at Strond, Klaksvík is an important part of this plan. The hatchery is expected to start operation during 2018 and in full operation from 2020. The capacity growth from this investment program will gradually appear in harvested volumes from 2020. According to the agreement between Bakkafrost, P/F Fiskaaling and the Faroese Ministry of Foreign Affairs and Trade, Bakkafrost will take responsibility of the Faroese brood stock program from 1 April 2018 and continue to develop the brood stock program with the option to get the genome rights in 2021. Bakkafrost will use the next three years to examine the feasibility of the brood stock program and whether investments will be needed in a new brood stock facility. VAP (Value added products) Bakkafrost has signed contracts covering around 14% of the expected harvested volumes for 2018. The contract coverage is reduced, compared to previous year, because some contracts were not renewed in Q4 2017. Bakkafrost’s long-term strategy is to sell around 40-50% of the harvested volumes of salmon as VAP products at fixed price contracts. The VAP contracts are at fixed prices, based on the salmon forward prices at the time they are agreed and the expectations for the salmon spot price for the contract period. The contracts last for 6 to 12 months. FOF (Fishmeal, -oil and feed) The outlook for the production of fishmeal and fish oil is dependent on the availability of raw material. The ICES 2018 recommendation for blue whiting is 1,388 thousand tonnes, compared with 1,342 thousand tonnes in 2017. The production of fishmeal and fish oil in 2017 was record high because of good availability of raw material. Bakkafrost expects relatively high production volumes of fishmeal and fish oil in 2018. The new salmon meal and salmon oil plant is expected to start operation in the beginning of Q2 2018 with full production in the second half of 2018. This operation will increase the value of offcuts from salmon harvested and processed in the new harvest/-VAP factory at Glyvrar. The major market for Havsbrún´s fish feed is the local Faroese market including Bakkafrost’s internal use of fish feed. Havsbrún’s sales of fish feed in 2018 are expected to be at 85,000 tonnes, depending on external sales. Investments In June 2016, Bakkafrost announced a five-year investment plan from 2016 to 2020. The total investments for the period are DKK 2.2 billion, including maintenance CAPEX. Investments of around DKK 130 million in the two service vessels, M/S Martin and M/S Róland during 2016 and 2017, and the upgrading cost of around DKK 40 million during 2017 and 2018 of the harvest operation in Vágur, Suðuroy, are not included in the DKK 2.2 billion from the investment plan from 2016. The purpose of the investment plan is to continue to have one of the most cost-conscious value chains in the farming industry, to carry out organic growth, increase flexibility and reduce the biological risk to meet the future consumers’ trends and to be more end-customer orientated. Financial Favourable market balances in the world market for salmon products and cost-conscious production will likely maintain the financial flexibility going forward. A high equity ratio together with Bakkafrost’s bank financing, which was renewed for five years in Q1 2018, makes Bakkafrost’s financial situation strong. This enables Bakkafrost to carry out its investment plans to further focus on strengthening the Group, M&A’s, organic growth opportunities and to fulfil its dividend policy in the future. Please find the Company’s Q4 2017 report and the Q4 2017 presentation enclosed. Contacts: Regin Jacobsen, CEO of P/F Bakkafrost: +298 235001 (mobile) Gunnar Nielsen, CFO of P/F Bakkafrost: +298 235060 (mobile) This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. About Bakkafrost: Bakkafrost is the largest salmon farmer in the Faroe Islands. The Group is fully integrated from feed production to smolt, farming, VAP and sales. The Group has production of fishmeal, fish oil and salmon feed in Fuglafjørður. The Group has primary processing in Glyvrar, Kollafjørður and Vágur, and second­ary pro­cessing (VAP) in Glyvrar. The Group operates sea farming in Norðoyggjar, Eysturoy, Streymoy and Suðuroy. The headquarter is located in Glyvrar, and the company has 960 fulltime employees. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES. This press release does not constitute or form part of an offer or solicitation to purchase or subscribe for securities. The securities referred to herein may not be offered or sold in the United States absent registration or an exemption from registration as provided in the U.S. Securities Act of 1933, as amended. Copies of this announcement are not being made and may not be distributed or sent into the United States, Australia, Canada or Japan.

Nordic Nanovector ASA: Invitation to Fourth Quarter and Full Year 2017 Results Presentation and Webcast

Oslo, Norway, 20 February 2018 Nordic Nanovector ASA (OSE: NANO) announces its fourth quarter and full year 2017 results on Tuesday, 27th of February 2018. A presentation by Nordic Nanovector’s senior management team will take place at 8:30 am CET at: Thon Hotel Vika Atrium, Munkedamsveien 45, 0250 Oslo Meeting Room: NYLAND The presentation will be recorded as a webcast and will be available at www.nordicnanovector.com in the section: Investors & Media The results report and the presentation will be available at www.nordicnanovector.com in the section: Investors & Media/Reports and Presentation/Interim Reports/2017 from 7:00 am CET the same day. For further information, please contact: IR enquiries:Malene Brondberg, VP Investor Relations and Corporate CommunicationsCell: +44 7561 431 762Email: ir@nordicnanovector.com Media EnquiriesMark Swallow/David Dible/Isabelle Andrews (Citigate Dewe Rogerson)Tel: +44 207 638 9571Email: nordicnanovector@citigatedewerogerson.com About Nordic Nanovector:Nordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care. The company aspires to become a leader in the development of targeted therapies for haematological cancers. Nordic Nanovector's lead clinical-stage candidate is Betalutin®, a novel CD37-targeting Antibody-Radionuclide-Conjugate (ARC) designed to advance the treatment of non-Hodgkin's Lymphoma (NHL). NHL is an indication with substantial unmet medical need, representing a growing market forecast to be worth nearly USD 20 billion by 2024. The company aims to rapidly develop Betalutin®, alone and in combination with other therapies, for the treatment of major types of NHL, targeting first regulatory submission in relapsed/refractory follicular lymphoma in 2019.Nordic Nanovector intends to retain marketing rights and to actively participate in the commercialisation of Betalutin® in core markets. The company is also advancing a pipeline of ARCs and other immunotherapies for multiple cancer indications. Further information about the company can be found at www.nordicnanovector.com

Notice to annual general meeting in HiQ International AB (publ)

At the general meeting inter alia the following proposals will be presented: · The Board of Directors proposes that a share split 2:1 combined with a compulsory redemption procedure shall be carried out. The procedure will imply that each share will split into one ordinary share and one redemption share. The redemption share will then be redeemed for SEK 3.30 per share. · The Nomination Committee has proposed that the following directors shall be re-elected: Gunnel Duveblad, Ken Gerhardsen, Lars Stugemo, Ulrika Hagdahl, Erik Hallberg and Raimo Lind. Susanne Ehnbåge is proposed for election. Gunnel Duveblad is proposed to be re-elected as Chairman of the Board of Directors. · The Nomination Committee has proposed that KPMG is elected as the Company’s auditor. · The Board of Directors proposes that the General Meeting authorises the Board of Directors to pass a resolution on one or more occasions for the period up until the next Annual General Meeting on purchasing so many shares that the Company’s holding does not at any time exceed 10 per cent of the total number of shares in the Company. · The Board of Directors proposes that the General Meeting adopts a resolution to issue not more than 1,000,000 warrants. The right to subscribe for the warrants shall inure to the wholly owned subsidiary HiQ Stockholm AB, which shall transfer the warrants to current and future employees of the group in Denmark, Finland and Sweden. The purpose of the proposal is to create opportunities to keep and to recruit competent employees to the HiQ group and to increase the motivation amongst the employees. · The Board of Directors proposes that the Board of Directors shall be authorised to resolve on an issue against payment in kind of no more than 5,000,000 shares, at one or several occasions, during the period until the next Annual General Meeting in connection with acquisitions. · Guidelines for determining salary and other remuneration to the managing director and other persons in the company’s management. For further information, please see the enclosed notice. HiQ International AB (publ)The Board of Directors For further information, please contact:Lars Stugemo, President and CEO, HiQ, tel. +46 8 588 90 000Fredrik Malm, CFO, HiQ, tel. +46 8 588 90 000 

NeuroVive Pharmaceutical AB Year End Report January - December 2017

Business operations Significant events October-December 2017 · NeuroVive received a positive opinion from the EMA’s Committee for Orphan Medicinal Products (COMP) regarding orphan drug designation for KL1333. · Greg Batcheller, the Chairman of NeuroVive’s Board for the past 17 years, resigned on November 6. The Board elected David Laskow-Pooley as the new Chairman. · On November 3, 2017, NeuroVive issued shares totaling SEK 5.3 million before transaction costs through a private offering to Floyd Associates Europe Limited. · NeuroVive and Lund University were granted funding by the Swedish Foundation for Strategic Research (SSF) for collaboration around liver cancer research. · NeuroVive signed a collaboration agreement with the University of Florida for TBI biomarker development. · NeuroVive presented results from preclinical TBI trials related to the NeuroSTAT project at the 2017 Nordic Neurotrauma Conference. · NeuroVive presented its innovative metabolic regulators for the non-alcoholic steatohepatitis (NASH) liver disease at the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) on October 20-24, 2017 in Washington DC, USA. · NeuroVive’s partner, the Children’s Hospital of Philadelphia (CHOP), was granted research funding by the US National Institutions of Health (NIH) to study NeuroVive’s NVP015 compounds as countermeasures against chemical threats. · NeuroVive selected a candidate compound in the NVP015 project for mitochondrial disorders for continued preclinical development. · NeuroVive reported progress in the Korean Phase I trial of KL1333. · KL1333 was granted orphan drug designation by the European Commission Important events after the end of the period · NeuroVive reported a breakthrough for the NVP025 project for mitochondrial myopathies. · The Board of Directors of NeuroVive has resolved, subject to approval by the Extraordinary General Meeting, to issue shares and warrants with preferential rights for existing shareholders. Upon full subscription to the rights issue, NeuroVive will receive approximately MSEK 78.5 before issuance costs. In full exercise of the warrants issued in the Rights issue, NeuroVive will receive an additional MSEK 37.3 before issuance costs. Financial information Fourth quarter (October-December 2017) · Net revenues were SEK 0 (14,000) and other operating income was SEK 9,000 (14,000) · Loss before tax was SEK 14,779,000 (loss: 14,580,000) · Loss per share* was SEK 0.29 (loss: 0.34) · Diluted loss per share** was SEK 0.29 (loss: 0.34) Full-year (January-December 2017) · Net revenues were SEK 27,000 (14,000) and other operating income was SEK 558,000 (104,000) · Loss before tax was SEK 71,603,000 (loss: 71,845,000) · Loss per share* was SEK 1.33 (loss: 1.67) · Diluted loss per share** was SEK 1.33 (loss: 1.67) * Profit/loss for the period divided by average number of shares before dilution at the end of the period. ** Profit/loss for the period divided by average number of shares after dilution at the end of the period. The complete Year End report is available for download below and through the NeuroVive web site www.neurovive.com. For more information concerning this report, please contact CEO Erik Kinnman. Telephone: +46 (0)46-275 62 20. The information was submitted for publication, through the agency of the contact person set out above, at 08:30 a.m. CET on 20 February 2018. NeuroVive Pharmaceutical AB (publ) Medicon Village, SE-223 81 Lund, Sweden Tel: +46 (0)46 275 62 20 (switchboard) www.neurovive.com About NeuroVive NeuroVive Pharmaceutical AB is a leader in mitochondrial medicine, with one project in clinical phase II development for the prevention of moderate to severe traumatic brain injury (NeuroSTAT®) and one project in clinical phase I (KL1333) for genetic mitochondrial diseases. The R&D portfolio consists of several late stage research programs in areas ranging from genetic mitochondrial disorders to cancer and metabolic diseases such as NASH. The company’s strategy is to advance drugs for rare diseases through clinical development and into the market. The strategy for projects within larger indications outside the core focus area is out-licensing in the preclinical phase. NeuroVive is listed on Nasdaq Stockholm, Sweden (ticker: NVP). The share is also traded on the OTCQX Best Market in the US (OTC: NEVPF).

DXC Technology joins the IFS Partner Network as a channel partner in France

DXC helps organizations solve challenges by modernizing business processes, applications, and infrastructure with next-generation solutions. DXC has extensive experience delivering successful ERP projects to businesses in industries such as manufacturing, aerospace and defense, automotive, consumer products, energy, retail, technology, travel and transportation, and utilities. Through the new partnership, DXC will promote, sell, implement, and manage IFS Applications™  and associated services for clients in France. IFS and DXC already have a number of joint French customers, including FH Orthopedics, an innovative company specializing in orthopedic prosthetics. “I believe DXC and IFS share the same focus on delivering innovation and digital transformation to our customers, which makes this partnership a great fit for both our companies,” said Pierre Bruno, ‎vice president and general manager, South Europe region, DXC Technology. “We will leverage our existing knowledge and experience of deploying IFS Applications and combine it with the greater access to high-value training and projects that being a member of the IFS Partner Network provides, in order to further improve our IFS expertise. Our joint clients will benefit from the best products, services, and support for their digital transformation—delivered by a partner who understands their specific business needs.” Amor Bekrar, president of IFS in France, added, “We are delighted to welcome DXC as an official member of the IFS Partner Network. DXC has comprehensive expertise in many key industry sectors, and is a recognized specialist in helping companies digitally transform. The partnership will benefit our clients as well as enable IFS to further reinforce its presence in our targeted sectors throughout France.” To learn more about the IFS Partner Network, please visit www.ifsworld.com/corp/partners/.

Copenhagen Blinds from Inwido and Danfoss collaborate with new app

Inwido brand Art Andersen CPH, which develops intelligent designer accessories for windows and doors, has launched a brand-new type of Venetian blinds under the name Copenhagen Blinds. In addition to their modern design, Copenhagen Blinds also differ from classic Venetian blinds in that they can be controlled remotely using a smartphone or tablet. This new thinking about blinds has led to a strategic cooperation with Danfoss, which in recent years has developed a series of digital thermostats under the Living Connect brand. The partnership has resulted in an app that can control the home’s Danfoss thermostats and sun-screening in the form of Copenhagen Blinds Venetians, making it even easier to control the indoor climate and increase comfort at home. “Danfoss radiator thermostats are installed in most homes and offices in Scandinavia. Accordingly, we perceive considerable value in this partnership because it offers new opportunities for us to help improve the indoor climate in homes,” says Johan Ambuhm, Business Development Manager for Digital Solutions in the Inwido Group. “Both Danfoss and Art Andersen CPH are working to develop intelligent climate solutions for homes, so it’s quite natural for us to join forces with this solution. The app allows you to screen out strong sunshine using the blinds and to turn the radiators up or down to achieve an even and comfortable indoor temperature.” “Digitization in Scandinavian homes is increasing. New digital solutions are being demanded at an increasing pace, making everyday life easier for users, while also allowing savings to be made.” About ART ANDERSEN CPHART ANDERSEN CPH develops intelligent design accessories for windows and doors. With innovative solutions, we advance the limits of energy, comfort, form and function.Read more at www.copenhagenblinds.com About Copenhagen BlindsCopenhagen Blinds, offered by Art Andersen CPH, are powered Venetian blinds with a unique design that efficiently screen out the sun and help keep homes from heating up when the sun is shining. By means of an app, you can close, lower, group and schedule the blinds, which are powered by batteries that only need charging for three hours twice a year. Besides being controlled using the app, Copenhagen Blinds can also be controlled manually. Read the pressrelease in the pdf attached

Kährs Group appoints new Regional Manager Finland & Baltic

Heli has a background in sales development and marketing, as well as experience from working with building materials and construction. Most recently, she held the position of Sales Director in Finnish company Pukkila Oy Ab, which is part of the Italian Ricchetti Group, one of the leading ceramic tiles manufacturing companies in Europe. Heli joined on 15 February and is member of Kährs Group’s management team. In the role of Regional Manager, Heli will be responsible for the sales and marketing of Kährs Group's wood flooring range in Region Finland & Baltic. “The region is an important market for Kährs, and we are happy to have recruited Heli with her solid experience in sales of flooring solutions in the Finnish market. As Regional Manager, Heli gets a key role to secure growth and develop the business in the region,” says Christer Persson, President and CEO of Kährs Group.  For more information, please contact:Helén Johansson, Corporate Communication, Kährs Group, tel: +46 70 364 60 30  About Kährs GroupKährs Group is a Europe-leading flooring manufacturer in hardwood and resilient flooring with several strong brands in its product portfolio, including Kährs, Karelia and Upofloor. Kährs’ innovations have shaped the industry throughout history and the company is dedicated to providing private, commercial and public spaces with environmentally sound and long-lasting flooring solutions. Kährs Group, which delivers products to more than 70 countries, is the market leader in Sweden, Finland and Russia and holds a strong position in other key markets, such as Norway, the UK and Germany. The Group has approximately 1,700 employees and annual sales of more than SEK 3 billion. www.kahrsgroup.com

Adelis Equity Partners secures successful exit of Med Group

Adelis acquired a majority in Med Group, which caters to the public sector as well as individual customers across Finland, in 2014. During Adelis ownership period the turnover of the company has more than doubled to €100 million and the number of employees has increased from approximately 800 to 3,000. Today, Med Group is leading not only in ambulance services but also in dentistry and home services to the disabled and elderly. Rasmus Molander, Partner at Adelis and Chairman of Med Group, says: “We are grateful to have had the opportunity to work with Med Group to contribute to solving the challenges facing the care and healthcare sectors in Finland. Together with management we have developed a leading player, in terms of quality and size, in the niches we have chosen to focus on. We are happy that also the new owners are committed to supporting Med Group’s management team in pursuing a growth strategy based on trust and quality of care”. Med Group’s CEO Kari Virta says: “Adelis has been a great partner in supporting our growth. Through investments in people, technology and add-ons their ownership approach has provided a solid foundation for growth. Through the creativity and hard work of our employees we have been able to build leading positions in home services and dentistry in addition to ambulance services. These positions also provide a solid platform for future growth”. Adelis was advised by Carnegie, Borenius and KPMG. The parties have agreed not to disclose the purchase price. The transaction is subject to customary regulatory approvals. For further information, please contact Rasmus Molander, Partner, Adelis Equity Partners, (+46 70 823 7433) About Med Group Med Group is a Finnish care and healthcare services company. The company develops the quality, impact and cost-effectiveness of health services. Med Group employs about 3,000 employees in the care and healthcare sectors and has revenues of approximately €100 million. For more information please visit www.onniterveys.fi. About Adelis Equity Partners Adelis is an active partner in creating value at mid-sized Nordic companies. Adelis was founded with the goal of building the leading middle market private equity firm in the Nordics. Since raising its first fund in 2013, Adelis has been one of the most active investors in the Nordic middle-market, acquiring 14 platform companies and making more than 30 add-on acquisitions. Adelis now manages approximately €1 billion in capital. For more information please visit www.adelisequity.com.

AirFaas awarded as the potential future European Tech giant by EU Commissioner

The “DIGITALEUROPE SME AWARD” aims at celebrating and rewarding SMEs which have the potential to become the future European Tech giants. The winner 2018 is AirFaas from Finland, and the award is handed over today in Brussels by Mariya Gabriel, European Commissioner for Digital Economy & Society. AirFaas is an Airbnb for factories, a portal that allows companies to manufacture their machines and components without owning factories, production equipment or having production workers. A win-win for manufacturers but also for the environment. “Masters of Digital 2018” is the annual flagship event of DIGITALEUROPE, the leading trade association which represents the digital technology industry in Brussels and across Europe since 1999. CEO Edward Blomstedt says AirFaas will revolutionize the manufacturing industry the same way UBER and Airbnb revolutionized consumer behaviour. AirFaas is a portal for manufacturers, Faas means "factory as a service". They will no longer need to own a factory for their production. They will find the best factory for their production, somewhere in the world, through AirFaas. AirFaas takes care of location, planning, logistics, distribution, budgeting and financing the product. So manufacturers can focus on other important things. Like product development and marketing. To be a part of the AirFaas family, they just have to upload the specifications of the product in the system, and after a week the system returns with a full proposal including everything. AirFaas is supported by investors, industrialists and top politicians in Finland and presented as a great example of the roadmap for platform economies, being one of the top subjects at industry gatherings globally. Edward Blomstedt, Finnish industry´s ”Golden Boy”, is full of confidence facing the future of AirFaas. -Someone asked me one year ago where we will be in ten years. I told him that AirFaas will be one of the worlds 50 largest companies. I am even more convinced of that today, he says. The confidentiality around the project has been extreme during the five years of testing the concept. The name ”AirFaas” has been released just now, and the real manufacturing according to the AirFaas concept has, during these five years, been executed by another company in the AirFaas sphere, Combi Works. https://airfaas.com/references.html Picture: From left: Cecilia Bonefeld-Dahl, Director General of Digital Europe, Mariya Gabriel, European Commissioner for Digital Economy & Society, European Commission, Edward Blomstedt, CEO and founder of AirFaas. For more information:  www.airfaas.com  Edward Blomstedt, CEO. +358 50 3005598 / edward.blomstedt@airfaas.com Pontus Nyström, Marketing Director. +46 734 053 053 / pontus.nystrom@airfaas.com

All-In-One Gaming Platform with Ground breaking AMD Ryzen™ Embedded V1000 processor & “Cabinet-Ready I/O”

                      February 21, 2018 Taipei - Advantech-Innocore the gaming focused business group of Advantech Corp, announces the new DPX-E140 gaming system. The DPX®-E140 is a complete gaming system for the regulated casino and AWP gaming markets combining all the hardware features necessary for a gaming platform together in a high performance industrial grade system. Breaking new ground in integrated graphics performance, the new AMD Ryzen™ Embedded V1000 processor with AMD Radeon™ Vega Graphics allows the DPX-E140 to meet the ever increasing demands placed on casino slot machines for a multi-screen, high resolution, immersive player experience. The new DPX-E140 is designed with the same format as the mid-range DPX-E135 and has the same “Cabinet-ready I/O”. This innovative design puts all the connectors conveniently in one area and uses typical slot industryconnectors to provide an economical, robust harnessing arrangement. The need for additional connector boards or backplanes is eliminated saving cost and simplifying cabinet layout and harnessing. At the heart of the DPX-E140 is the AMD Ryzen™ Embedded V-Series platform, which includes high performance dual and quad core APU devices based on AMDs revolutionary new “Zen” CPU architecture. Supporting up to 32GB DDR4 system RAM, the DPX-E140 is also ready for mission critical applications which require an ECC memory option. The “Discrete-level Graphics” core (Radeon™ Vega graphics ) outputs to four independent monitors via four DisplayPort 1.4 DP++ ports. The graphics engine features the latest AMD GCN 5 architecture with up to 11 graphics compute units, providing unrivalled performance and features including Direct X 12, EGL 1.4, OpenGL 4.6, and support for video decoding VP9, H.265[1]  (10 bit). The new display engine is optimized for 4K displays and multiple planes (Windows MPO), supports Radeon™ FreeSync technology, and is ready for HBR3 & HDR (high dynamic range displays). In spite of the high performance of the APUs, the DPX-E140 is passive-cooled for APUs up to 25W cTDP, requiring no CPU fan in most applications and therefore reducing maintenance costs for potential fan failures in the field. APUs up to 54W cTDP are supported with a high reliability fan for top end performance. A choice of enclosure covers is available for the DPX-E140 depending on the customer’s preference and local requirements. The system can be supplied with no cover, a short cover with casino grade lock to secure the logic/storage area, or a full length cover that covers both logic and cable/IO areas. A full feature set of I/O and COMs designed specifically for gaming devices is also included and the system is compatible with Advantech’s software solutions for security, media validation, SAS and diagnostics. A wide variety of storage devices are supported including SATA DOM, C-Fast, USB drive and the system has a built in easy-service tray for 2.5” SATA HDD/SSDs. The DPX-E140 is the ideal integrated platform for many gaming, amusement and kiosk applications calling for a cost-effective, very high performance gaming platform. Key features ·  Dual and Quad core AMD Ryzen™ Embedded V1000 Series APUs up to 3.5GHz with Radeon™ Vega high performance graphics ·  Comprehensive gaming features including dedicated ports for CCTALK, SAS, GPIO, I2C, meter connect, ID003, RS485, and 5.1 surround sound. ·  Passive cooled system up to 25W, (54W with fancooler) ·  12V DC single input or ATX power ·  “Cabinet-ready” I/O connectors on-board   ·  Casino grade lock and intrusion monitoring (Battery backed and logged) ·  Long lifecycle (guaranteed 5 years in production)  Craig Stapleton, Advantech’s Product Director, commented, “Following the success of our DPX-E135 product with ‘Cabinet-ready I/O,’ we are pleased to be able to bring customers a high performance follow on product, the DPX-E140. The DPX-E140 is one of the first products to utilize the revolutionary new AMD Ryzen™ Embedded V1000 Series platform. The new AMD “Zen” CPU architecture has proved very impressive in consumer and server markets and we are excited to bring it to our gaming customers. The AMD Ryzen™ Embedded V1000 Series platform benefits from the “Zen” core’s 52% CPU IPC performance boost at the same power compared to previous generation AMD cores. That performance increase together with the amazing graphics engine packaged in the DPX-E140 product will be an unbeatable combination for the gaming OEM”. Stephen Turnbull, Director of Product Marketing, Datacenter and Embedded Solutions Business Group, AMD, added, “AMD and Advantech are longstanding partners with shared goals of delivering stunning graphics capabilities, support for multiple simultaneous 4K displays and an immersive experience for always-on casino gaming and AWP systems. With the new Ryzen Embedded V1000 processor integrated into the Advantech DPX-E140 gaming platform, we raise the bar yet again by optimizing performance and driving game console caliber graphics, all with tremendous energy efficiency.” DPX-E140 samples will be available late February 2018 and the product will be on show at the Embedded World tradeshow in Nuremburg February 27th to March 1st. Advantech is proud to be a launch partner with AMD for the AMD Ryzen™ Embedded V1000 platform. 

Invitation to Ericsson’s Annual General Meeting 2018

The Nomination Committee proposes among other things: · Ronnie Leten as new Chairman of the Board after resigning Leif Johansson (item 12) · Kurt Jofs as new member of the Board. Kristin Skogen Lund and Sukhinder Singh Cassidy have decided to leave the Board. (item 11) · Unchanged Board fee, fee to the Chairman of the Board of Directors and for work on the Committees of the Board (item 10) The Board of Directors proposes among other things: · A dividend of SEK 1 per share (item 8.3) · A Long-term Variable Compensation Program for the ExecutiveTeam, with a one-year Group operating income target for 2018 and three-year total shareholder return targets, all targets with a three-year vesting period (item 17) Welcome to the Annual General Meeting of shareholders 2018 of Telefonaktiebolaget LM Ericsson Telefonaktiebolaget LM Ericsson’s shareholders are invited to participate in the Annual General Meeting of shareholders to be held on Wednesday, March 28, 2018 at 3.00 p.m. at Kistamässan, Arne Beurlings Torg 5, Kista/Stockholm. Registration to the Annual General Meeting starts at 1.30 p.m. Registration and notice of attendance Shareholders who wish to attend the Annual General Meeting must · be recorded in the share register kept by Euroclear Sweden AB, the Swedish securities registry, on Thursday, March 22, 2018; and · give notice of attendance to the Company at the latest on Thursday, March 22, 2018. Notice of attendance can be given by telephone +46 (0)8 402 90 54 on weekdays between 10 a.m. and 4 p.m. or on Ericsson’s website www.ericsson.com. Notice may also be given in writing to:Telefonaktiebolaget LM EricssonGeneral Meeting of shareholdersc/o Euroclear Sweden ABBox 191SE-101 23 StockholmSweden When giving notice of attendance, please state name, date of birth or registration number, address, telephone number and number of attending assistants, if any. The Annual General Meeting will be conducted in Swedish and simultaneously translated into English. Shares registered in the name of a nominee In addition to giving notice of attendance, shareholders having their shares registered in the name of a nominee, must request the nominee to temporarily enter the shareholder into the share register as per Thursday, March 22, 2018, in order to be entitled to attend the Annual General Meeting. The shareholder should inform the nominee to that effect well before that day. Proxy Shareholders represented by proxy shall issue a power of attorney for the representative. A power of attorney issued by a legal entity must be accompanied by a copy of the entity’s certificate of registration (should no such certificate exist, a corresponding document of authority must be submitted). In order to facilitate the registration at the Annual General Meeting, the power of attorney in the original, certificate of registration and other documents of authority should be sent to the Company in advance to the address above for receipt by Tuesday, March 27, 2018. Forms of power of attorney in Swedish and English are available on Ericsson’s website, www.ericsson.com.Agenda 1. Election of the Chairman of the Annual General Meeting 2. Preparation and approval of the voting list 3. Approval of the agenda of the Annual General Meeting 4. Determination whether the Annual General Meeting has been properly convened 5. Election of two persons approving the minutes 6. Presentation of the annual report, the auditor’s report, the consolidated accounts, the auditor’s report on the consolidated accounts and the auditor’s report whether the guidelines for remuneration to group management have been complied with, as well as the auditor’s presentation of the audit work with respect to 2017 7. The President’s speech. Questions from the shareholders to the Board of Directors and the management 8. Resolution with respect to   8.1. adoption of the income statement and the balance sheet, the consolidated income statement and the consolidated balance sheet;   8.2. discharge of liability for the members of the Board of Directors and the President; and   8.3. the appropriation of the results in accordance with the approved balance sheet and determination of the record date for dividend 9. Determination of the number of Board members and deputies of the Board of Directors to be elected by the Annual General Meeting 10. Determination of the fees payable to members of the Board of Directors elected by the Annual General Meeting and members of the Committees of the Board of Directors elected by the Annual General Meeting11. Election of the members and deputies of the Board of DirectorsThe Nomination Committee's proposal for Board members:   11.1.          Jon Fredrik Baksaas  11.2.          Jan Carlson  11.3.          Nora Denzel  11.4.          Börje Ekholm  11.5.          Eric A. Elzvik  11.6.          Kurt Jofs (new election)  11.7.          Ronnie Leten (new election)  11.8.          Kristin S. Rinne  11.9.          Helena Stjernholm  11.10.        Jacob Wallenberg 12. Election of the Chairman of the Board of DirectorsThe Nomination Committee’s proposal:The Nomination Committee proposes that Ronnie Leten be elected Chairman of the Board. 13. Determination of the number of auditors 14. Determination of the fees payable to the auditors 15. Election of auditors 16. Resolution on the guidelines for remuneration to Group Management 17. Resolution on implementation of Long-Term Variable Compensation Program 2018 (“LTV 2018”) 18. Resolution on transfer of treasury stock in relation to the resolutions on the Long-Term Variable Compensation Programs 2014, 2015, 2016 and 2017 19. Resolution on proposal from the shareholder Einar Hellbom that the Annual General Meeting resolve to delegate to the Board to present a proposal on equal voting rights for all shares at the Annual General Meeting 2019 20. Resolution on proposal from the shareholder Mats Lagström that the Annual General Meeting resolve to instruct the Nomination Committee to propose to the next general meeting of shareholders a differentiated fee plan for the members of the Board of Directors, including the Chairman of the Board 21. Closing of the Annual General Meeting ______________________ Item 1 Chairman of the Annual General Meeting The Nomination Committee, appointed in accordance with the Instruction for the Nomination Committee resolved by the Annual General Meeting 2012, is composed of the Chairman of the Committee Johan Forssell (Investor AB), Christer Gardell (Cevian Funds), Bengt Kjell (AB Industrivärden and Svenska Handelsbankens Pensionsstiftelse), Johan Held (AFA Försäkring), Anders Oscarsson (AMF Försäkring and Fonder) and Leif Johansson (Chairman of the Board of Directors). The Nomination Committee proposes that Advokat Sven Unger be elected Chairman of the Annual General Meeting of shareholders 2018. Item 8.3 Dividend and record date The Board of Directors proposes a dividend of SEK 1 per share and Tuesday, April 3, 2018, as record date for dividend. Assuming this date will be the record date, Euroclear Sweden AB is expected to disburse dividends on Friday, April 6, 2018. Item 9 Number of Board members and deputies to be elected by the Annual General Meeting According to the articles of association, the Board shall consist of no less than five and no more than twelve Board members, with no more than six deputies. The Nomination Committee proposes that the number of Board members elected by the Annual General Meeting of shareholders shall be ten and that no deputies be elected. Item 10 Fees payable to members of the Board of Directors elected by the Annual General Meeting and to members of the Committees of the Board elected by the Annual General Meeting The Nomination Committee proposes that fees to non-employee Board members elected by the Annual General Meeting and non-employee members of the Committees of the Board elected by the Annual General Meeting be paid as follows: · SEK 4,075,000 to the Chairman of the Board of Directors (unchanged); · SEK 990,000 each to the other Board members (unchanged); · SEK 350,000 to the Chairman of the Audit and Compliance Committee (unchanged); · SEK 250,000 each to the other members of the Audit and Compliance Committee (unchanged); · SEK 200,000 each to the Chairmen of the Finance, the Remuneration and the Technology and Science Committee (unchanged); and · SEK 175,000 each to the other members of the Finance, the Remuneration and the Technology and Science Committee (unchanged). A basic principle when assessing Board fees is that these shall be competitive and make it possible to recruit and retain individuals with the best possible competence. When assessing the level of fees, a comparison has been made in relation to the Board fees in companies of equal size and complexity and it should be considered that the Ericsson Group has customers in more than 180 countries and that sales in 2017 amounted to approximately SEK 200 billion. The Nomination Committee considers that the fees for Board and Committee work are reasonable, and proposes that all fees remain unchanged. Fees in the form of synthetic shares Background The Nomination Committee believes that it is appropriate that Board members elected by the shareholders hold shares in Ericsson, in order to strengthen the Board members’ and the shareholders’ mutual interests in the company. The Nomination Committee recommends Board members elected by the shareholders to, during a five-year period, build a holding of shares or synthetic shares in Ericsson at least corresponding to the value of the annual Board fee (excluding fees for Committee work), and that such holding be kept during the time the Board member remain Board member in Ericsson. In relation to previous years, the recommendation has changed so that the holding shall correspond to the annual Board fee instead of the annual Board fee after tax. To make it possible for Board members to create an economic interest in the company and considering that it is in many cases difficult for Board members to trade in the company’s share due to applicable insider rules, the Nomination Committee proposes that the Board members should, as previously, be offered the possibility of receiving part of the Board fees in the form of synthetic shares. A synthetic share constitutes a right to receive payment of an amount which corresponds to the market value of a share of series B in the Company on Nasdaq Stockholm at the time of payment. Proposal The Nomination Committee therefore proposes that the Annual General Meeting of shareholders 2018 resolve that part of the fees to the Directors, in respect of their Board assignment (however, not in respect of Committee work), may be paid in the form of synthetic shares, on the following terms and conditions. · A nominated Director shall be able to choose to receive the fee in respect of his or her Board assignment, according to the following four alternatives: (i)            25 percent in cash – 75 percent in synthetic shares(ii)           50 percent in cash – 50 percent in synthetic shares(iii)          75 percent in cash – 25 percent in synthetic shares(iv)          100 percent in cash. · The number of synthetic shares to be allocated shall be valued to an average of the market price of shares of series B in the Company on Nasdaq Stockholm during a period of five trading days immediately following the publication of Ericsson’s interim report for the first quarter of 2018. The synthetic shares are vested during the term of office, with 25 percent per quarter of the year. · The synthetic shares give a right to, following the publication of Ericsson’s year-end financial statement in 2023, receive payment of a cash amount per synthetic share corresponding to the market price of shares of series B in the Company at the time of payment. · An amount corresponding to dividend in respect of shares of series B in the Company, resolved by the Annual General Meeting during the holding period, shall be disbursed at the same time as the cash amount. · Should the Director’s assignment to the Board of Directors come to an end no later than during the third calendar year after the year in which the Annual General Meeting resolved on allocation of the synthetic shares, payment may take place the year after the assignment came to an end. · The number of synthetic shares may be subject to recalculation in the event of bonus issues, split, rights issues and similar measures, under the terms and conditions for the synthetic shares. The complete terms and conditions for the synthetic shares are described in Exhibit 1 to the Nomination Committee’s proposal. The financial difference for the Company, should all Directors receive part of their fees in the form of synthetic shares compared with the fees being paid in cash only, is assessed to be very limited. Item 11 Election of Board members and deputies of the Board of Directors The Nomination Committee proposes that the following persons be elected Board members: 11.1               Jon Fredrik Baksaas11.2               Jan Carlson11.3               Nora Denzel11.4               Börje Ekholm11.5               Eric A. Elzvik11.6               Kurt Jofs (new election)11.7               Ronnie Leten (new election)11.8               Kristin S. Rinne11.9               Helena Stjernholm, and11.10             Jacob Wallenberg In the composition of the Board of Directors, the Nomination Committee considers, among other things, experience and competence needed in the Board and its Committees, and also the value of diversity in age, gender and cultural/geographic background as well as the need for renewal. The Nomination Committee has applied the Swedish Corporate Governance Code, Section 4.1, as diversity policy. The Nomination Committee also assesses the appropriateness of the number of members of the Board and whether the Board members can devote the necessary time required to fulfill their tasks as Board members in Ericsson. The Nomination Committee primarily searches for potential Board member candidates for the upcoming mandate period but also considers future competence needs. In its appraisal of qualifications and performance of the individual Board members, the Nomination Committee takes into account the competence and experience of each individual member along with the individual member’s contribution to the Board work as a whole and to the Committee work. The Nomination Committee has met with the members of the Board of Directors to get their views regarding the Board work. The Nomination Committee has further thoroughly familiarized itself with the results of the Board work evaluation that was led by the Chairman of the Board. The Nomination Committee believes that it is very important that the composition of Board members proposed includes complementing experiences and competencies to make it possible for the Board to contribute to a positive development of Ericsson. The Nomination Committee aims to propose a Board of Directors that constitutes a good team to lead Ericsson. The Nomination Committee is of the opinion that the current Board and Board work is well functioning. Further it is the Nomination Committee’s view that the Board fulfils high expectations in terms of composition and that the Board as well as the individual Board members fulfil high expectations in terms of expertise. Leif Johansson, Kristin Skogen Lund and Sukhinder Singh Cassidy have advised that they wish to leave the Board. The Nomination Committee proposes that two new Board members be elected: Ronnie Leten is proposed as new Chairman of the Board and Kurt Jofs is proposed as new Board member. As President and CEO of Atlas Copco, Ronnie Leten has successfully led Atlas Copco during many years and he also has valuable experience as Board Chairman, for example from Electrolux. Ronnie Leten is a skilled businessman, technically savvy and strategically versatile and he has significant experience from digitalization of major operations, which the Nomination Committee believes will be beneficial for Ericsson’s focused work together with its customers. Kurt Jofs has deep knowledge of and background from the telecom and IT-industry, for example from his experiences as Head of Ericsson Networks between 2003 and 2008 and as Board Chairman of Tieto. It is the Nomination Committee’s assessment that the proposed Board members, with their respective experiences, will add valuable expertise and experience to the Board. With these changes, the Nomination Committee believes that the company is given the right conditions for realizing its long-term potential. Out of the proposed Board members to be elected by the Annual General Meeting of shareholders (excluding the President and CEO) 33% are women. Information regarding proposed Board members Information regarding the proposed Board members is presented in Exhibit 2 to the Nomination Committee’s proposal. Information on proposed new Board members +------------------------------------------------------------------------------+|Kurt Jofs ||Born 1958. Master of Science in Engineering, Royal Institute of Technology, ||Stockholm, Sweden. ||Nationality: Sweden ||Board Chairman: Tieto Corporation and Vesper Group. ||Board Member: FEAL AB, Höganäs AB and Silver Resorts AB. ||Holdings in Ericsson: None*. ||Principal work experience and other information: Entrepreneur and investor ||with extensive experience in various industries. Previous positions include ||Executive Vice President and responsible for Ericsson’s Networks business 2003||-2008, CEO of Segerström & Svensson 1999-2001, CEO of Linjebuss 1996-1999, and||various positions within ABB and Ericsson. ||Ronnie Leten ||Born 1956. Master of Science in Applied Economics, University of Hasselt, ||Belgium. ||Nationality: Belgium ||Board Chairman: AB Electrolux (resigning in connection with the AB Electrolux ||Annual General Meeting 2018) ||Board Member:  AB SKF ||Holdings in Ericsson: 55,620 Class B shares*. ||Principal work experience and other information: President and CEO of Atlas ||Copco AB 2009-2017 and various leadership positions within the Atlas Copco ||Group 1997-2009 and 1985-1995. Previous positions include plant manager of ||Tenneco Automotive Inc, Belgium, 1995-1997 and various positions within ||General Biscuits 1979-1985. Chairman of the Board of Epiroc AB. ||* The holdings in Ericsson are as of the date of the notice convening the ||Annual General Meeting and includes holdings by related persons as well as ||holdings of ADS, if applicable.   |+------------------------------------------------------------------------------+ Independence of Board members The Nomination Committee has made the following assessments in terms of applicable Swedish independence requirements: (i)         The Nomination Committee considers that at least the following Board members are independent of the Company and its senior management: ads. Jon Fredrik Baksaasadt. Jan Carlsonadu. Nora Denzeladv. Eric A. Elzvikadw. Kurt Jofsadx. Ronnie Letenady. Kristin S. Rinneadz. Helena Stjernholmaea. Jacob Wallenberg (ii)        From among the Board members reported in (i) above, the Nomination Committee considers that at least the following are independent of the Company’s major shareholders: ads. Jon Fredrik Baksaasadt. Jan Carlsonadu. Nora Denzeladv. Eric A. Elzvikadw. Kurt Jofsadx. Kristin S. Rinne Moreover, the Nomination Committee considers that at least the following Board members are independent in respect of all applicable independence requirements: ads. Jon Fredrik Baksaasadt. Jan Carlsonadu. Nora Denzeladv. Eric A. Elzvikadw. Kurt Jofsadx. Kristin S. Rinne Item 12 Election of the Chairman of the Board The Nomination Committee proposes that Ronnie Leten be elected Chairman of the Board (new election). Item 13 Number of auditors According to the articles of association, the company shall have no less than one and no more than three registered public accounting firms as auditor. The Nomination Committee proposes that the company should have one registered public accounting firm as auditor. Item 14 Fees payable to the auditor The Nomination Committee proposes, like previous years, that the auditor fees be paid against approved account. Item 15 Election of auditor In accordance with the recommendation of the Audit Committee, the Nomination Committee proposes that PricewaterhouseCoopers AB be appointed auditor for the period as of the end of the Annual General Meeting 2018 until the end of the Annual General Meeting 2019 (re-election). Item 16 Guidelines for remuneration to Group Management The Board of Directors proposes that the Annual General Meeting resolve on the following guidelines for remuneration to Group Management for the period up to the 2019 Annual General Meeting. Compared to the guidelines resolved by the 2017 Annual General Meeting, it has been added that the mutual notice period can be increased to a maximum of 12 months on a case by case basis, with the condition that in all circumstances, fixed salary during the notice period plus any severance pay payable in total will not exceed an amount equivalent to the individual’s 24 months fixed salary. Information on estimated costs for variable remuneration is appended to the proposal. Guidelines for remuneration to Group Management For Group Management consisting of the Executive Team, including the President and CEO, total remuneration consists of fixed salary, short- and long-term variable compensation, pension and other benefits. The following guidelines apply for the remuneration of the Executive Team: · Variable compensation is in cash and stock-based programs, awarded against specific business targets derived from the long-term business plan approved by the Board of Directors. Targets may include share-price related or financial targets at either Group or unit level, operational targets, employee engagement targets or customer satisfaction targets. · All benefits, including pension benefits, follow the competitive practice in the home country taking total compensation into account. · By way of exception, additional arrangements can be made when deemed necessary. An additional arrangement can be renewed but each such arrangement shall be limited in time and shall not exceed a period of 36 months and twice the remuneration that the individual would have received had no additional arrangement been made. · The standard mutual notice period is no more than six months. Upon termination of employment by the Company, severance pay amounting to a maximum of 18 months fixed salary is paid. Notice of termination given by the employee due to significant structural changes, or other events that in a determining manner affect the content of work or the condition for the position, is equated with notice of termination served by the Company. · On a case to case basis, the mutual notice period can be increased to no more than 12 months in which case there will be a corresponding reduction in severance pay (where applicable). In all circumstances, fixed salary during the notice period plus any severance pay payable will not together exceed an amount equivalent to the individual’s 24 months fixed salary. +-----------------------------------------------------------------------------+|Appendix to proposal on guidelines for remuneration to Group Management ||Details of our Remuneration Policy and how we deliver on our policy and ||guidelines, including information on previously decided long term variable ||compensation that has not yet become due for payment, can be found in the ||Remuneration Report and in Note C28, “Information regarding Members of the ||Board of Directors, the Group Management and Employees” in the annual report ||2017. ||With the current composition of the Executive Team, the Company’s cost during||2018 for variable remuneration to the Executive Team can, at a constant share||price, be estimated to amount to between 0 and 360 percent of the aggregate ||fixed salary cost, all excluding social security costs. |+-----------------------------------------------------------------------------+ Item 17 Implementation of Long-Term Variable Compensation Program 2018 (“LTV 2018”) Following its continuous evaluation of the company’s long-term variable compensation, the Board of Directors has concluded to propose LTV 2018. LTV 2018 is an integral part of the Company's remuneration strategy, in particular the Board of Directors wishes to encourage the leadership to build significant equity holdings to align the interests of the LTV Program participants with those of shareholders. While LTV 2017 only included three-year targets relating to total shareholder return (TSR[1] ), the targets for LTV 2018 have been developed to also include a one-year Group Operating Income target for 2018 to support achieving the Company’s 2020 targets as communicated at the Capital Markets Day on 8 November 2017. All targets have a three-year vesting period. Proposals The Long-Term Variable Compensation Program 2018 The Board of Directors proposes that the Annual General Meeting resolve on the implementation of a Long-Term Variable Compensation Program 2018 in accordance with the proposals set out below. Implementation of the LTV 2018 The Board of Directors proposes that the Annual General Meeting resolves on the LTV 2018 for members of the Executive Team, comprising a maximum of 3 million shares of series B in Ericsson as set out below. Objectives of the LTV Program The LTV Program is designed to provide long-term incentives for members of the Executive Team (the “Participants”) and to incentivise the Company’s performance creating long-term value. The aim is to attract, retain and motivate executives in a competitive market through performance-based share related incentives and to encourage the build-up of significant equity holdings to align the interests of the Participants with those of shareholders. The LTV Program in brief The LTV Program is proposed to include all members (current and future) of the Executive Team, currently comprising of 14 employees, including the President and CEO. Awards under LTV 2018 will be granted free of charge entitling the participant, provided that i.a. certain performance conditions set out below are met, to receive a number of shares, free of charge, following expiration of the three-year vesting period (“Performance Share Awards”). Allotment of shares pursuant to Performance Share Awards will be subject to the achievement of performance conditions, as set out below, and will generally require that the Participant retains his or her employment over a period of three years from the date of grant (the “Vesting Period”). All major decisions relating to LTV 2018 will be taken by the Remuneration Committee, with approval by the full Board of Directors as required. Granting of Performance Share Awards Granting of Performance Share Awards to the Participants will generally take place as soon as practicably possible following the Annual General Meeting 2018. For 2018, the value of the underlying shares in respect of the Performance Share Award made to the President & CEO will not exceed 180% of the annual base salary at the time of grant, and for other participants, the value will not exceed 70% of the participants’ respective annual base salaries at the time of grant. In 2018, the maximum value of the underlying shares in respect of the Performance Share Award made to Executive Team members other than the President & CEO is proposed to be increased from 22,5% to a maximum of 70% of the participants’ respective annual base salaries at the time of grant. This is proposed to be done by way of transferring some part of the short-term variable compensation opportunity to long-term variable compensation following the principle of total remuneration to remain unchanged. The intention is to increase the long-term focus and alignment with the long-term expectations of the shareholders. The share price used to calculate the number of shares to which the Performance Share Award entitles will be the volume-weighted average of the market price of Ericsson B shares on Nasdaq Stockholm during the five trading days immediately following the publication of the Company’s interim report for the first quarter 2018. Performance criteria The vesting of Performance Share Awards will be subject to the satisfaction of challenging performance criteria related to 2018 Group Operating Income target and TSR, which will determine what portion (if any) of the Performance Share Awards will vest at the end of the Vesting Period. The 2018 Group Operating Income target relates to 50% of the Performance Share Award and the maximum vesting level is 200%. The performance criteria based on TSR are absolute TSR development and relative TSR development for the Ericsson B share over the period January 1, 2018 - December 31, 2020 (the “TSR Performance Period”).[2]  The TSR performance criteria relate to a total of 50% of the Performance Share Award and the maximum vesting level for each of the TSR performance criteria is 200%. The following conditions will apply to the performance criteria: ·     2018 Group Operating Income target 50% of a Performance Share Award granted to a Participant will be subject to fulfilment of a Group Operating Income target for the 2018 financial year. The 2018 Group Operating Income target established by the Board of Directors will stipulate a minimum level and a maximum level. The vesting level of Performance Share Awards related to 2018 Group Operating Income will be determined by the Board of Directors when the audited result for the financial year 2018 is available. If the maximum performance level is reached or exceeded, the vesting will amount to (and will not exceed) the maximum level of 200% of the Performance Share Award related to the 2018 Group Operating Income target. If performance is below the maximum level but exceeds the minimum level, a linear pro-rata vesting of shares will occur. No vesting will occur if performance amounts to or is below the minimum level. The allotment of the shares will not occur until the end of the Vesting Period in 2021. · TSR performance Absolute TSR performance 30% of a Performance Share Award granted to a Participant will be subject to fulfilment of an absolute TSR performance requirement over the TSR Performance Period. If the absolute TSR development reaches or exceeds 14% per annum compounded, the maximum vesting of 200% of the Performance Share Award related to absolute TSR shall occur. If the absolute TSR development is below or reaches only 6% per annum compounded, no vesting will occur in respect of the Performance Share Award related to the absolute TSR. A linear pro-rata vesting from 0% to 200% of the Performance Share Award related to absolute TSR shall apply if the Company’s absolute TSR performance is between 6% and 14% per annum compounded. Relative TSR performance 20% of a Performance Share Award granted to a Participant will be subject to fulfilment of a relative TSR performance requirement over the TSR Performance Period, compared to a peer group consisting of 12 peer companies (the “Peer Group”)[3] . The vesting of the relative TSR related Performance Share Award varies depending on the Company’s TSR performance ranking versus the other companies in the Peer Group. If the Company’s relative TSR performance is below the TSR development of the company ranked 7th in the Peer Group, no vesting will occur in respect of the Performance Share Award related to relative TSR performance. Vesting of the Performance Share Award related to relative TSR performance will occur at the following percentage levels, based on which ranking position in the Peer Group the Company’s TSR Performance corresponds to: Position within the Peer Group                     Associated vesting percentage level 7 or lower                                                                                 0% 6                                                                                             40% 5                                                                                             80% 4                                                                                             120% 3                                                                                             160% 2 or higher                                                                                200%If the Company’s TSR performance is between two of the ranked companies, a linear pro-rata vesting shall apply between the vesting percentage levels for the relevant ranked positions. Information about the outcome of the performance criteria will be provided not later than in the annual report for the financial year 2020. Allotment of shares Provided that the performance critera above have been met and that the Participant has retained his or her employment (unless special circumstances are at hand) during the Vesting Period, allotment of vested shares will take place as soon as practicably possible following the expiration of the Vesting Period. When determining the final vesting level of Performance Share Awards, the Board of Directors shall examine whether the vesting level is reasonable con­sidering the Company’s financial results and position, conditions on the stock market and other circumstances, and if not, as determined by the Board of Directors, reduce the vesting level to the lower level deemed appropriate by the Board of Directors. In the event delivery of shares to Participants cannot take place under applicable law or at a reasonable cost and employing reasonable administrative measures, the Board of Directors will be entitled to decide that Participants may, instead, be offered a cash settlement. Financing The Board of Directors does not currently propose any method for securing the undertakings under the LTV 2018. Delivery of Performance Shares in accordance with the terms of the LTV 2018 will take place in 2021. Costs The total effect on the income statement of the LTV 2018, including financing costs and social security fees, is estimated to range between SEK 55 million and SEK 131 million distributed over the years 2018-2021. Dilution The Company has approximately 3.3 billion shares in issue. As per December 31, 2017, the Company held approximately 50.3 million shares in treasury. The number of shares that may be required for ongoing long-term variable compensation programs as per December 31, 2017 is estimated to approximately 45 million shares, corresponding to approximately 1.4 percent of the number of outstanding shares. In order to implement LTV 2018, a total of up to 3 million shares are required, which corresponds to approximately 0.1 percent of the total number of outstanding shares. The effect on important key figures is only marginal. Majority rules The resolution of the Annual General Meeting on implementation of the program requires that more than half of the votes cast at the Annual General Meeting approve the proposal. Description of ongoing variable compensation programs The Company's ongoing variable compensation programs are described in detail in the Annual Report 2017 in the note to the Consolidated Financial Statements, Note C28 and on the Company's website. The Remuneration Report published in the Annual Report outlines how the Company implements its guidelines on remuneration to Group management in line with the Swedish Corporate Governance Code. Item 18 The Board of Directors’ proposal for resolution on transfer of treasury stock in relation to the resolutions on the Long-Term Variable Compensation Programs 2014, 2015, 2016 and 2017 Background The Annual General Meetings 2014, 2015, 2016 and 2017 resolved on a right for the Company to transfer in total not more than 15,000,000 shares of series B in the Company on a stock exchange to cover certain payments, mainly social security charges, which may occur in relation to the Long-Term Variable Compensation Programs 2014, 2015, 2016 and 2017. Each resolution has only been valid up to the following Annual General Meeting. Resolutions on transfer of treasury stock for the purpose of the above mentioned programs have therefore been repeated at the subsequent Annual General Meeting. In accordance with the resolutions on transfer of in total not more than 15,000,000 shares, 436,100 shares of series B have been transferred up to February 20, 2018. Proposal The Board of Directors proposes that the Annual General Meeting resolve that the Company shall have the right to transfer, prior to the Annual General Meeting 2019, not more than 14,563,900 shares of series B in the Company, or the lower number of shares of series B, which as per March 28, 2018 remains of the original 15,000,000 shares, for the purpose of covering certain payments, primarily social security charges that may occur in relation to the Long-Term Variable Compensation Programs 2014, 2015, 2016 and 2017. Transfer of shares shall be effected on Nasdaq Stockholm at a price within the, at each time, prevailing price interval for the share. Majority rules The resolution of the Annual General Meeting on a transfer of treasury stock requires that shareholders holding at least two-thirds of the votes cast as well as the shares represented at the Annual General Meeting vote in favor of the proposal. ______________________ Shares and votes There are in total 3,334,151,735 shares in the Company; 261,755,983 shares of series A and 3,072,395,752 shares of series B, corresponding to in total 568,995,558.2 votes. The Company’s holding of treasury stock amounts to 47,386,842 shares of series B, corresponding to 4,738,684.2 votes. Information at the Annual General Meeting The Board of Directors and the President shall, if any shareholder so requests and the Board of Directors believes that it can be done without material harm to the Company, provide information regarding circumstances that may affect the assessment of an item on the agenda and circumstances that can affect the assessment of the Company’s or its subsidiaries’ financial situation and the Company’s relation to other companies within the Group. Documents The complete proposals of the Nomination Committee with respect to Items 1 and 9 – 15 above, including a description of the work of the Nomination Committee before the Annual General Meeting and Exhibit 1 and 2 to the Nomination Committee’s proposals, and the shareholder letters (in original language) under items 19 and 20, are available at the Company’s website www.ericsson.com. The documents will be sent upon request to shareholders providing their address to the company. In respect of all other items, complete proposals are provided under the respective item in the invitation. The Annual Report and the Auditor’s Report as well as the Auditor’s statement regarding the guidelines for remuneration to Group management will be made available at the Company and posted on the Company’s website www.ericsson.com no later than three weeks prior to the Annual General Meeting. The documents will be sent upon request to shareholders providing their address to the company. Stockholm, February 2018 The Board of Directors  ---------------------------------------------------------------------- [1]  Total shareholder return, i.e. share price growth including dividends.  [2]  To provide a stable assessment of performance, the TSR development will be calculated based on the average closing price of the Ericsson B share on Nasdaq Stockholm (or the corresponding closing share price of the relevant peer group company) for the three-month period immediately prior to the commencement and expiration of the Performance Period.  [3]  The Peer Group consists of the following companies: Cap Gemini, CGI Group, Cisco Systems, Cognizant, Corning, F5 Networks, Harris, International Business Machines, Juniper Networks, Motorola Solutions, Nokia, and Qualcomm. TSR will be measured in Swedish Krona (SEK) for all companies in line with best practice. 

Minesto raises SEK 72.5m in Rights Issue

“We have now secured funds to carry out crucial value-creating activities in the coming year, including demonstration of our unique Deep Green technology in Utility Scale in Wales. The strategy of product range enhancements together with site and market development in the EU and Taiwan is firm and will be funded by the now acquired equity together with existing and new public funding”, said Dr Martin Edlund, CEO of Minesto. This is a summary of the regulatory press release issued in Swedish by Minesto AB on the 21st of February 2018 at 08:30 CET, available via this link . For additional information please contact: Magnus MatssonCommunications Manager, Minesto AB+46 70 570 75 08press@minesto.com About Minesto Minesto is a marine energy technology company with the mission to minimise the global carbon footprint of the energy industry by enabling commercial power production from the ocean. Minesto’s award winning and patented product, Deep Green, is the only verified marine power plant that operates cost efficiently in areas with low-flow tidal streams and ocean currents. In May 2015, Minesto secured a €13m investment from the European Regional Development Fund through the Welsh European Funding Office, for the commercial rollout of Deep Green. Minesto was founded in 2007 and has offices in Gothenburg, Sweden, Holyhead, Wales and Portaferry, Northern Ireland. The major shareholders in Minesto are BGA Invest and Midroc New Technology. The Minesto share (MINEST) is traded on the Nasdaq First North Stockholm stock exchange, with G&W Fondkommission as Certified Adviser. Read more about Minesto at www.minesto.com Press images and other media material is available for download via bit.ly/minestomedia.

Year-end Report, January – December 2017 Coor Service Management Holding AB

Fourth quarter of 2017 · Net sales increased by 8 percent in the fourth quarter to SEK 2,112 (1,956) million. Organic growth was 9 percent. · Adjusted EBITA increased by 3 percent to SEK 125 (122) million. The operating margin was 5.9 (6,2) percent. · EBIT was SEK 71 (73) million. Profit after tax was SEK 48 (49) million. · Earnings per share were SEK 0.5 (0.5). · Operating cash flow was SEK 306 (214) million. · The Board of Directors proposes a dividend for 2017 of SEK 4.00 (3.00) per share, of which SEK 1.80 (1.55) is ordinary and SEK 2.20 (1.45) extra dividend. Full year 2017 · Net sales for the full year 2017 increased by 6 percent, to SEK 7,722 (7,272) million. Organic growth was also 6 percent. · Adjusted EBITA increased by 7 percent to SEK 468 (435) million. The operating margin increased to 6.1 (6.0) percent. · EBIT was SEK 268 (242) million. Profit after tax was SEK 188 (123) million. · Earnings per share were SEK 2.0 (1.3). · Operating cash flow was SEK 492 (414) million. "Growth and a strong cash flow create opportunities for both value-enhancing acquisitions and increased dividends."Mikael Stöhr, President and CEO of Coor +-------------------------+------+------+------+------+|GROUP EARNINGS SUMMARY * | Oct - Dec | Jan - Dec |+-------------------------+------+------+------+------+|(SEK million) | 2017| 2016| 2017| 2016|+-------------------------+------+------+------+------+|Net sales  |2,112 |1,956 |7,722 |7,272 |+-------------------------+------+------+------+------+|Organic growth, %  | 9 | -1 | 6 | 3 |+-------------------------+------+------+------+------+|Adjusted EBITA  | 125 | 122 | 468 | 435 |+-------------------------+------+------+------+------+|Adjusted EBITA-margin, % | 5.9 | 6.2 | 6.1 | 6.0 |+-------------------------+------+------+------+------+|EBIT  | 71 | 73 | 268 | 242 |+-------------------------+------+------+------+------+|Income for the period  | 48 | 49 | 188 | 123 |+-------------------------+------+------+------+------+|Operating cash flow  | 306 | 214 | 492 | 414 |+-------------------------+------+------+------+------+|Earnings per share, SEK  | 0.5 | 0.5 | 2.0 | 1.3 |+-------------------------+------+------+------+------+ * The report refers to the continuing operation of the Group following the sale of the damage services business. See page 23 for definitions and calculations of key performance indicators. Non-recurring items are presented in Note 3.Invitation to press and analyst presentationOn 22 February, at 9 a.m. CET, the company’s President and CEO together with the CFO will give a presentation on developments in the fourth quarter in a webcast.To participate in the webcast, please register in advance of the meeting using the following link: http://edge.media-server.com/m/p/y7wwfar7. To listen to the presentation via telephone, dial +46856642509 (Sweden), +4723500253 (Norway), +4582333178 (Denmark), +358981710491(Finland) or +442030089808 (UK).The briefing material and a recording of the webcast will be published on the company’s website www.coor.com under the tab Investors/Reports-and-presentations, after the presentation.Annual General Meeting 2018The Annual General Meeting will be held on 26 April, at 15:00 p.m., at the Kista Entré conference centre, Knarrarnäsgatan 7, Kista, Sweden. Information on how to register along with the notice of AGM and other information will be available on the company’s website from 20 March.Financial calendar 2018 Interim report   January – March 2018         26 April 2018Interim report   January – June 2018           18 July 2018Interim report   January – September 2018            24 October 2018Interim report   January – December 2018 21 February 2019 The Annual Report 2017 will be published on the company’s website in week 14 of 2018.More information and contactFor questions concerning the financial report, please contact Olof Stålnacke, CFO and IR Manager (+46 10 559 59 20, olof.stalnacke@coor.com). For other questions concerning the operations or the company, please contact CEO Mikael Stöhr  (+46 10 559 59 35, mikael.stohr@coor.com) or Communications Director Magdalena Öhrn  (+46 10 559 55 19, magdalena.ohrn@coor.com). IR Coordinator: Sara Marin (+46 10 559 59 51, sara.marin@coor.com). More information is also available on our website: www.coor.com.This information is such that Coor Service Management Holding AB (publ) is obliged to publish in accordance with the EU market abuse regulation. This information was submitted through the efforts of the above-mentioned contact persons for publication on 22 February, 2018, at 7:30 a.m. CET.  Coor is a leading provider of facility management services in the Nordics, focusing on integrated and complex service undertakings (IFM). Coor offers specialist expertise in workplace services (soft FM), property services (hard FM) and strategic advisory services for development of customers’ service activities. Coor creates value by executing, leading, developing and streamlining its customers’ service activities, ensuring that they provide optimal support to the core business over time. Coor’s customer base includes many large and small companies and public-sector organisations across the Nordic region, including ABB, AB Volvo, Aibel, Det Norske Veritas, E.ON, Ericsson, EY, NCC, Politiet (Danish Police), Saab, Sandvik, SAS, Statoil, Telia Company, Swedish Transport Administration, Vasakronan and Volvo Cars.Coor was founded in 1998 and is listed on Nasdaq Stockholm since 2015. Coor takes responsibility for the operations it conducts, in relation to its customers, employees and shareholders, as well as for its wider impact on society and the environment. Read more at www.coor.com

Sobi™ publishes its report for the fourth quarter and full-year 2017

Swedish Orphan Biovitrum AB (publ)  (Sobi™) today announces its results for the fourth quarter and full-year 2017. Total revenues for the full-year amounted to SEK 6,511 M, an increase of 25 per cent. Revenues for the quarter were SEK 1,875 M, an increase of 45 per cent. Product sales for the full-year amounted to SEK 5,917 M, an increase of 30 per cent, and for the quarter SEK 1,746 M, an increase of 53 per cent. Business highlights Q4 2017 · Continued strong growth driven by successful launches of Elocta® and Alprolix® · Alprolix approved in Saudi Arabia · First patients enrolled in the ReITIrate study to evaluate immune tolerance induction with Elocta · Initiated phase 1/2 trial for rFVIIIFc-VWF-XTEN (BIVV001) in haemophilia A · Double-digit growth for Kineret® and Orfadin® · Orfadin oral suspension formulation approved in Canada · First patient randomised in the anaSTILLs study to evaluate Kineret as potential treatment for Still’s disease Financial summary Q4 2017 (Q4 2016) · Total revenues were SEK 1,875 M (1,292), an increase of 45 per cent (50 per cent at CER) · Product revenues were SEK 1,746 M (1,144), an increase of 53 per cent (58 per cent at CER) · Gross margin was 71 per cent (67) · EBITA rose 195 per cent to SEK 619 M (210) · Earnings per share of SEK 1.33 (0.27) Financial summary FY 2017 (FY 2016) · Total revenues were SEK 6,511 M (5,204), an increase of 25 per cent (24 per cent at CER). Adjusted for one-time credits in 2016, the increase was 45 per cent · Product revenues were SEK 5,917 M (4,548), an increase of 30 per cent (29 per cent at CER) · Gross margin was 72 per cent (70) · EBITA of SEK 2,053 M (1,543) · Cash position of SEK 1,478 M (786) at year-end · Repaid bank loan of SEK 500 M · Earnings per share of SEK 4.27 (2.99) · The Board of Directors proposes that no dividend be paid for the 2017 financial year. Outlook 2018(1)Sobi expects total revenues for the full-year to be in the range of SEK 7,500 – 7,700 M.The gross margin is expected to be at least 70 per cent.Sobi expects EBITA for the full-year to be in the range of SEK 2,500 – 2,700 M. (1)At current exchange rates (CER). Guido Oelkers, CEO:“2017 was an outstanding year for Sobi. We delivered and exceeded expectations. Our Haemophilia franchise continues to grow rapidly. During the year, we established our new business area Specialty Care which we expect to be a strong contributor to future growth. We also made advancements in our pipeline portfolio, initiating several clinical studies.” Financialsummary Q4 Q4 Full Full -year -yearAmounts in SEK 2017 2016 Change 2017 2016 ChangeMTotal 1,875 1,292 45% 6,511 5,204 25%revenues(1)Gross 1,337 860 56% 4,657 3,651 28%profit(2)Gross margin 71% 67% 72% 70%EBITA 619 210 195% 2,053 1,543 33%EBIT 509 100 410% 1,600 1,133 41%(Operatingprofit/loss)Profit for the 357 73 387% 1,149 802 43%period(1)Full-year2016 revenuesinclude a one-time creditof SEK 322 Mreceived in Q1relating tothe firstcommercialsales ofElocta, and aone-timecredit of SEK386 M receivedin Q2 relatingto the firstcommercialsales ofAlprolix.(2)Full-year2017 includesa one-timeinventoryadjustment ofSEK 59 M in Q1due to delayedrelease ofKineret drugsubstancemanufacturedin 2016. Telephone conference Financial analysts and media are invited to participate in a telephone conference, which will include a presentation of the results, today at 14:00 CET. The event will be hosted by Sobi’s CEO and President, Guido Oelkers, and the presentation will be held in English. The presentation can be followed live, or afterwards on www.sobi.com. Slides used in the presentation will be made available on Sobi’s website prior to the telephone conference. To participate in the telephone conference, please call:SE: +46 8 566 426 94UK: +44 203 008 9809US: +1 855 831 5948 Click here to go to the live event. (The recording will be made available via the audience URL within three hours after the live broadcast.)   Sobi's report for the fourth quarter and full year 2017 can be found here. About Sobi™Sobi™ is an international speciality healthcare company dedicated to rare diseases. Our vision is to be recognised as a global leader in providing access to innovative treatments that make a significant difference for individuals with rare diseases.The product portfolio is primarily focused on treatments in Haemophilia and Specialty Care. Partnering in the development and commercialisation of products in specialty care is a key element of our strategy. Sobi has pioneered in biotechnology with world-class capabilities in protein biochemistry and biologics manufacturing. In 2017, Sobi had total revenues of SEK 6.5 billion and approximately 850 employees. The share (STO:SOBI) is listed on Nasdaq Stockholm. More information is available at www.sobi.com. ---For more information please contact  Media relations Investor relationsLinda Holmström, Senior Jörgen Winroth, ViceCommunications Manager President, Head of Investor Relations+46 70 873 40 95 +1 347 224 0819, +1 212 579 0506linda.holmstrom@sobi.com  jorgen.winroth@sobi.com  This information is information that Swedish Orphan Biovitrum AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of Linda Holmström, Senior Communications Manager, at 08:00 CET on 22 February 2018. 

Ayima Year End Report, January to December 2017

Key points for Full Year 2017 · Total revenue amounted to 129.6 MSEK (121.2) an increase of 7% from the same period in 2016. In GBP, the increase  was  12% however exchange rate fluctuations resulted in a variance when converted to SEK · Profit after tax amounted to -10.7 MSEK (7.0) · Gross Profit amounted to 68.8 MSEK, a decrease of 10% from the same period in 2016 · Operating expenses excluding depreciation amounted to 83.9 MSEK, an increase of 20% from the same period in 2016. · Balance Sheet assets amounted to 73.0 MSEK (41.1) · Cash flow from operating activities amounted to -14.6 MSEK. Net cash decreased by 0.6 MSEK in the period to 0.9 MSEK · Earnings per share was -2.0 SEK (1.3) in the period Key Points for Q4 · Total revenue amounted to 34.7 MSEK (28.4) an increase of 22% from the same period in 2016. In GBP the increase was 31%. · Profit after tax amounted to 2.5 MSEK (-0.6) · Gross Profit amounted to 21.2 MSEK (16.6), an increase of 28% from the same period in 2016 · Operating expenses excluding depreciation amounted to 24.1 MSEK (18.4), an increase of 31%. · Earnings per share was 0.5 SEK (0.0) in the period For further Information:CEO/VD Michael Jacobson+44-20 7148 5974press(at)ayima.comwww.ayima.com About Ayima  Originally founded in 2007, Ayima is a digital marketing agency with around 145 employees across its offices in London, Stockholm, New York, San Francisco and Vancouver. Ayima have created a number of market-leading software tools that are used in by clients and agencies around the world, including ‘Updatable’, ‘Redirect Path’, ‘Page Insights’, ‘Pulse’ and ‘Appotate’. This information is insider information that Ayima Group AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on February 22, 2017. 

Advantech SOM-5871 New Quad Display Solution with AMD RyzenTM Embedded V1000 Processors

Feb. 22th, 2018, Germany- Advantech, a leading embedded computing solution provider, today detailed its forthcoming roll-out plan for its new high-performance computing and graphics module solution, SOM-5871, prior to the opening of Embedded World 2018. SOM-5871 is equipped with the latest and first 14nm AMD RyzenTM Embedded V1000 Processor (12-54W TDP) with up to four cores and eight threads. The AMD “Zen” core micro-architecture on the new COM Express (PICMG COM.0) R3.0 Type 6 basic module provides high computing power, and advanced graphics performance. With the integration of the AMD Ryzen Embedded V1000, the SOM-5871 can offer an ideal balance of superior performance and low power consumption for Advantech customers.  Designed for High Graphic Performance Requirements SOM-5871 uses up to 32GB of dual channel DDR4 3200 MT/s memory (both ECC and non-ECC) with higher memory bandwidth for better performance and efficiency. The new COM Express Basic module supports quad independent displays with VGA, LVDS, eDP, DisplayPort, HDMI, and HDR playback support. VP9 decode and H.265 (HEVC) hardware decode and encode[1]  as well as four 4K display outputs are supported by leveraging the AMD Ryzen Embedded V1000. The premium performance of the SOM-5871 drives 4K animation and content, and the second DisplayPort will be able to support up to 8K resolution. SOM-5871 is built for use in demanding applications such as casino gaming, arcade gaming, digital signage, medical, industrial control, automation, thin clients, and communications infrastructure fields. Optimized Solutions Extend Design Flexibility SOM-5871 adopts 10/100/1000 Mbps speeds Ethernet controller and flexible I/O interface options with: 1 x PCIex4, 3 x PCIex1 through a PCIe Bridge, 2 x SATA Gen. 3 @ 6.0Gb/s, 3 x USB 3.0, 8 x USB 2.0 via USB Hub, 2 x COM ports (2-Wire), TPM 2.0, CAN Bus function (optional support), watchdog timer, and GPIO to fulfill a wide variety of functions and high performance system extension requirements. And for better mechanical stability , SOM-5871 added an extra mounting hole design around the CPU for a stronger board structure that avoids board bending and improves thermal throughput to fulfill higher CPU TDP requirements. Software API for System Monitoring and Management Advantech iManager  provides a valuable suite of programmable APIs such as multi-level watchdog, hardware monitor, and other user-friendly interfaces. Since this is a built-in solution on chip, iManager ensures that functions operate even if the operating system fails, helping enhance system stability and compatibility, and reducing effort on carrier board design and platform migration. “With the AMD Ryzen Embedded V1000 processors integrated into the Advantech SOM-5871 New Quad Display Solution, we extend our longstanding partnership by enabling a new embedded module with stunning graphics capabilities,” said Stephen Turnbull, director of product marketing, Datacenter and Embedded Solutions Business Group, AMD. “This high-performance processor that integrates the CPU and GPU onto a single processor enables customers to develop products that not only support a premium visual interface with features such as four simultaneous 4K displays, but also helps to increase efficiency and scalability.” SOM-5871 will be available in Q2 2018. Please contact your local Advantech sales representative or visit the website for more details. http://www.advantech.eu SOM-5871 Features: · PICMG COM.0 R3.0 Type 6 pin-out basic module · AMD RyzenTM Embedded V1000 processor with AMD Radeon™ Vega graphics · Dual channel DDR4, max 32GB (Supports both ECC & non-ECC) · Supports Quad independent symmetrical displays · Supports up to 4 x 4K displays (2nd DisplayPort will be able to support up to 8K) · Multiple I/O Interfaces – 2 x SATA, 3 x USB3.0, 8 x USB2.0, 2 x COM, TPM 2.0, CAN Bus (Optional) · Supports iManager, WISE-PaaS/RMM and Embedded Software APIs ---------------------------------------------------------------------- [1]  HEVC (H.265), H.264, and VP9 acceleration are subject to and not operable without inclusion/installation of compatible HEVC players. GD-81